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ABSTRACT 
STUDY OF PHARMACEUTICAL CRYSTAL HYDRATES AND THEIR 
PREDICTION BASED ON PRE-NUCLEATION AGGREGATION 
It is well documented that hydrate formation is a constant problem in the 
pharmaceutical industry as its formation can reduce the drug’s aqueous solubility and 
may impact the overall stability and safety. Furthermore, the current technology used 
in the prediction and screening process demands time, money, effort, as well as some 
elements of serendipity, leaving hydrate formation largely unpredictable and a 
challenge. This study probes hydrate formation passively and actively. Passive 
investigation demands the crystalline hydrate form to be present prior to analysis, 
while the active probe does not. The use of common solid-state characterisation 
techniques in the passive analysis shows the complexity in the solid-state landscape of 
crystalline hydrate forms. Two different systems in the form of charged and neutral 
pharmaceutical compounds, namely sodium diatrizoate and tranilast (Chapter 3 and 4) 
best highlight the passive approach. The focus of the research then shifts to the 
development of an active hydrate prediction technology (Chapter 5) exploiting the 
principles of host-guest chemistry, titration techniques and binding constants to show 
the affinity of solute molecules to water in the pre-nucleation state for compounds 
forming stable hydrates. The novel active approach is further scrutinised in Chapter 6 
with the analysis of metastable and non-hydrate forming compounds, followed by a 
blind study to predict the hydrate-forming ability of several other compounds. In the 
final chapter, the potential usage of the developed prediction method is expanded to 
stable solvated crystal forms and protein binding affinity prediction. The usefulness of 
the developed method will grow with more compounds and systems analysed. In 
addition, analysis of more hydrate-forming compounds with different hydrate-forming 
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ability will further clarify, update and expand the current database. KEYWORDS: 
hydrate; prediction; binding constant; pre-nucleation state. 
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CHAPTER 1  
 GENERAL INTRODUCTION, THEORY, AND BACKGROUND 
1.1 Introduction 
1.1.1 Background, significance and problem with hydrate in pharmaceuticals 
Polymorphism is a phenomenon in which the same chemical compound 
exhibits different crystal structures,1 and the occurrence affects numerous fields 
especially the pharmaceutical industry. Initial interest towards polymorphism in 
pharmaceutical industry was low. Nevertheless, high profile litigation cases in the 90’s 
propelled the interest and since then, the phenomenon has been vastly studied.2 With 
a multibillion-pound industry at stake, pharmaceutical companies are doing as much 
as they can to unravel, control, and in some cases, take advantage of the seemingly 
unpredictable phenomenon.3 Thus, the problem is investigated from different angles 
in order to understand the forces at work. The pharmaceutical industry is heavily 
affected due to the definite use of solids in the production of pharmaceuticals.  
Solids can be classified into two major categories based on molecular packing 
which can be either amorphous or crystalline. According to IUCr, crystalline solid is 
any solid having three-dimensional lattice periodicity and essentially discrete 
diffraction pattern.4 In contrast, amorphous solids’ structural regularity is limited to 
the immediate neighbours of any particular molecule within the solid.5  
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While both solid forms are pharmaceutically relevant, the latter is more widely 
used in most active pharmaceutical ingredients (APIs) as well as excipients as they 
provide stability, ease of processing and handling, compared to other physical forms.6 
There are many areas of the unit operation in the pharmaceutical industry such as 
grinding, milling, heating, and compressing, or manufacturing conditions that include 
a solvent, like crystallisation, lyophilisation, wet granulation, coating process, or 
spray-drying,7 that provide environments or conditions that may contribute to the 
emergence of multiple forms of the crystalline solids like polymorphs, solvates or 
hydrates (Figure 1.1). 
 
Figure 1.1 Solid as one of the three classical classifications for states of matter, along with its sub-classification. 
Crystalline form and its division is also highlighted. 
The vast arrays of crystalline forms can be a double-edged sword. Sudden 
emergence of an unexpected crystalline form is a massive problem to a pharmaceutical 
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company, e.g. in the case of antiretroviral drug ritonavir, which led to the removal and 
subsequent relaunch of the drug.8,9 On the positive side, the multitude option of 
crystalline forms allows drug developers and manufacturers advantage over patent 
length. In addition, modifications to crystalline form, e.g. solvent inclusion, salt 
formation, co-crystal formation which also allow tailoring of desired physical and 
chemical properties of a compound.   
Amongst all of the mentioned crystalline modifications (Figure 1.1), hydrate 
formation is deemed most problematic in the pharmaceutical industry primarily due to 
the crystalline form’s improved stability which led to it having lower solubility in 
water compared to its anhydrous form.10 The term hydrate is generally applied to 
crystals that have water as an integral part of the crystal lattice which is incorporated 
into the structure.11 It is the most frequently identified solvate within small organic 
drug molecules, with approximately a third of drug compound can form a hydrate.12 
The fact that water is ubiquitous means that pharmaceutical solids are inevitably 
exposed to water, intentionally or unintentionally, whether during processing, storage 
or even after production or sale, all of which could lead to hydrate formation.13,14 
Consistent and good aqueous solubility is crucial for pharmaceutical processing. 
During manufacturing, solubility differences between the anhydrate and hydrate forms 
can affect handling and processability of the compound. In addition, a sudden 
reduction in aqueous solubility due to hydrate formation will force modification to the 
processing of the compound, e.g. additional solvent usage or unit process, and can 
eventually lead to increase in manufacturing costs. Hydration of a drug compound is 
unavoidable as contact to water during the manufacturing process of a drug is 
extensive, due to the direct use or indirect exposure. For instance, in processes like 
lyophilisation,15 and wet granulation, the use of water and water containing materials, 
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e.g. excipients, that are capable of transferring water to the drug molecule could cause 
a hydrate to form.16 Furthermore, the potentially different habits between the anhydrate 
and hydrate form may impede the flowability, as well as affecting the particulate level 
properties.  
Moreover, crystalline hydrate formation may lead to increased rate of chemical 
degradation.17 This is because, bound water molecules can be mobile and migrate 
within the crystal lattice, or along the solid surface,18 resulting to water absorption.The 
presence of water enhances the drug molecular mobility, enhancing the chemical 
reactivity,19 and consequently leading to drug degradation. However, this is not true 
for all cases as the apparent chemical incompatibility between water and -lactams 
drugs, which are notoriusly known to be suseptible to hydrolysis of the lactam ring by 
water,20,21 is reduced through crystallisation or hydrate formation.22  
Hydrate formation can also occur after leaving the production facility. 
Hydration due to high relative humidity (RH) or direct contact with water, may occur 
during storage, in a retail setting, e.g. on shelves, or even after sales during application 
of the formulation by the patient, being swallowed with a glass of water or improper 
container closure. One such case of hydrate formation due to exposure to high RH 
conditions during storage is for the drug berberine chloride dihydrate, transforming 
into a tetrahydrate during storage at 75% RH.23 Similar cases were also reported for 
the drug dexmedetomidine hydrochloride 24 and droloxifene citrate 25 which exhibited 
similar conversion into their respective hydrate forms at high RH. The conditions in 
the gastrointestinal tract are more complicated and would present a bigger risk if a 
drug forms a hydrate in the biological environment. The bioavailability of the final 
drug product can be affected by the reduced solubility and dissolution rate. An example 
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where product changes after consumption is the conversion of carbamazepine 
anhydrate to hydrate as simulated in intestinal fluids.26 
All in all, unintentional hydrate formation at any point, represents a major 
problem and will cause poor repercussion towards the overall safety, manufacturing, 
performance and effectively hamper the final medicinal product’s full potential. 
Therefore, it is very important to identify any possible hydrate form(s) in the early 
phases of the drug development process. 
1.1.2 Hydrate classification 
Hydrate is generally classified based on the manner and amount (in moles) of 
water is released upon disassociating with the crystal, i.e. stoichiometric or non-
stoichiometric.6,10,27,28 A stoichiometric hydrate has well-defined water content and the 
incorporated water interact strongly with the host compound and each other. Upon 
dehydration, the absence of water molecule causes instability to the crystal network, 
which would collapse forming a new reduced water content crystal form or an 
amorphous state.29 The resultant anhydrous crystal form would also have a distinctly 
different crystal structure and pattern to that of the hydrate form. Also, the sorption 
isotherm (Figure 1.2 A) would show a step-shaped phase change which is measured 
by the mass change, following hydration/dehydration due to variation in relative 
humidity or water vapour pressure,28 as reported for nedocromil sodium hydrates, 
transitioning under isotherm from hemiheptahydrate to trihydrate to monohydrate with 
reducing RH, and to anhydrous form with subsequent heating.30  
In contrast, non-stoichiometric hydrates have a weak binding of water in crystal 
lattice channels.27 When exposed to high or low humidity; the crystal lattice may 
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undergo expansion or contraction resulting from changes in the dimensions of unit 
cells,6,28 which would translate into continuous sorption-desorption isotherm curve, 
with no step-like feature (Figure 1.2 B). Non-stoichiometric hydrates pose additional 
problems in dosage form development due to the unpredictability of water content.6 
One such case is the continuous changes in the crystal lattice of cromolyn sodium. 
Cromolyn sodium forms non-stoichiometric hydrates as the compound continuously 
liberates and absorbs water. The incessant variations of the lattice made cromolyn 
sodium physically variable, which complicates formulation and processing.31 A single 
compound may exist as both stoichiometric and non-stoichiometric hydrates as shown 
in the case of brucine, where the HyA is non-stoichiometric, while HyB and C are 
stoichiometric hydrates.32 Similar feature is observed in 3-(4-dibenzo[b,f][1,4]oxepin-
11-yl-piperazin-1-yl)-2,2 dimethylpropanoic acid (DB7), where Hy 2 is a 
stoichiometric hydrate and Hy A is non-stoichiometric.33  
 
Figure 1.2. Typical DVS sorption and desorption curve cycles for hypothetical compound A (A) and B (B) 
Hydrate can also be classified based on the structural aspects of the water 
positions in the crystal lattice.34 Water can be incorporated into the lattice via three 
methods: firstly, water molecules can be isolated from one another by parts of the host 
molecule (in cavities or chambers) within the crystal. 34 One such example is reported 
7 
 
on paroxetine hydrochloride as illustrated in Figure 1.3 (a).35 Another example of 
isolated hydrate form is Hy A of DB7 shown in Figure 1.3 (b).33 
a) b)  
Figure 1.3. a) Paroxetine hydrochloride form II packing showing void (brown) occupied by water;35 b) DB7 HyA 
packing showing void (yellow) occupied by water.33 
The second way of incorporation involves the interaction of water molecules 
with each other and their located in channels within the crystal, as in the case of 
sitagliptin L-tartrate hydrates (SLT).36 SLT was reported to exist as five hydrate forms, 
which include a tetrahydrate, and four other phases having 0.5 moles of water per 
molecule of SLT located. The channel feature is reported in Phase 1, 2, and 4 of the 
SLT hemihydrate forms (Figure 1.4). 
 
Figure 1.4. Packing motif of SLT phase 4 showing channel feature with water’s oxygen atoms represented in space-
fill style. Figure adapted from Tieger et al.36 
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Other examples of channel hydrate includes sitafloxacin hydrate,37 norfloxacin 
hydrate,38 Hy2 of DB7,33 as well as AMG 222 tosylate.39 Similar to the SLT hydrate 
behaviour, AMG 222 tosylate showed whereupon dehydration an isostructural 
dehydrate is formed, and the channels remain void and accessible to water for 
rehydration.  
Finally, oxygen atoms (in water molecules) can be attracted towards specific 
positive sites in the crystal such as cations (e.g. sodium or calcium) as in the case of 
diatrizoic acid (DA) monosodium40 and disodium salt.41 The DA monosodium hydrate 
form is the tetrahydrate, which showed four molecules of water coordinated to the 
sodium cation, two of which is shared with a second sodium cation form a second 
molecule. In the other hand, DA disodium is mixed a solvate with 8.5 molecules of 
water and one molecule of ethanol per molecule of salt, showing one water molecule 
coordinated to three sodium cations (Figure 1.5).  
 a) b)  
Figure 1.5. a) DA monosodium tetrahydrate showing sodium coordinated water molecule,40 while b) shows DA 
disodium salt, with water molecule coordinated to three different sodium cations.41 
There is also report of two types of water interaction in a single unit cell as in 
the case sulfadiazine calcium (hydrate I) where both channel-type and ion-coordinated 
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water present.42 The ratio of water molecules with to host molecules for hydrate are 
commonly denoted as numerical prefix of mainly Greek origin: Hemi – ½, Mono – 1, 
Sesqui - 1½, Di – 2, Tri – 3, Tetra – 4, Penta – 5, Hexa – 6, Hepta – 7, Octa – 8, Nona 
– 9, Deca – 10, Undeca – 11 and Dodeca – 12.43 
1.1.3 Water of crystalline hydrate interaction preference 
A recent study suggests that there is a preference towards the hydrogen bond 
patterns for the water molecules in organic crystalline hydrates.44 Report from crystal 
structure database (CSD) data analysis on the distribution pattern of the hydrogen-
bonded environment of the water molecules in hydrates reveals that, three (3) number 
of hydrogen bonds (NHB) per water molecule coordination is the most frequent motif 
with 2390 observations (accounting for 52%), out of 4616 molecules. Only about 1% 
of water molecules do not show any hydrogen bonds, signifying true ‘inclusion 
compounds’, filling in space between molecules. The report also identifies donor 
bonds OH…X as (D), while acceptor bonds O…HX as (A), and subsequently 
determine the most common environment based on these identifications. The two (2) 
donor-bonds and one (1) acceptor-bond, DDA 50%, is the most common 
configuration, followed by DDAA at 17%, DD at 14%, and DA at 7% (Figure 1.6). 
Although these observations account for water motif and orientation in the solid-state, 
any connection towards this preference in the solution-state would be interesting, 
hinting that the common feature/ prominent role of water feature exists earlier, as early 
as the pre-nucleation stage.  
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(a) (b) 
Figure 1.6 (a) Distribution of the total number of hydrogen bonds per water molecule and (b)Patterns of hydrogen 
bonds around water molecules as a frequency (%) for each observed environment44 
1.2 A view on Crystal Structure Prediction (CSP) 
The interest and technological advancement geared towards finding and 
predicting all possible form for a crystalline compound, especially hydrate is ever 
present and growing. The current experimental approach includes screening using 
solution crystallisation,45–47 liquid-assisted grinding (LAG)48, water slurry 
experiment,49–51 and etc., all of which require time, money and effort, as well as an 
element of serendipity. Therefore, the move towards hastening and automating the 
process is very tempting. Recently, the in-silico approach is slowly being extended to 
predict hydrate formation e.g. via computational and statistical models.52–57  
One such method is using crystal structure prediction (CSP), which works by 
simulating trial crystal structures of solids, which are then assessed based on their 
calculated energies. The computed crystal energy landscapes are now being used to 
aid polymorph screening of small molecule pharmaceuticals.55 A different 
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computational approach which uses of electrostatic potential as a reliable indicator to 
predict hydrogen bond formation, and potentially hydrate formation propensity, also 
faces problem as the approach is limited to specific compound only.58 Another 
computational method also aimed towards hydrate prediction is using conductor-like 
screening model for real solvents (COSMO-RS). COSMO-RS has been used for 
virtual screening of solvents for solid desolvation and co-formers for co-
crystallisation, but recently the use is extended towards virtual hydrate screening of 
organic molecules.59 The outcome however is not so positive as the chosen parameters 
provide a poor prediction of hydration propensities of pharmaceutical organic 
molecules.  
Most of the in-silico approaches faces a few hurdles, e.g. generalisations of 
hydrate formation remains implausible as each solid compound responds uniquely to 
the possible formation of hydrate,6 the inconsistent modelling of water,60 huge 
computing power and time consuming as calculation is limited to one stoichiometry 
of variable at a time in the asymmetric unit of the theoretical structure (e.g. co-crystals, 
salts or solvates/hydrates),55 and finally the computational approach also does not 
inform the crystallisation technique to obtain the calculated or predicted stable hydrate 
form. With regards to water models, though advances have been made,61 there is yet 
to exists a system that can accurately and adequately model all of water 
abnormalities.60 As it is, the perfect theoretical approach to lattice energy calculations 
still does not exist.62 In the end, the in silico approach still demands time, money, and 
effort, leaving hydrates formation largely unpredictable and remains a challenge in 
crystal engineering. 63 
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1.3 Hydrates and crystallisation theory  
The simplest way to prepare a hydrate is through re-crystallisation with water 
or from solvent mixture that contain water. Stable hydrates can also be formed by 
suspending the anhydrous form in water. From a purely thermodynamic point of view, 
crystallisation occurs when super-saturation, under-cooling or pressure causes the 
crystalline phase to be more stable than the corresponding solution or melt (Figure 
1.7).64  
 
Figure 1.7 Solubility curve and metastable zone plotted against temperature and concentration. The figure is 
adapted from Panagiotou and Fisher.65  
Fundamentally, there are two main processes in crystallisation, namely 
nucleation and growth.66 Nucleation is a first-order phase transition, during which 
particles are made from their constituents, ions, atoms, or molecules. The growth of 
these nuclei occurs because the flux of molecules attaching to the crystal surface 
exceeds the flux of molecules detaching from the surface which is true for 
crystallisation from the melt, solution or gas phase.66 Based on Gibbs free energy 
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change (Equation 1.1), spontaneous crystallisation must have a negative ΔG value. 
The ΔH is the enthalpy change, in joule, ΔS is the entropy change, in joule per kelvin, 
T is Temperature in kelvin. 
(Equation 1.1) 
ΔG = ΔH – TΔS 
The crystalline phase presents less entropy or disorder than an amorphous solid 
which is unstructured or chaotic, so ΔS is negative. That means that the crystallisation 
process is enthalpy driven. Therefore, ΔH has to be negative and large enough to make 
up for the loss of entropy, in order to make the process spontaneous. 
 
Figure 1.8. The Gibbs free energy in relation to the radius of nuclei. The figure was adapted from three sources.67–
69 
Figure 1.8 illustrates the Gibbs free energy for crystallisation (ΔG) as a 
function of the radius of the nucleus or aggregate size (R), shown as a solid line. Dotted 
lines represent contributions of surface formation and bulk incorporation. R* and ΔG* 
represent the size of the critical nucleus and the activation free energy, i.e. the energy 
barrier for nucleation, respectively. At R < R*, only transient aggregates form and re-
dissolve. Since the energy barrier has yet been overcome, nucleation does not occur. 
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Upon exceeding the critical radius, crystal–liquid interfacial energy is lower than the 
activation energy, prompting the nucleus to grow in size spontaneously and become a 
crystal.68,70 Scientists have long referred to the classical nucleation theory framework 
to explain the nucleation kinetics of the transition from liquid to solid, or crystallisation 
and from gas to liquid, or condensation.71–74 Recently, the non-classical theory has 
been proposed for crystal formation.42–50  
 
1.3.1 Classic nucleation theory (CNT) vs non-classical theory 
Developed by Volmer, CNT is a model of first-order phase transition involving 
crystal nucleation from a supersaturated phase.71 With the continual refinement of the 
original idea over the decades, CNT has been widely referred to with regards to 
nucleation from aqueous solution. It assumes that the molecular structure of a nucleus 
is similar to that of the final crystal form,71–73 hence the crystals forms from solution 
in a single step transitioning from solution to solid with the initial formation of a crystal 
nucleus. CNT also assumes that the surface free energy of the nuclei according to this 
model will equal one of the crystal interfaces and that the size of the nuclei, i.e. radius 
for spherical nuclei, or the side length for cubic clusters, decreases smoothly as 
supersaturation increases.75 Nevertheless, some might argue that CNT cannot explain 
some phenomena like dense liquid phases 76,77 or (meta)stable clusters 78 associated 
with pre-nucleation intermediates and thus making CNT appear too simplified.79 
Therefore, all of the recent reports of the emergence of pre-nucleation aggregates as 
well as recent crystallisation kinetic studies have opened the possible alternative to the 
CNT dubbed the non-classical theory. Reports of stable solute species in a 
15 
 
homogeneous solution; like the pre-nucleation ion clusters forming in an 
undersaturated solution of dissolved biominerals seen in calcium carbonate, phosphate 
and oxalate,78 or the metastable (pseudo-)phases in protein crystallisation,80,81 suggest 
a two-step mechanism in crystallisation process contradicting the CNT. A recent report 
even proposes a variety of pathways with more than two steps proposed to crystal 
formation (Figure 1.9 (b)).82 One common theme is that a distinct separation between 
clusters is proposed; first being the stable dense phase, followed by the crystalline 
order. 83 The stable dense phase is simply identified as the pre-nucleation cluster 
(PNC).84  
a)      b)  
Figure 1.9.Crystallisation theories. a) Representation of CNT and non-classical theory85,86  b) Schematic showing 
the free energy variation for a variety of possible pathways for crystallisation from ions in solution *DOLLOP = 
Dynamically Ordered Liquid-Like Oxyanion Polymer *ACC = aggregating clusters amorphous/crystalline 82 
1.4 The relationship between solid and solution-state analysis  
Solution state analysis has been used to succesfully show intermolecular 
interaction reflective to the solid-state successfully. In 2004, Christopher Hunter and 
his team used proton (1H) NMR to probe crystal nucleation. They found that the 
structures of the aggregates formed by the two (2) compounds tested in solution are 
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similar to the structures of dimer motifs found in the crystalline material. The finding 
supports the notion that solution NMR experiments can be an experimental tool for 
probing the organisation of molecules in the solid state.87 In another recent report, the 
formation of mesostructure (structure or superstructure of intermediate size or 
complexity) during crystallisation of DL-valine was observed using Dynamic Light 
Scattering and Brownian microscopy. The mesostructure was found to be present in 
both undersaturated and supersaturated solutions below the temperature of 35 °C. 
Here, the authors showed the relationship between mesostructure size and the rate of 
nucleation, measured in the solution state.88  
More interestingly, in another report, also linking the use of solution state 
analysis to crystal nucleation, whereby here, a direct relationship between molecular 
self-association in solution and hydrogen bonded motifs in the subsequently 
crystallised tetrolic acid was reported. Although the actual process of molecular 
clustering is still unknown, the authors note that IR spectroscopy is an efficient tool to 
be used in indicating the formation of the fundamental growth units in the 
crystallisation event.89 In the experimental framework, they identified two major IR 
absorption bands corresponding to different hydrogen bonded motifs which are the –
C=O anti-symmetric stretch (1740–1660 cm-1) and the –OH…O– (960–875 cm-1) 
which characterises the carboxylic acid dimer. The author then emphasised the 
persistence or absence of the hydrogen-bonded motifs in the solutions. They also 
associate an unusually high peak –C=O at 1710 cm-1 in saturated and diluted dioxane 
to a major weakening of intermolecular hydrogen bonds, or the existence of 
monomeric solute species. 
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Another example of solution state analysis association to the solid state is 
through the report on ortho-methyl carbazolone (OCB).90 OCB has four polymorphs, 
with only form I showing catemer motif, while the dimer was observed in remaining 
three forms. The authors use FTIR titration to prove the existance of OCB dimers in 
solution through the observation of N–H vibration in solution. When the solution IR 
spectra were compared to the solid-state spectra of forms I–IV, they found comparable 
N–H vibration at 3300 cm-1 in solution to that of the three-dimer crystal forms, forms 
II, III, and IV showing N-H vibration at 3369 to 3366 cm-1, which corresponds to the 
said motif. The result again shows close relationship between the solution and solid-
state, which was observable via FTIR.  
1.5 Noncovalent interactions  
Noncovalent interactions play vital roles in chemical system, e.g. 
crystallisation, self-assembly91 as well as biological system, e.g.  DNA, RNA, and 
proteins synthesis.92,93 Noncovalent bond does not involve the sharing of electrons, but 
rather involves more dispersed variations of weak, reversible, inter- and intramolecular 
attractive forces which “holds” molecule together. Possible noncovalent interaction 
that could form in solution include van der Waals, dipole-dipole, hydrophobic bonds, 
hydrogen bonds and ionic bonds. The binding strength of these noncovalent interaction 
is illustrated in Figure 1.10, which typically lower compared to the energy for covalent, 
e.g. C– C or C–H bond. Variation of the mentioned noncovalent interactions involving 
molecules having benzene ring in their make-up is also possible which include π–π 
stacking interaction, polar–π interaction, CH–π interaction, cation–π interaction, 
aromatic CH–π, or T-shaped stacking interaction and π–π stacking interaction (Figure 
1.11). 
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Figure 1.10. Comparison of non-covalent interactions and their typical range of binding strength, in comparison 
to covalent bonds. The figure is adapted from Steed and Atwood.94 
  (a)  (b)   (c)   
(d)   (e)   (f)  (g)  (h)  
Figure 1.11. Selected illustration of noncovalent bond interactions, (a) ionic bond, (b) van der Walls, 
(c) hydrogen bond, (d) polar–π interaction, (e) CH–π interaction, (f) cation–π interaction, (g) aromatic 
CH–π, (h) π–π stacking interaction 
Among all the mentioned noncovalent interaction, hydrogen bonding is one of 
the stronger interaction (compared to van der Walls), and the most common ones. 
H Y
+ -
δ- 
δ 
δ- 
δ 
δ- 
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Hydrogen bonds ranges widely in strength from very strong (gas phase enthalpies of 
~40 kcal/mol, e.g. [F ··· HF]-) to weak (gas phase enthalpies of 1 – 5 kcal/mol, e.g. 
[HOH···OH2]), the latter (weak) are most prevalent in chemistry and biology. From 
an electronic standpoint, a “classic” hydrogen bond is simply an interaction between a 
partially positively charged hydrogen atom (denote as Hδ+, usually identified as proton 
donor), and a partially negatively charged atom in the acceptor molecule, (denote as 
Yδ-, in Figure 1.11 (c)), which have a lone pair in the vicinity of the H atom.
95  
However, it must be stressed that the effect of hydrogen bond formation to the 
electron density takes place not only in the immediate locality of the H and Y atoms 
but within entire molecules.96  Following a hydrogen bond, all atoms and bonds of the 
whole complex take part in the interactions as illustrated below Figure 1.12. 
 
Figure 1.12. Maps of two (2) water molecules (dimer), representing a donor (left) and acceptor (right), showing the regions of 
increased and decreased electron densities. Red indicates the loss of electron density while blue represent regions of electron 
density build-up. This figure was obtained from Scheiner and Kar.96 
1.5.1 Water interaction in solution 
Structurally, the water molecule has a tetrahedral distribution of two positively 
and two negatively charged regions as indicated in Figure 1.13. Therefore, we 
anticipate the following water-solute interactions. 
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Figure 1.13. Tetrahedral structure of water (downloaded from google free media repository) 
Firstly, on each negatively charged region, the water molecule interacts with 
its neighbours via a coordinate covalent (dative) bond, where one atom, e.g. the oxygen 
of water, contributes both of the electrons in the shared pair. Once formed, a coordinate 
covalent bond behaves in the same as any other covalent bond. The oxygen of the 
water molecule can also act as a proton acceptor and forms hydrogen bond with 
neighbours which are electron acceptor groups (or proton donors, i.e. Lewis acid).  
Meanwhile, on each of the positively charged regions, the water molecule interacts 
with its neighbours which are electron donor groups (or proton acceptors, i.e. Lewis 
base) by donating proton to hydrogen bond. The interaction is indicated in Figure 1.14 
a) and b).  
a)  b)  
Figure 1.14. a) Lewis acid-base depiction b) Example of water as Lewis acid and base (downloaded from 
google free media repository) 
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1.6 Host-guest chemistry 
In our effort to investigate the role of water in hydrate formation, host-guest 
chemistry is utilise to probe possible water-compound complex formation, which are 
potentially driven and held together by the mentioned noncovalent bonds (1.3) and 
forming distinctive structural relationships in solution.  
 
Figure 1.15. Typical interactions in a host-guest interaction in solution. H is the host, and G represent the G. 
Host-guest chemistry is a branch of supramolecular chemistry, typically 
utilised to probe the extend, structure and binding affinity in molecular complexes 
(Figure 1.15).97 Our solution-state analysis is based on a modified host-guest chemistry 
titration, where water will be the guest and added in small aliquots with respect to a 
constant host, which method is discussed in detail in Chapter 2. The solvent is chosen 
based on two main criteria; adequate host and host:guest complex solubility, and the 
guest-solvent miscibility. The measures taken ensures that the change later observed 
is not due to host concentration variations or solvent separation. Essentially, the 
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titration method used allows for determination of binding constant (Ka or K) between 
the water (guest, G) and a tested compound (host, H), based on the physical change 
(ΔY), e.g. NMR peak shifts, and the two known parameters, of host initial host ([H]0) 
and guest ([G]0) concentration using an open source software, Bindfit obtained from 
http://supramolecular.org/. The software uses algorithm and some initial guesses for K 
and calculate ΔY, and compare it to the measured ΔY and then vary K and ΔY until a 
good fit is obtained. Once K is obtained, it is easy to calculate the Gibbs free energy 
(ΔG), form the formula, ΔG = -RT ln (K), which would indicate the strength of 
interaction between the reactants. 
1.6.1 Binding constant 
A chemical equilibrium is the state in which the forward reaction rate, which 
is the binding constant (Ka or K) and the reverse reaction rate, which is the 
disassociation constant (Kd) are equal (Equation 1.2, where host = H, guest = G and a, 
b are stoichiometry of the reactants). Binding constant value would represent the 
foward relationship favouring the formation of the products in relation to reactants 
present at equilibrium in a reversible chemical reaction at a given temperature. 
Meanwhile, the Kd can be obtained from the inverse of Ka value (Ka=1/Kd). Binding 
constant would also reflect the binding affinity of a host toward particular guest under 
equilibrium conditions. The unit for Ka is in Molar
-1 (M-1) while for Kd is in Molar 
(M). The affinity of a H toward a G in the case of 1:1 stoichiometry is defined by 
Equation 1.3, which results from the rearrangement of Equation 1.2 to express binding 
constant K or Ka in relation to host, guest, and product or complex concentration, when 
a and b values in Equation 1.2 are one (1).  
(Equation 1.2) 
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a[H]+b[G] HaGb 
 
(Equation 1.3) 
K or Ka = [HG] 
    [H][G] 
 
If the concentration of the complex [HG] is known, the remaining 
concentrations can be determined by the mass balance equation for total or initial host 
(Equation 1.4) or guest (Equation 1.5) concentration  
(Equation 1.4) 
[H]0 = [H] + [HG] 
(Equation 1.5) 
[G]0 = [G] + [HG] 
 
In Equation 1.4 and 1.5, the total concentrations of the host and the guest are 
represented by [H]0 and [G]0. Meanwhile, [G] and [H] here is the free host and guest 
respectively. Once [H], [G], and [HG] are all known, then Ka is easily calculated. 
Regrettably, direct measurement of [HG] (or [H] and [G]) is not possible. Therefore, 
the next best approach is to measure the concentration of the complex [HG] indirectly 
through titration experiments. The only experimentally determined values are the 
concentrations of the H and G, and the physical property (Y), which is changing (ΔY) 
which are then fitted to the theoretical binding isotherm. The basis for this indirect 
assumption is that the ΔY, e.g. NMR resonance peak shift or Δδ, observed during the 
course of a titration, is correlated to the concentration of the complex [HG] (YHG). 
ΔY in the system are monitored and then plotted as a function of guest added to host 
(equivalent guests, [G]/[H]). The Ka mathematical model is developed by realising that 
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the mentioned correlation (ΔY or Δδ correlates directly to the concentration of the 
complex [HG]). 
Historically, the linear approach e.g. Benesi-Hildebrand plot,98,99 Lineweaver-
Burke plots,100 Scatchard plots101,102 were used to determine K, which frequently 
involves shortcuts e.g. assuming that initial guest concentration is much larger or that 
complex formed completely at the end of titration. The later assumption, would incline 
that the reaction is indeed linear and thus misrepresent the result.99,103 The older 
references also overly simplify the equations by transforming the HG relationship to 
linear equations (y = mx + c), which could then be plotted by hand to obtain the Ka 
and other parameters of interest, by going-over the slope and intercepts. In fact, a non-
linear regression approach with exact solutions of the quadratic equation would 
produce the most accurate result.  
Ka experimental measurement method also often depend on the analysis of a 
binding isotherm. A binding isotherm is not experimentally measured, but rather 
generated by using mathematical model, i.e. Nelder-Mead algorithm104 which is based 
on solving a quadratic line. The binding isotherm would simulate theoretical change 
in the concentration of one component as a function of the concentration of another 
component at a constant temperature.  
In term of the formed species, is unlikely that only a singular species is formed 
from the interacting reactants, especially in a dilute solution as shown in Figure 1.15. 
Several species can co-exist in the same equilibria. Fast analytical tool, e.g. infra-red 
analysis, could observe these overlapping species in solution, however, a slower 
timescale instrument, i.e. nuclear magnetic resonance (NMR) would only detect the 
average change of species. Key association aside from 1:1 are, 1:2 and 2:1 in 
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stoichiometry. Limited binding and a mathematical model to that of the mentioned 
stoichiometries means that only these species are analysed, although in reality a variety 
of species can be present especially in a dilute solution environment. For a 2:1 or 1:2 
complex to form from a direct simultaneous collision of one host with two guests, is 
rather implausible. Therefore, a stepwise process following modified Equation 1.2 
when a and b values are one (1) and two (2) respectively resulting in Equation 1.6 and 
Equation 1.7 is more plausible. For a 2:1 interaction, the modification in the 
stoichiometry value is reversed, where a is two (2) and b is one (1). In a 1:2 
complexations, the initial step K1 is expressed in Equation 1.6, while the second step, 
K12 (OR K21) is expressed in Equation 1.7, in relation to host, guest, and product or 
complex concentration. 
 (Equation 1.6)  
K1 = [HG] 
       [H][G] 
 
(Equation 1.7) 
K12 = [HG2] 
        [H][G] 
 
OR 
 
K21 = [H2G] 
        [H][G] 
As mentioned, direct measurement of [HG] (or [H] and [G]) is not possible, 
however, by modifying Equation 1.3, it is possible to determine free [G], by combining 
it with Equation 1.4, as shown below. 
i. Ka  = [HG] 
[H][G] 
 
ii. Ka  = [HG] 
([H]0-[HG])([G]) 
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Firstly, Equation 1.4 is rearranged and expressed as [H] = [H]0-[HG], and subsequently 
used to replace the [H] in Equation 1.3 (i-ii). 
 
iii. Ka ([H]0-[HG])([G]) = [HG] 
 
iv. Ka [H]0[G] - Ka [HG][G] - [HG] = 0 
 
Next, the formula is rearranged and expressed as [HG] (iii), and solved to 0 (iv). 
 
v. Ka [H]0[G] - [HG] (Ka [G] +1) = 0 
The expression (v) is simplified by factoring [HG]. 
 
vi. Ka [H]0[G] = [HG] (Ka [G] +1) 
 
vii. Ka [H]0[G] = [HG]  
           (Ka [G] +1) 
 
The formula is rearranged (vi) and expressed as [HG] (vii). 
 
 
viii. Ka [H]0[G] = [G]0 - [G] 
                 (Ka [G] +1) 
Value for [HG] in (viii) is replaced with the rearranged Equation 1.5 which is 
expressed as [HG]. 
 
ix. Ka [H]0[G]  +  [G] = [G]0 
           (Ka [G] +1) 
 
The whole formula is rearranged again in (ix), this time expressed as [G]0  
 
x. Ka [H]0[G]  +  [G] (Ka [G] +1) = [G]0 (Ka [G] +1) 
The whole equation in (x) is multipled by (Ka [G] +1) to remove the denominator. 
 
xi. Ka [H]0[G]  +  Ka [G]2 + [G] = Ka [G][G]0 + [G]0 
 
xii. [H]0[G]  +  [G]2 + [G] = [G][G]0 + [G]0 
       Ka     Ka 
The expression in (xi) is divided by Ka and subsequently rearranged (xii).  
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xiii. [H]0[G] - [G][G]0 + [G]2 + [G] -[G]0 = 0 
                                        Ka   Ka 
 
The expression in (xiii) is rearranged and solved to zero. 
 
xiv. [G]2 + [G] ([H]0 -[G]0 + 1) -[G]0 = 0 
                                Ka   Ka 
 
Factoring [G] in formula (xiv) yeilded a quaratic equation of ax2 – bx – c = 0, 
where ‘a’ equals to 1, x is [G], ‘b’ is [H]0 - [G]0 -1/Ka and ‘c’ equals to [G]0/Ka 
 
The quadratic equation (xiv) is solve using quadratic formula for x, resulting 
in the final Equation 1.8, which is the expression for free guest [G] concentration as a 
function of the total host (H0), total guest (G0), and Ka. 
103 
𝑥 =
−𝑏 ± √𝑏2 − 4𝑎𝑐
2𝑎
 
 (Equation 1.8) 
 
By modifying Equation 1.3, it is possible to determine free [HG], by combining 
it with Equation 1.4 and Equation 1.5 as shown below. 
xv. Ka  =  [HG] 
  [H][G]  
 
xvi. Ka  =  [HG] 
([H]0-[HG])([G]0-[HG]) 
 
Firstly, Equation 1.4 and Equation 1.5 are rearranged and expressed as [H] = 
[H]0-[HG] and [G]= [G]0-[HG] respectively, and subsequently used to replace the [H] 
in Equation 1.3 (xv and xvi). 
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xvii. Ka =   [HG] 
[H]0[G]0-([H]0[HG])-([G]0[HG])+ [HG]
2) 
 
Next, the denominator are expanded resulting in (xvii). 
 
xviii. Ka ([H]0[G]0-([H]0[HG])-([G]0[HG])+ [HG]2)) = [HG] 
 
The formula (xviii) is rearranged and expressed as [HG]. 
 
xix. Ka [H]0[G]0- Ka [H]0[HG]- Ka [G]0[HG]+ Ka [HG]2- [HG] = 0 
 
xx. Ka [HG]2 – [HG] (Ka [H]0+ Ka [G]0+1) + Ka [H]0[G]0 = 0 
 
Formula in (xix) is solved to 0 and rearranged to get (xx). 
 
xxi. Ka [HG]2 – [HG] (Ka [H]0+Ka[G]0+1) -Ka[H]0[G]0 = 0 
Ka  
 
xxii. [HG]2 – [HG] ([H]0+[G]0+1) + [H]0[G]0 = 0 
                       Ka 
Formula in (xx) is divided with Ka as in (xxi), resulting in the quadratic 
equation (xxii). The quadratic equation (xxii) is solve using quadratic formula for x, 
ax2 + bx + c = 0, where ‘a' equals to 1, ‘x’ is [HG], ‘b’ equals to –([H]0+[G]0+1/Ka) 
and ‘c’ is -([H]0[G]0). Solving using quadratic formula for x below results in the final 
Equation 1.9, which is the expression for host-guest [HG] concentration as a function 
of the total host (H0), total guest (G0), and Ka.
103 
𝑥 =
𝑏 ± √𝑏2 ∓ 4𝑎𝑐
2𝑎
 
(Equation 1.9) 
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Equation 1.9 is  very important, as based on this, we can now use the already 
available total or initial concentrations of the host ([H]0) and guest ([G]0) to quantify 
the free host [H] and guest [G] in Equation 1.4 and 1.5. Using the Ka measured from 
the titration experiment, substituted into this equation, all of the components are now 
measurable, and would provide insight into the speciation at play in solution. For a 2:1 
or 1:2 complexation, similar rearrangement of Equation 1.7 once K12 OR K21 is 
obtained would allow measurement to similar equations and values as described in (i-
xxii). 
1.6.2 Thermodynamics of molecular interactions and relation to binding constant 
According to Hirose, whilst binding constant is measured to quantify the host-
guest complexation process, thermodynamic parameters e.g. enthalpy, entropy and 
Gibbs free energy are more suitable criteria to represent the strength of the 
interaction.105  
Substituting Equation 1.1, (ΔG = ΔH – TΔS) into Equation 1.10, yielded  the 
van’t Hoff equation, Equation 1.11. Based on the van’t Hoff equation, the 
thermodynamic parameters mentioned are now interrelated to each other. 
Equation 1.10 Gibbs free energy for a system at chemical equilibrium
G = – R T ln K 
 
Equation 1.11. The van’t Hoff equation 
ln K = –  ΔH + 1 + ΔS 
      R     T     R 
In principle, if more than one binding constants are obtained at different 
temperatures, van’t Hoff equation (Equation 1.11) can be utilised to solve the 
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remaining thermodynamic parameters, from the slope and intercept of the line in 
Figure 1.16.  
 
Figure 1.16. Correlation of thermodynamic parameters, K and temperature according to van’t Hoff equation. Figure 
adapted from Hirose.105 
1.6.3 Job’s plot 
The continuous variation method, or Job’s plot,106 has always been the most 
popular method for determining stoichiometry in host-guest chemistry. The method 
requires the total molar concentration of the tested two binding components, e.g. the 
host and the guest to be kept constant, but their mole respective fractions are varied. 
The physical change (Y) e.g. NMR peak shifts from the opposing mole fraction 
variation are plotted against the mole fractions of either of the two components, 
typicially the host. The maximum value on the plot would then correspond to the 
stoichiometry of the chosen component of the two species. Essentially, Job plot 
considers only one complex in solution which predominates over all others species 
under the conditions of the experiment (Figure 1.17). This requirement means that only 
systems with high association constants, or systems in which only one stoichiometry 
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can form. However, this requirement is also the biggest limitations,107 as in solution; 
there are potentially more than one complex could be present. 
  
Figure 1.17. Typical Job plot showing the change physical property (P) with the change in the mole fraction of 
compound A (ΧA). The Ymax at XA = 0.5, indicating a 1:1 (host to guest) stoichiometry. Left skew would be 
associated to 1:2, while the opposite, 2:1 respectively. 
In addition, a recent report shows that the observed maxima in the Job’s plot 
can be misleading, showing clear sensitive to the binding ratio and host concentration 
than to the real stoichiometry.108 In short, the method is not working in the 
supramolecular system, misleading about stoichiometry assembly and finally, can lead 
to incorrect Ka determination.
108 Job plot can, however, be an educated gauge to the 
possible interaction, and the result from the analysis is considered with caution. 
1.7 Ideal and non-ideal aqueous mixing and the importance of water activity 
Ideal mixture in general is a mixture of two very closely similar substances, 
which would result in a very small overall energy (enthalpy) change when the two 
substances are mixed. The more chemically identical the two mixing compounds are, 
the closer their mixing will be to an ideal mixture, however, the more dissimilar their 
1:1 1:2 2:1 
Y 
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nature are, the more strongly the solution is expected to differ from ideality. Therefore, 
by this definition, all our solution state analysis involving organic solvent-water 
mixture would be in a non-ideal binary solvent mixture, as none of the solvent used is 
analogous in chemical structure to water. For example, DMSO and acetonitrile both 
miscible with water at any mixing ratio, however, the thermodynamic properties of 
mixing for the different solvents with water are completely different from one another 
and suggests non-ideal mixture with water as the enthalpy of mixing ≠ 0: which is 
endothermic for acetonitrile-water109 and exothermic for DMSO-water (Figure 
1.18).110  
 
Figure 1.18. The enthalpy of mixing of DMSO and acetonitrile to water as functions of mole fraction of water, 
adapted from Shin et al.111 Wakisaka et al.109 and Lai et al.110. The dashed line corresponds to the ideal binary 
mixture whose excess enthalpy of mixing is zero 
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However, two different solvents can still achieve ideal mixing property based 
on the amount e.g. mole fraction and partial pressure of each component present in the 
mixture, as indicated by Raoult’s Law for ideal mixture (Equation 1.12). Ideal mixture 
follows Raoult's Law, and the law states that the partial vapour pressure of a 
component in a mixture is equal to the vapour pressure of the pure component at that 
temperature multiplied by its mole fraction in the mixture. The total vapour pressure 
of the mixture is then equal to the sum of the individual partial pressures 
(Equation 1.12)  
i. Pa = Xa x Pa 
ii. Pb = Xb x Pb  
iii. Pa + Pb = Ptot 
Xa and Xb are the mole fractions of components a and b respectively, while Pa 
and Pb are the partial pressure of the respective pure liquids. The ideal mixture total 
partial pressure line can be generated by the sum of Pa and Pb.or Ptot (Figure 1.20). For 
a nearly ideal mixture, experimental or measured partial pressure of the mixture is near 
enough to generated straight line. On the other hand, the less ideal the mixture is, the 
more curved the lines become.  
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Figure 1.20. Raoult’s Law ideal total partial pressure line (Ptot, red line) generated form the pure partial pressure of 
each component respectively (solid black line). 
For example, considering DMSO-water mixture; pure DMSO have a vapour 
pressure of 0.075 kPa while the partial pressure of liquid water is 3.124 kPa at 25℃, 
Qian et al.112 has measure the total vapour pressure of DMSO and water binary system, 
and reconstruction of their data (Figure 1.21) and compared to the Ptot line for ideal 
mixture reveals that the experimental line112 close to generated straight line for an ideal 
mixture with negative deviation observed. 
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Figure 1.21. The vapour pressure of pure components (solid black lines), the ideal vapour pressure of the binary 
mixture (solid red line) and the total vapour pressure of DMSO and water binary system ( 3kPa, black dashed 
line)112 at 25℃ showing negative deviation. 
The negative deviation of the experimental data suggests that the forces 
between the DMSO and water in the mixture are stronger than the mean of the forces 
between the particles in the pure liquids, most likely due to hydrogen bonding as 
reported in other binary mixture.113 The hydrogen bonding interaction proposed is in 
line with the observed exothermic reaction (typically correlate bond formation)114 of 
the mixture111 and echoed in a molecular dynamics (MD) simulation study which 
reported that in an aqueous solution containing low DMSO concentrations, the DMSO 
molecule is likely to bound to water in a 1:2 ratios,115 while in another MD simulation 
study, in a mixture of above 50% DMSO content, the stoichiometry changes, favouring 
the 2 DMSO:1 water complexes.116 Also, in a water-rich DMSO mixtures, tetrahedral 
ordering of water molecules is observed,117 suggesting that the water clusters were 
observed only at much higher water mole fractions:  Xw > 0.93.111 However, in another 
recent finding, DMSO is said to exhibit either ideal-solution-like between 30–90 mole 
% or self-interaction, or aggregation, regime above 90 mole %.118 The report suggests 
that, > 30% DMSO-water mixture, DMSO is more likely to self interact hence DMSO-
water mixture and would show good homogeneity, which in line with the mentioned 
law. Therefore, throughout our experiments amount (mole fraction) of guest e.g. water 
added is monitored with respect to the main solvent, e.g. DMSO, acetonitrile, or 
acetone, as to ensure that the overall mixture is close to being ideal. 
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1.8 Hypothesis and aim 
Crystallographic analysis has always been the approach to investigate hydrate 
formation, behaviour and phase-transition. The search for the most suitable crystal 
form at the early stages of drug development usually involves screening and 
identifying any, if not all possible hydrate form(s) as a part of the overall intellectual 
property protection strategy for a given compound. However, due to the 
unpredictability surrounding hydrate formation, as well as the tremendous amount of 
time, money, and effort required for crystal forms screening, and subsequent 
characterisation for a single compound, a faster and more efficient prediction approach 
for hydrates is warranted. 
It has been highlighted in 1.3 that solution-state analysis can provide positive 
evidence reflective to the solid state, and similar approach with hydrate if successful 
would open a new door towards understanding hydrate formation. We stipulate that 
there is some degree of molecular recognition between a hydrate-forming compound 
and water which would lead to formation of pre-nucleation complexes in solution. The 
said interaction would yield a significant structural “value” rather than a random 
interaction, especially for a compound that can form a stable hydrate. This project thus 
will focus on probing the role of water in hydrate formation by analysing not only the 
solid-state but also the solution state. We are interested in taking this approach because 
a successful connection of the solution and the solid state would allow the possibility 
of an early prediction of hydrate formation. Successful application of the approach 
would ultimately lead to a faster and more focused screening process.  
The various solid-state analytical methods will be use to dissect any, if not all 
the hydrate form obtained. The information gained should provide insight towards the 
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prominent interactions present and aid the understanding of the subsequent solution-
state analysis. We hypothesise, in the solution-state, that there will be significant 
interactions between the active compound and water, showing a stronger interaction 
in solution for a more stable hydrate. We will hence test this hypothesis initially on the 
class of stable hydrates, and moving on to lower stability ones from there. We will 
only use water-organic solvent mixture at different mole fractions. Doing so would 
allow us to control the water content and activity. The focus will be on the molecular 
interactions crucial for hydrate formation, namely the hydrogen bond interactions.  
All in all, this investigation is an attempt to understand the influence and early 
role and influence of water on hydrate formation. The focus is on understanding this 
phenomenon by studying the ability of water and drug molecule to interact, in both the 
solid hydrate crystalline (crystallographic) state, as well as the earlier stages of the pre-
nucleation state (in solution). Thus, the efforts towards understanding the forces at play 
- prior, throughout and after the crystallisation process is ever-relevant and utmost 
importance. While active, pre-nucleation (in solution) analysis utilised to probe events 
leading towards crystallisation of a specific crystal form (hydrate) is an exciting 
approach, our effort also covers a thorough investigation on crystals in their solid-state, 
of which the fundamentals and the method are discussed in the chapter 2. 
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CHAPTER 2  
 MATERIALS, METHODOLOGIES AND THEIR PRINCIPLES  
2.1 Materials  
2.1.1 Analysed compounds 
Sodium diatrizoate (DTS), diatrizoic acid (DTA), cimetidine (CIM), piroxicam 
(PXM), naproxen (NAP), paracetamol (PCM), flurbiprofen (FBN), 4,4-dipyridyl 
(DPY), pyrazine (PYZ) and 4-hydroxybenzoic acid (PHBA) were purchased from 
Sigma-Aldrich having ≥98.0% purity. Acetazolamide (ACT), 5-Phenyl-1H-tetrazole 
(5PHT) and 5-(4-pyridyl)-1H-tetrazole (54PYT) were purchased from Alfa Aesar with 
99% purity. Dapsone (DAP, ≥97.0%) and 2-chloro-4-hydroxybenzoic acid (2C4HBA, 
≥98.0%) were purchased from Tokyo Chemical Industry Co. Ltd. (TCI). Tranilast 
(TRN, ≥98.0%) was purchased from Flurochem Ltd. All compounds were used 
unrefined in all experiments. The 4-(1H-tetrazol-5-yl) phenol (TTZ) was synthesised 
by Dr. Clinton Veale’s group at the University of KwaZulu Natal in South Africa.  
Acetonitrile (≥99.9%), n-amyl alcohol (1-pentanol, ≥99.0%), 1-butanol 
(≥99.4%), 2-butanol (≥99.5%), dimethyl sulfoxide (DMSO, ≥99.9%), 1,4-dioxane 
(≥99.0%), N,N-dimethyl formamide (DMF, anhydrous 99.8%), dichloromethane 
(DCM,≥99.8%), ethyl acetate (anhydrous ≥99.8%), 2-butanone (ethyl methyl ketone, 
≥99.0%), hexane (anhydrous 95.0%), 1-propanol (anhydrous 99.5%), 2-propanol 
(anhydrous 99.5%), nitromethane (96.0%), were purchased from Sigma-Aldrich. 
Diethyl ether (99.99%), chloroform (99.98%) acetone (≥99.8%), ethanol (≥99.8%), 
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and methanol (≥99.6%) were purchased from VWR International. Tetrahydrofuran 
(THF, anhydrous 99.9%) was purchased from Acros Organics. All solvents were used 
without further purification. 
Heavy water (D2O), DMSO-d6 and acetonitrile-d3 were purchased from Sigma-
Aldrich, while acetone-d6 and DMF-d7 were purchased from Apollo Scientific Ltd. All 
deuterated solvents were ≥99.8% pure and used without further purification. 
Tetramethylsilane (TMS) and 4,4-dimethyl-4-silapentane-1-sulfonic acid 
(DSS) were purchased from Sigma-Aldrich and used as standard for all NMR analysis. 
The Karl Fisher titration reagents used were HYDRANALTM Coulomat A, 
Coulomat CG and Water Standard 1.0 which were purchased from Honeywell. 
2.2 Analytical methods 
2.2.1 Crystallisation screening 
Polymorph screen is done with the aim to find most of the crystal forms from 
a selected compound. Thermodynamically controlled experiments i.e. slow cooling, 
and kinetically controlled experiments i.e. fast cooling, evaporation, and precipitation 
crystallisation are used in our screening (Figure 2.1). Approximately 20 mg of the 
selected compound is used in each of the crystallisation experiments. For the cooling 
experiments, each of the tested compounds is dissolved in sufficient solvent (i.e. 
acetonitrile, n-amyl alcohol 1-butanol, 2-butanol, DMSO, 1,4-dioxane, DMF, DCM, 
ethyl acetate, 2-butanone, hexane, 1-propanol, 2-propanol, nitromethane, diethyl ether, 
chloroform, acetone, ethanol, methanol, and THF), to produce a hot saturated solution. 
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The hot mixture is then cooled at different cooling rates. There different rates are 
generated by either placing the hot sample in an insulating wooden block which is left 
then to cool to 25 C or immidiately quenching the hot sample in an ice and water bath 
at 0 C. For evaporation, the material is dissolved in sufficient solvent to produce an 
undersaturated solution at room temperature and left to evaporate at ambient 
conditions. Precipitation is conducted by producing a saturated solution at 25 C and 
adding a second solvent which the compound is not soluble in or anti-solvents, that is 
miscible with the first solvent. In the case of the fast cooling and precipitation 
experiments, the crystals were immediately removed from solution once they formed, 
whereas evaporation and slow cooling experiments were left for 24 hours before 
analysis.  
 
Figure 2.1 Illustration of the different crystallisation experiments used and their impcat to the solubility curve, 
adapted from Giulietti et al.1 
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2.2.2 Karl Fischer titration 
Karl Fischer (KF) titration remains among the most common water 
quantification method for most compounds or products, and the method is based on 
the Bunsen reaction between iodine and sulphur dioxide in an aqueous medium 
(Equation 2.1).2 In 1935, Karl Fischer published a paper in Angewandte Chemie in 
Germany which entitled (translated), “New method for the dimensional analysis of the 
water content of liquids and solid bodies”.3 In the paper, he reported that the Bunsen 
reaction could be modified and used for water determination in a non-aqueous system 
containing an excess of sulphur dioxide.3 In the early iteration of the method, a primary 
alcohol (e.g. methanol) was used as the solvent, and a pyridine base as the buffering 
agent (note that reagents used nowadays are pyridine-free and contain imidazole or 
primary amines instead).4  
(Equation 2.1) 
2H2O + SO2+ I2  H2SO4 + 2HI 
(Equation 2.2) shows the corrected KF equation,5 with a subsequent two-step 
process suggested by Scholz.4 The equation indicates that the alcohol reacts with 
sulphur dioxide (SO2) and base to form an intermediate alkyl sulphite salt (A), which 
is then oxidized by iodine to an alkyl sulphate salt (B).6,7 
(Equation 2.2) 
A. ROH + SO2 + R’N  [R’NH]SO3R  
B. [R’NH]SO3R + H2O + I2 + 2R’N  2[R’NH]I + [R’NH]SO4R  
The ROH in the equation 2.2 corresponds to any primary? alcohol. SO2 is sulphur 
dioxide and R’N is the pyridine base. The [R’NH]SO3R corresponds to the formed 
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alkyl sulphite salt. The 2[R’NH]I and [R’NH]SO4R in the equation represent the final 
products of hydroiodic acid salt and alkyl sulphate salt, respectively. 
The oxidation reaction (Equation 2.2 B) consumes water and iodine in a 1:1 ratio 
and thus allows for the accurate determination of water contents. In our experiments, 
the KF titrations were performed using a Metrohm AG 899 coulometer titrator 
(Metrohm Ltd., Herisau, Switzerland) as the method allows for the measurement of 
small water contents (10 µg to 200 mg water).8 In coulometric KF, iodine is generated 
electrochemically in situ during the titration, and the amount of water determination is 
based on the current required for the generation of iodine, according to Equation 2.3. 
Water content quantification is based on the total charge passed (Q) to generate the 
corresponding iodine, as measured by Equation 2.3, where Q =  charge in coulombs, 
C,  I = current in amperes, Aand t= time in seconds, s. C corresponds to Coulomb, a 
unit of electric charge. Note that one (1) mg of H2O = 10.72 C.
7 
Equation 2.3 
Q = It  
The KF medium was calibrated using Water Standard 1.0 and titrated to 
dryness before each analysis. Between 5 and 10 mg of sample was weighed (±0.1 mg) 
using a Kern ABJ 200-4NM analytical balance (Kern & Sohn GmbH, Balingen, 
Germany) for each analysis.  
The 860 KF Thermoprep oven setup (Metrohm Ltd., Herisau, Switzerland) was 
used alongside the coulometer titrator for compounds which could not be analysed by 
direct KF titration. This could be due to limited solubility in the reagents, reaction with 
the KF reagent under generation of water, very slow release of the incorporated water 
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only, or release not until heated to high temperatures. An initial blank vial which was 
exposed to ambient humidity was measured, followed by the measurement of the 
sample using tightly sealed sample vials with a nitrogen purge over the sample, which 
washes any emission from the oven-heated sample into the coulometric KF titrator and 
subsequently analysed. 
2.2.3 Thermal analysis 
The thermal analysis measures the specific property of a sample upon change 
in temperature. Three methods were used in our experiments, which were hot-stage 
microscopy, thermogravimetric analysis and differential scanning calorimetry. All 
three methods provide complementary information towards the characterisation of a 
sample. 
2.2.3.1 Hot-stage microscopy 
Hot-stage microscopy provides optical observations of the sample during 
temperature change. Events such as crystallisation, melting, decomposition, phase 
transition and desolvation can be visually monitored through the normal or polarised 
light microscope. Polarised light has waves that vibrate only in one direction. The used 
of polarising microscope with crossed polarisers setup allows for contrast generation 
of an anisotropic sample against the background, therefore the sample would “light 
up” in the dark surrounding. Crossed polarisers (Figure 2.2, usually consist of an 
analyser, attached on the eye-piece, and the polariser above the light source), would 
generate a dark field if their transmission directions are aligned at the right angles. 
Typically, polarised microscope is particularly useful when examining birefringent 
effect, which is an effect that occur when a ray of light is split or double refracted by 
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polarisation into two rays of different paths upon incident with anisotropic crystal 
which selectively absorb the polarised light (Figure 2.2). Polarised microscope also 
helps in identification of single crystal as the sample is rotated, a single crystal would 
appear as a uniformed coloured image, instead of multi-coloured.  
 
Figure 2.2. Schematic on the cross polariser setup in a polarised microscope, showing the effects upon observation 
of different samples. 
The sample for thermal microscopy is mounted as either dry or in paraffin oil 
embedded preparation, allowing observation of the different thermal events. A dry 
preparation allows for observation of phase transition, melting, decomposition and the 
loss of birefringence. An oil embedded preparation can also observe similar events, in 
addition to events which involves liberation of volatile inclusion e.g. dehydration or 
desolvation. For example, in a paraffin oil embedded preparation, a desolvation event 
would typically be accompanied by bubble formation (Figure 2.3 A). Following 
melting, the observed solid may appear as a droplet and loses the ability to diffract 
light (Figure 2.3 B). In addition, as the crystalline form desolvates a sample may will 
lose some birefringent, meaning the sample is less able to diffract light hence 
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appearing darker (Figure 2.3 D). Though the observations are subjective and 
qualitative, the method does provide quick, easy, and visually stimulating data.  
 
Figure 2.3. Example of thermal microscopy observation of a sample in a paraffin oil preparation under polarised 
light. A) Depicts typical desolvation process with bubbles formation. B) Depicts melting C) and D) shows the lost 
of birefringent  
Hot-stage microscopic observations were carried out using a Leica DM 2700P 
polarising microscope (Leica Microsystems GmbH, Wetzlar, Germany) equipped with 
THMS600 heating and freezing microscope stage and controller (Linkam Scientific 
Instruments, Tadworth, U.K.). The setup was completed with QICAM Fast1394 
(Qimaging, British Colombia, Canada) colour video camera attachment, supported by 
Linksys32 version 2.4.3. 
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2.2.3.2 Thermogravimetric analysis 
The second thermal analysis method used is the thermogravimetric analysis 
(TGA). TGA measures the changes in weight of the sample over time or a temperature 
range (Figure 2.4).TGA is a common technique used to characterise materials in 
various fields, including pharmaceuticals. A TGA instrument consists of a sample pan 
that is supported by a precision balance. Following initial weight measurement, the 
pan is loaded into in a furnace which is then heated or cooled. A sample purge gas, 
which may be inert or a reactive gas, flows over the sample and exits through an 
exhaust, controls the sample environment. Several events can be discovered through 
the observations of a TGA curve, e.g. showing the anhydrous state of a compound 
when no weight change is observed over the different temperature range (Figure 2.4, 
hypothetical compound I), accurate determination of the amount of volatile inclusion 
released from the sample (Figure 2.4, hypothetical compound II), rapid desolvation 
curve characteristics of surface solvent or non-stoichiometric hydrate (Figure 2.4, 
hypothetical compound III), multi-stage desolvation, with relatively stable 
intermediate, e.g. solvate-hydrate transitioning to a stable hydrate, before complete 
desolvation into the anhydrous form (Figure 2.4, hypothetical compound IV), and 
multi-stage desolvation, with no stable intermediate (Figure 2.4, hypothetical 
compound V). The measured weight change also aids in the identification of the 
volatile components, especially for water when compared to the value obtained from 
KF titration. Our TGA scans were carried out with either Q 500 or Q 50 (TA 
Instruments, New Castle, DE, U.S.A). Nitrogen served as the purge gas at a flow rate 
of 60 mL min-1. Samples of 1 to 5 mg were accurately weighed (±0.1 mg) into 50 μL 
platinum pans. A heating rate of 10 °C min-1 was used and each sample was heated 
from 25 °C to 300 °C.  
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Figure 2.4. Thermogravimetric thermograms of hypothetical materials I-V, showing different TGA curves 
corresponding to various events that could be observed following heating/analysis. 
2.2.3.3 Differential scanning calorimetry 
Finally, differential scanning calorimetry (DSC) measures the amount of 
energy or energy flow required to minimise the temperature difference between a 
sample and a reference as function of temperature. Both the sample and reference are 
heated or cooled to a specific temperature e.g. 300 ℃ at similar rate in each 
experiment, hence any physical transition to the sample, e.g. phase transition, 
desolvation, melting would result in heat being absorbed or released from the sample 
in comparison to the reference. Endothermic events e.g. desolvation, melting, glass 
transition, polymorphic transition in enantiotropic system which require heat uptake 
by the sample in comparison to the reference, hence would typically result in an 
upwards plot on the DSC thermogram (Figure 2.5). The reverse could be said to 
exothermic events, e.g. polymorphic transition in a monotropic system, crystallisation, 
oxidation and cross-linking, where the sample releases energy from the system to its 
surrounding, resulting in a downward plot on the DSC thermogram (Figure 2.5 A). 
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Note that the up/down plot is software and user preference dependent. There is no 
fixed convention on the upward/downward direction of the respective thermal event. 
Other information that could be extracted from a DSC thermogram would be from the 
integration of its peak (Figure 2.5 B). The peak, is characterised by the onset, the peak 
and the offset temperature. The onset is a thermodynamic event, while the peak is 
kinetically controlled, therefore in melting point determination, the onset will remain 
the same for the same compound, while the peak may differ due to different sample 
amount or prep. From the cross-point of the onset and offset temperatures defines the 
maximum or minimum point the peak temperature of the corresponding thermal event, 
e.g. melting point (Figure 2.5 B).The area under the curve of a thermal event gives its 
enthalpy. 
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Figure 2.5. Endothermic and exothermic events typically observed in a DSC thermogram curve (A), while (B) 
depict the onset and offset of the curve with their cross-point which is the peak.  
The DSC scans are carried out either on Q 2000 or Q 20 (TA Instruments, New 
Castle, DE, US). Nitrogen served as the purge gas at a flow rate of 60 mL min-1. 
Approximately 1 to 5 mg of the different samples was accurately weighed (±0.1 mg) 
using a microbalance (Sartorius, Göttingen, Germany), loaded into aluminium 
standard pans (TA Instruments, New Castle, DE, U.S.A) and sealed. A heating rate of 
10 °C min-1 was used and each sample was heated from 25 °C to 300 °C or up until 
decomposition, whichever is earlier. 
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2.2.4 Gravimetric moisture sorption analysis 
The influence of water vapour towards phase transition cannot be overstated, 
and stability tests at elevated relative humidity is a requirement in the American and 
European Pharmacopoeia.9,10 Storing the test sample in a closed desiccator over a 
saturated salt solution having a specific relative humidity (RH) would achieve the goal 
for testing the stability at that particular humidity, however the method is laborious 
due to the static system, as well as the numerous saturated-salt-solution desiccators are 
required to achieve a complete RH range. Gravimetric moisture sorption analysis 
provides a faster, systematic, and more comprehensive alternative. The technique 
measures the change in mass of a sample upon exposure to various RH. 
The measurement is done by exposing the selected sample to a series of RH 
and monitoring the mass change over the RH variation, at constant temperature of 25 
℃. The constant temperature ensures that humidity remains constant at equilibrium as 
both are interconnected. The sample mass was allowed to reach a gravimetric 
equilibrium of ±0.01% w/w at a specific humidity level, before progressing to the next. 
Then, the equilibrium mass values at each RH step were used to generate the isotherm. 
The calculated isotherms are typically divided into two components: sorption for 
increasing humidity steps and desorption for decreasing humidity steps (chapter 1, 
Figure 1.2). 
Gravimetric moisture sorption analysis was carried out using a humidity and 
temperature controlled dynamic vapour sorption (DVS) apparatus, (Surface 
Measurement Systems, Boro Labs Ltd. Aldermaston, Berks, U.K.) equipped with a 
Cahn D200 digital recording ultra-microbalance with a mass resolution of ±0.01 μg. 
Initially, samples between 10 to 15 mg were pre-weighed (±0.1 mg) using a Kern ABJ 
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200-4NM analytical balance (Kern & Sohn GmbH, Balingen, Germany) and then 
loaded in TA Tzero pans (TA Instruments, Switzerland). Moisture uptake and release 
cycles (reported relative to the dry weight) were monitored over a sorption/desorption 
range of 0 to 90% RH with increments of 10% RH at a constant temperature of 25 °C. 
Higher resolution runs with 1% RH steps were performed if deemed necessary, e.g. 
over phase transitions ranges. 
2.2.5 Fourier transform infrared spectroscopy 
Molecules have bonds that are continually vibrating and upon exposure to 
infrared (IR) radiation, different molecules would absorb the energy differently and 
reach the excited vibrational state at a different and specific frequency. The energy 
difference between ground and the excited states must be the exact same frequency to 
the radiation and causes a change in dipole moment for the vibration to be IR-active. 
For example, the symmetric stretch of a CO2 molecule does not result in a change to 
the initially zero dipole moment, so this vibration is IR-inactive. On the other hand, 
the asymmetric stretch and bending of the CO2 molecule do result in a change in dipole 
moment so these are IR-active. The resulting signal at the detector undergoes Fourier 
Transform, resulting in a spectrum representing a molecular ‘ID’ of the sample, which 
again corresponds to different vibrations of the different chemical bonds present. 
With regards to vibrating bonds, these bonds can vibrate with stretch motions 
or bending motions. The concept for the bond vibrations is best represented by the 
‘ball-and-spring theory’, as in Figure 2.6, showing three balls attached by a spring.  
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Figure 2.6. The ball-and-spring model for the gas phase of a CO2 molecule, and its vibration mode, adapted from 
Burghaus 11  
Based on the observation of CO2 molecule (Figure 2.6), the movement of 
oxygen and carbon balls or molecules toward, or away from the one another, along the 
line of the spring represents a stretching vibration, which can either be symmetric or 
asymmetric (1337 and 2349 cm-1stretch vibration, Figure 2.6). A bending vibration at 
667 cm-1 in Figure 2.6 occurs when the angle between atoms change. 
The spectra are generated as a function of transmittance, % transmittance, or 
absorbance, over frequency in wavenumber, which is the number of waves in one 
centimetre (cm-1). For historical reason, the unit for frequency in the x-axis is 
wavenumber (instead of wavelength) following general consensus in the scientific 
community. The wavenumber is the inverse of the wavelength in cm and the range 
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typically used is between 4000 to 400 cm-1, which corresponds to 2.5 to 25 µm in 
wavelength.  
The Fourier Transform infrared (FTIR) spectra of solid and solution phases 
were collected on a Spectrum Two IR Spectrometers (Perkin-Elmer, Massachusetts, 
U.S.A). For the solid-state analysis, samples were placed on a diamond Attenuated 
Total Reflectance (ATR) accessory. ATR measures the internally reflected infrared 
beam which creates an evanescent wave, which protrudes between 0.5 µ - 5 µ beyond 
the crystal surface and into the sample. Therefore, good contact between the sample 
and the crystal surface is crucial. In IR-active regions, the evanescent wave will be 
attenuated or altered, and passed to the detector in the IR spectrometer.12  
 
Figure 2.7. Schematics for FT-IR Spectroscopy ATR adapted from Perkin-Elmer technical note.12. 
Meanwhile, in FTIR solution-state analysis, both ATR and liquid transmission 
cell were used for measurement. Approximately 100 µL of the prepared solution was 
placed either directly on the ATR with hollow steel attachment placed around the 
diamond to help contain the test solution, or in the liquid cell sample holder through 
the filling port, where the sample solution was sandwiched between two zinc selenide 
salt plates (Perkin Elmer) of equal thickness (4 mm), with no spacer separating them. 
According to Kameya and Hanamura,13 using a liquid cell with no spacer is useful to 
evaluate compound with extremely strong absorption band. A constant path length is 
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necessary upon performing quantitative analyses, and thus we are discussing the 
obtained data only qualitatively. Two neoprene gaskets placed in front and the back of 
the salt plates helps seal the setup (Figure 2.8). 
 
Figure 2.8. FTIR liquid holder setup. Image obtained from google free image repository. 
In all IR experiments, four scans were collected for each sample over a 
wavenumber region of 4000 cm-1 to 400 cm-1, and the measure of significance for the 
FTIR experiments is a change in four (4) wavenumber. The resolution set was 4 cm-1, 
which means that the degree of fineness of the data obtained by measurement (i.e., the 
minimum peak interval that can be distinguished) is 2 cm-1. Therefore an unchanged 
peak can appear at different positions or ‘wiggle’ within  2 cm-1. A four wavenumber 
difference cut-off ensures that true peak shift change was observed if any does occur.  
The peak shift change may occur due to various reasons, e.g. hydrogen bond 
formation or breaking. The effect of the hydrogen bond formation is observed on the 
donor and acceptor side. For example on the donor side, the formation of hydrogen 
bond between an NH to a carbonyl in OCB,14 the N–H stretch of the monomer (3350 
cm-1) appears 181 cm-1 wavenumber higher than that of the hydrogen-bonded dimer. 
On the acceptor side, the hydrogen bond formed would stretches the carbonyl bond, 
effectively ‘pulling’ the C=O away from one another leading to the weakening of O=C 
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bond, shifting the peak to a lower stretching vibration frequency.15 These observations 
again follow the ‘ball and spring theory’, where weakening a bond (lengthening of the 
bond) will decrease the vibrational frequency (and vice versa).16,17   
2.2.6 X-ray diffraction 
X-ray diffraction (XRD) analysis is based on the scattering of X-rays by a 
crystalline sample, which then undergoes constructive and destructive interference, 
generating a distinct pattern. X-rays are generated through the collision of high-
velocity electrons produced by an anode filament (usually tungsten), with a metal 
target, usually copper (Cu) or molybdenum (Mo), in a cathode ray tube. The X-rays 
are then filtered using a graphite crystal or double mirror optic to produce 
monochromatic radiation, collimated to concentrate, and directed toward the sample 
as illustrated in Figure 2.9.  
 
Figure 2.9. Schematics of a typical X-ray diffraction setup. 
The interaction of the incident X-rays with the sample produces constructive 
interference (and a diffracted ray) when the conditions satisfy Bragg’s Law (nλ=2d sin 
θ,18 Figure 2.9) where θ is the scattering angle, n is a positive integer and λ is the 
wavelength of the incident wave, the mentioned pattern would be produced, which is 
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unique to the tested compound. Bragg’s law states that as the X-ray of wavelength λ is 
incident onto the surface of a crystal, at an angle of incidence, θ, the beam will be 
reflected back with a same angle of scattering, θ.18 Therefore, when the interplanar 
distance d, is equal to a whole number, n, of wavelength, a constructive interference 
will occur (Figure 2.10) leading to a peak formation on the detector, at the angle θ.18  
 
Figure 2.10. Bragg diffraction depicting two in-phase X-ray beams with wavelength λ. The beams are reflected 
from two different atoms in a crystal. The lower beam covers an extra distance of 2d sinθ, and will produce 
constructive inteference with the upper beam, leading to a peak pattern at the angle θ. Image adapted form google 
free media repository. 
2.2.6.1 Powder X-ray diffraction (PXRD) 
Powder X-ray diffraction (PXRD) data were obtained using an Empyrean 
powder diffractometer (PANalytical, Almelo, Netherlands) equipped with Cu-Kα 
radiation (wavelength of 1.5418 Å), graphite monochromator, 0.2 mm fixed Soller slits 
and PIXcel detector. In addition, a PANalytical X-Pert PRO (PANalytical Ltd, UK) 
equipped with Cu-Kα radiation (λ = 1.5418 Å) was also used. The operating tube 
voltage of 40 kV and tube current of 40 mA were used. For each sample, a scan was 
conducted in the Bragg-Brentano (θ-2θ) geometry between 2 to 40° 2θ, at a rate of 
0.5° 2θ per minute. The samples were prepared as a dry powder and placed on a zero-
background sample holder. 
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2.2.6.2 Humidity-controlled powder X-ray diffraction 
This experiment was performed with the help of Dr. Kevin Back of Pfizer and 
Dr. James McCabe of AstraZeneca.  
Humidity-controlled PXRD data were obtained using a D8 Discover powder 
diffractometer (Bruker, Coventry, UK) equipped with a Cu-Kα source (wavelength of 
1.5406 Å), primary motorised slits set at 10 mm fixed sample size, Soller slits, 
secondary motorised slits set at 48 opening angle and a LynxEye detector. The 
operating tube voltage of 40 kV and tube current of 40 mA was used, and the 
diffractometer was equipped with a CHCplus+ humidity chamber. The samples were 
mounted on a silicon wafer (zero background) mount and all scans were conducted in 
the Bragg–Brentano (θ-2θ) geometry from 2 to 40 2, with a step size of 0.018 2 
and a time per step of 0.2 seconds. The sample was held at 25 °C and the humidity 
varied in steps, with the sample allowed to equilibrate for 2 hours at each step. Analysis 
software used in AstraZeneca was DIFFRAC.EVA version 4.1.1.5. 
2.2.6.3 Single crystal X-ray diffraction 
This experiment was performed with the help of Dr. Christopher Jones and Dr. 
Katharina Edkins. 
Data were obtained on single crystals coated in perfluoropolyether oil and 
mounted on MiTeGen sample holders. The samples were placed directly into the pre-
cooled cryostream and kept at 120 K. Datasets of DTS Hy1 and the DMSO H2O 
solvate were collected on a D8 diffractometer (Bruker, Coventry, UK) operated with 
Mo-Kα radiation, double mirror monochromator and a photon detector. The DTS 
methanol solvate was measured on an Xcalibur diffractometer (Oxford Diffraction, 
Oxford, UK) operated with graphite-monochromated Mo-Kα radiation. The data were 
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reduced using the APEX2 software package (Bruker, Coventry, UK), solved with 
olex.solve and refined with olex.refine as included in the Olex2 software package.19  
Meanwhile, the single crystal data for TRN 2.3 hydrate, the ethanol and 2-
propanol solvates were obtained using SuperNova, Dual source EosS2 diffractometer 
(Rigaku) operated with Cu-Kα radiation. The operating tube voltage of 40 kV and tube 
current of 1.5 mA was used along with Atlas CCD detector and 4-axis KAPPA 
goniometer (Rigaku). The crystal was kept at 120 K during data collection. Data 
reduction by Crysalis (Rigaku). All non-hydrogen atoms were identified from electron 
density maps and refined anisotropically, whilst hydrogen atoms were modelled in 
geometrically ideal positions and refined as a riding model.  
The synchrotron radiation X-ray diffraction is used to analysed single crystal 
of very small size. This experiment was performed with the help of Dr. Dmitry S. Yufit 
and Dr. Katharina Edkins. 
Synchrotron X-rays are produced by high energy electrons as they circulate 
around the synchrotron, a particle accelerator, which is a machine that accelerates the 
said electrons to extremely high energy and then make them change direction 
periodically.20 The schematics of a synchrotron machine, or facility to be exact, is as 
in (Figure 2.11) along with their respective sections’ function. The electrons are 
generated by electron gun labelled as (1) in Figure 2.11. The electrons are then 
accelerated to close to the speed of light in linac (2). Booster ring (3) increases the 
energy of the circulating electron while storage ring (4) stores the high energy 
electrons which are kept on circular path through magnet. The constantly accelerated 
motion of the electrons leads to the emission of radiation in the form of X-rays. 
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Additional magnets (wigglers and undulators) typically located in the storage ring, 
change the electrons’ acceleration which produce different synchrotron spectrum. 
 
Figure 2.11. Schematics of a synchrotron facility21 1) electron gun – ganerate the electron via thermionic emission, 
2) linac – short for linear accelerator, where electrons are accelerated to close to the speed of light 3) booster ring 
– ramp or boost the enegy of the circulating electron, typically from 100-200 mega electron volts to 3-6 giga 
electron volts 4) storage ring –  an injection system transfers electrons with enough energy to produce light from 
the booster ring, 5) beamline and 6) end station.– comprises of the optics cabin, the experimental cabin, and the 
control cabin.which allow radiation tailoring, house the support mechanism, and the environment  for  the sample 
study and cotain the detector to control the experiments and collect the data. Image adapted from google free image 
repsitory and labelled acccordingly. 
The resulting X-rays are emitted as bright white light, i.e. they contain a wide 
range of wavelengths, and are guided towards a beamline and instrument next to the 
accelerator. If monochromatic X-rays are needed, a crystal with the appropriate lattice 
spacing is used to diffract that wavelength out of the white beam. This monochromatic 
beam is significantly less intense in terms of number of photons per time, however, 
since the overall intensity of the synchrotron beam is high, the lower intensity is not 
an issue. Synchrotron X-rays are leaps and bounds better than laboratory X-ray in 
terms of brightness and the angular spread of the beam. The high energy beams provide 
deeper penetration. Also, the small wavelengths allow the probing of smaller features, 
e.g. bonds in molecules at a shorter timescale.20 
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The dataset for DTS0.5-0.35 were collected on instrument I19 at the Diamond 
Light Source, Didcot, UK at 120 K. The data were reduced using an APEX2 software 
package (Bruker, Coventry, UK), solved with olex.solve and refined with olex.refine 
as included in the Olex2 software package.19 All non-hydrogen atoms were identified 
from electron density maps and refined anisotropically, whilst hydrogen atoms were 
modelled in geometrically ideal positions and refined as a riding model. 
2.2.7 Calculations and stock solution preparation. 
In our titration analysis, G:H molar ratio is used in order to generate the 
required data point for the binding constant measurement. The measurement requires 
that the host concentration to remained constant, while the guest concentrations are 
varied. Molar concentration calculations and values guide the actual molar ratio used 
in all titration analysis. For all experiments, a host concentration of either 0.02, 0.05 
or 1.0 M was used. A stock solution of the host was made by weighing the solid in a 
vial and adding a weighed amount of solvent necessary to produce the required 
concentration. Throughout the experiments, various calibrated Hamilton precision 
glass syringes with maximum volume capacity from 10 to 1000 µL were used, with 
the weight of the added solvent additionally recorded using Ohaus Adventurer Pro 
balance (New Jersey, USA) to maximise accuracy. An adequate volume of the stock 
was prepared so that it was sufficient to prepare the subsequent guest stocks.  
For the titration and dilution experiments (FTIR or NMR), it is equally 
important to determine the guest concentration needed throughout the experiment. For 
water as the guest, several problems occur: the very low molecular weight of 18.015 g 
mol-1 compared to the host molar mass limits the measurable amount which can be 
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prepared. The fact that water is ubiquitous and will be absorbed into any solvent when 
exposed to the environment makes the lower G:H ratios very difficult to obtain, 
especially when a lower host concentration (0.02 M) is used. Therefore, one molar 
ratio gaps were used in our titrations at low guest concentrations, followed by 10 and 
then 50:1 G:H ratio gaps at higher guest concentrations.  
To ensure small aliquots of water could be incorporated into the solvent 
mixture for the titration experiments, several guest stocks were prepared at a specified 
guest concentration, i.e. 0.5, 5.0 and 20.0 M (named STOCK 1, 2, and 3 respectively). 
The mentioned guest stock concentrations are used as they allowed for the syringe-
able amount (more than 20 μL each time), especially at lower guest concentration ratio, 
and that the total solution volumes were less than 1.1 mL.  
To prepare the guest stock solutions, the guest was weighed accurately into a 
vial and host stock solution (STOCK 0) was carefully added to obtain the correct 
concentration. This was to ensure that the host concentration remained constant 
throughout the titration and that resulting changes were due to guest addition and not 
host dilution. 
To estimate the volume (VB) from STOCK 1, 2, and 3, that were needed to 
obtain the required concentration of G:H ratio for all the mentioned data points, the 
following modifed molar concentration (Figure 2.6) was used. Note that the 
concentration mentioned is referring to guest or water concentration as the host was 
kept constant. 
(Equation 2.4) 
MAVA + MBVB = MCVC 
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MA is the initial molar concentration while VA is the initial volume. MB 
corresponds to the  molar concentration of stock used. VB is the volume of stock needed. 
MC is targeted concentration corresponding to Vc, the total volume of A nd B. The 
volume that an NMR tube could accommodate also limits the sum of VB that was 
added. The tube was emptied between stock change intervals, with overlapping 
measurement done on the re-tubing point to ensure accuracy. Ideally, the peak position 
of the overlapping run would be the same, however, if a volatile solvent was used, 
small differences were expected due to evaporation of the solvent. The average 
between the two overlapping peaks was used as it would better represent the data point. 
Table 2.1. Example of water-compound titration setup 
[Host] M 
[Guest] M 
MA or MC G:H 
Initial vol. 
VA 
add (μL) 
VB 
from STOCK # 
MB 
0.02 0 0 600.00 Initial STOCK 0 ( 0 M) 
0.02 0.02 1 625.00 25.0 STOCK 1 (0.5 M) 
0.02 0.04 2 652.17 27.2 STOCK 1 (0.5 M) 
0.02 0.06 3 681.82 29.6 STOCK 1 (0.5 M) 
0.02 0.08 4 714.29 32.5 STOCK 1 (0.5 M) 
0.02 0.1 5 750.00 35.7 STOCK 1 (0.5 M) 
0.02 0.12 6 789.47 39.5 STOCK 1 (0.5 M) 
0.02 0.14 7 833.33 43.9 STOCK 1 (0.5 M) 
0.02 0.16 8 882.35 49.0 STOCK 1 (0.5 M) 
0.02 0.18 9 937.50 55.1 STOCK 1 (0.5 M) 
0.02 0.2 10 1000.00 62.5 STOCK 1 (0.5 M) 
0.02 0.2 10 600.00 Initial Re-tube 
0.02 0.4 20 626.09 26.1 STOCK 2 (5.0 M) 
0.02 0.6 30 654.55 28.5 STOCK 2 (5.0 M) 
0.02 0.8 40 685.71 31.2 STOCK 2 (5.0 M) 
0.02 1 50 720.00 34.3 STOCK 2 (5.0 M) 
0.02 1.2 60 757.89 37.9 STOCK 2 (5.0 M) 
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0.02 1.4 70 800.00 42.1 STOCK 2 (5.0 M) 
0.02 1.6 80 847.06 47.1 STOCK 2 (5.0 M) 
0.02 1.8 90 900.00 52.9 STOCK 2 (5.0 M) 
0.02 2 100 960.00 60.0 STOCK 2 (5.0 M) 
0.02 2 100 600.00 Initial Re-tube 
0.02 3 150 635.29 35.3 STOCK 3 (20.0 M) 
0.02 4 200 675.00 39.7 STOCK 3 (20.0 M) 
0.02 5 250 720.00 45.0 STOCK 3 (20.0 M) 
0.02 6 300 771.43 51.4 STOCK 3 (20.0 M) 
0.02 7 350 830.77 59.3 STOCK 3 (20.0 M) 
0.02 8 400 900.00 69.2 STOCK 3 (20.0 M) 
0.02 9 450 981.82 81.8 STOCK 3 (20.0 M) 
0.02 10 500 1080.00 98.2 STOCK 3 (20.0 M) 
The mixed solutions were made homogeneous by inverting the tube at least 
three times. It must be stressed that although volume measurements were used to guide 
our titration, actual weights of all compounds and solvents added to or removed from 
the tube (e.g. to avoid overfilling) were determined to ensure accuracy. The G:H ratios 
were then re-calculated for the final presented data to ensure that correct values were 
used in the subsequent binding constant determination. Resultant peak shifts are 
plotted following requirements of the binding constant determination software, 
discussed in subsection 2.4. 
2.2.8 Proton nuclear magnetic resonance (1H-NMR) spectroscopy  
Nuclear magnetic resonance (NMR) spectroscopy is a technique used to 
observe the local magnetic fields around atomic nuclei, and plays a significant role in 
various fields including solving organic and biomolecular (e.g. DNA or protein) 
structural problems, obtaining three-dimensional structure of a specific protein, host-
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ligand interaction.22–24 The magnetic property of the atomic nuclei is fundamental to 
the technique. The technique relies on the fact that nuclei with odd mass and/or odd 
atomic number (e.g. 1H, 13C, 15N, 31P) have a spinning property. With respect to 1H, a 
spinning proton with nuclear spins of 1/2 generates a magnetic field, similar to a small 
magnet. In the absence of an external influence, the directions are randomly orientated, 
however, exposure to an external magnetic field, B0, causes the nuclei to either 
following the external magnetic field (spin aligned) or against it (spin opposed). The 
direction aligned with the external magnetic field is the lower energy spin state hence 
will be the more populated state (Figure 2.12). 
 
Figure 2.12. The effect of external magnetic spin on the 1/2 nuclear spin of some nuclei. 
A subsequent exposure to a radio frequency (RF, energy) radiation, leads to the 
nuclei absorbing the energy, which in turn affects the nuclear magnetic spin by 
changing or “flipping” the direction of the nuclear magnetic spin. The energy required 
to flip the direction depends on the strength of the used external magnetic field. The 
energy transfers between the low base energy state to a higher energy state take place 
at a wavelength that correspond to a specific radio frequency of about 60 - 100 MHz. 
As the spin returns to its base level, the absorbed energy is emitted at the same 
77 
 
frequency. The radio frequency signal emitted by the sample decays exponentially, 
generating a free induction decay signal (FID). The FID contains all of the information 
in the NMR that matches the transfer or gap, however it is difficult to acquire 
information in this format. Fourier transformation of the FID, a time domain signal, 
produces the frequency domain NMR spectrum which corresponds to the nucleus of 
interest.25 Flipping of the proton from one magnetic alignment to the other by radio 
waves is known as resonance condition. The resonance condition relies on the exact 
combination of external magnetic field and radio frequency. For a specific radio 
frequency e.g. 100 MHz, and depending on the neighbouring or attached atom, each 
hydrogen atom will need a slightly different applied magnetic field in order to bring it 
into the resonance condition. Therefore, the required magnetic field is a useful 
indication to the hydrogen atom's environment in the molecule.  
Our experiments are focused primarily on proton NMR (1H-NMR). The 
deuterated solvents were used to ensure that the solvent protons do not overpower the 
spectrum and hinders detection of the tested compounds. 1H-NMR data were acquired 
in commercially available deuterated solvents, i.e. DMSO-d6, acetonitrile-d6, acetone-
d3 or DMF-d7 on a Varian Inova-500 spectrometer (
1H at 499.77 MHz) and on Bruker 
Ultrashield 400 Plus (1H at 400 MHz). In general, an NMR spectrum can either be 
acquired by varying or sweeping the magnetic field over a small range while observing 
the radio frequency signal from the sample, or by varying the radio frequency radiation 
while holding the external field constant.26 For both instruments, the latter concept was 
used. The data from Varian Inova-500 spectrometer were analysed on MestRe nova 
(Mnova) software (Mestrelab Research). Meanwhile, the data obtained from Bruker 
Ultrashield 400 Plus were analysed using Topspin-NMR software (Bruker). The 
chemical shifts were measured in the range of +16 to -4 ppm. 
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For all the 1H-NMR experiment, the peak shift is only considered as significant 
when the value exceeds 0.002 ppm. The Varian Inova-500 and the Bruker Ultrashield 
400 Plus spectrometer are highly sensitive NMR instruments, capable of measuring 
changes to the resonance peak, i.e. peak shifts, up to the fourth decimal place ppm. 
However, along with the sensitivity comes measurement error due to various reasons 
e.g. different NMR tubes use, sample exposure to sunlight, the presence of metal object 
close to the NMR instrument, concentration variation etc. For example, different tube 
may have different concentricity and camber. Concentricity is the difference between 
two radial centres obtained by using the outer and inner tube's circumference as 
reference points, in short the thickness variation. Meanwhile, camber is a measurement 
of the degree of curvature of the tube with respect to the tube’s radial axis, in short the 
straightness of the tube.27 If the used tubes have high concentricity and camber values 
which vary significantly from one tube to another, it would lead to magnetic field non-
homogeneity and poor NMR spectra.27 Exposure to sunlight may increase the 
temperature of the sample prior to analysis. However, according to Loening and 
Keeler,28 in most cases minor temperature differences to the sample do not lead to 
much inaccuracies in the resultant spectrum, as long as the system temperature or the 
temperature reported by the spectrometer is constant. Since our measurements deal 
with very small shifts, however, these inaccuracies have an impact on the resulting 
data. Meanwhile, the presence of metal object close to the NMR instrument can disrupt 
the field around the superconducting coil and in consequence interfere with the super-
conducting magnet unit. A magnetically attached metal object to the NMR unit would 
disrupt the shimming and therefore resonance peak shape.29 
To minimise these errors, all experiments are done using a single tube, and 
started at approximately the same time of the day and room conditions (window blind 
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closed to avoid sunlight exposure) at relatively the same concentration and 
temperature. Zero-point standards were also used so that all generated chemical shifts 
can be calibrated internally. In the majority of our experiments, TMS was used as the 
standard, while in the D2O environment DSS was used due to limited solubility of 
TMS in water. These zero-point standards are susceptible to influence by temperature, 
as it has been reported that TMS varies slightly with temperature with -0.0004 ppm 
°C-1.30 However, since our measurements are at a constant temperature of 25 C with 
air conditioning in the room and temperature control within the magnet, this effect can 
be neglected. The temperature shift of the standard is also negligibly small when 
compared to the 0.002 ppm resolution of the instrument.  
2.2.9 Continuous variation method (Job’s plot) 
The fundamental of Job’s plot has been mentioned in Chapter 1. In principle, 
Job’s plot considers only one complex in solution which predominates over all other 
species under the conditions of the experiment. Job’s plot analysis requires that the 
sum of the host and guest concentrations is kept constant throughout the experiment 
whilst varying each component of the mixture. Using the stock solution as described 
in 2.3.1, the used mixtures are illustrated in Table 2.2. 
Table 2.2. Job's plot setup for 0.1 M host and 0.1 M guest compounds. 10 sets of tubes were used, each 
containing different volume which corresponded to the different intended host or guest fractions. 
[H] [G] Host fraction Vol. stock Host Vol. stock guest 
0.00 0.10 0.0 0 500 
0.01 0.09 0.1 50 450 
0.02 0.08 0.2 100 400 
0.03 0.07 0.3 150 350 
0.04 0.06 0.4 200 300 
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0.05 0.05 0.5 250 250 
0.06 0.04 0.6 300 200 
0.07 0.03 0.7 350 150 
0.08 0.02 0.8 400 100 
0.09 0.01 0.9 450 50 
0.10 0.00 1.0 500 0 
 All spectra were calibrated by fixing the shift to a TMS standard. The Job’s 
plot curve was generated by multiplying the change in the resonance peak shift by the 
host fraction. Plotting resultant peak shift against the host fraction or concentration 
would, in most cases, produce a quadratic curve, with a maximum at the host fraction 
(x-axis) equalling the stoichiometry of the host-guest complex. 
2.2.10 1H-NMR dilution experiment 
1H-NMR dilution experiments were performed to ensure that the subsequent 
peak shift observed is a result of the titration experiment due to interaction with guest 
e.g. water, and not the effect of dilution of the tested compound. 1H-NMR dilution 
experiments were carried out by preparing sufficient amount stock solutions of the 
selected compound in the respective deuterated solvent, as indicated in 2.3.1, and 
diluting the main stock with molar ratio aliquots of the main solvent comparable to the 
guest ratio added.  
2.2.11 1H-NMR titration experiment 
The titration experiment was done to probe the initial effect of water interaction 
with the tested compound. Sample preparation is as mentioned 2.3.1 and as indicated 
in Table 2.1. Selection of a suitable solvent system for the whole titration experiment 
is very important. Since the guest is water or DMF, two main criteria should be 
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fulfilled; adequate host and host:guest complex solubility, and the guest-solvent 
miscibility. The initial water content of the solvent was determined either through KF 
titration or by integrating the NMR water peak and comparing it to a known (host or 
TMS) concentration or mass. A high or lower host concentration can be used 
depending on required analysis, however, for most of our titration, a lower, NMR-
visible concentration was selected as it can avoid the precipitation of the resultant host-
guest complex. Although heating the solution can remove the precipitate, the heat 
introduced would affect the solution concentration (due to solvent evaporating) as the 
host concentration must be kept constant throughout the experiment using the 
measures mentioned in 2.3.1.  
The maximum guest concentration used was limited by the solubility of the 
host and/or the host-guest complex. Precipitation or peak shift plateau signalled the 
endpoint to the titration. Although reliable binding constants may be obtained from ten 
data points with equal spacing (c.f. Job’s plots), it is customary to obtain 15-20 data 
points with more values at lower guest concentrations (Table 2.1, setup for 27 data 
points).31 The higher number of data points at lower guest concentration is crucial as 
they provide early indication towards the trajectory of the subsequently fitted curve. 
The resultant resonance peak shifts were then recorded and plotted for binding constant 
measurement in following subsection (2.4). 
2.3 Binding constant determination using open source fitting tool: 
Supremolecular.org 
A web-based open-source freeware, BindFit from http://supramolecular.org 
was used to calculate the binding constants (Ka).
31–33 The binding constant 
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determination is based on the fitting of the observed peak shift data points to a 
simulated isotherm line (Figure 2.13).  
 
Figure 2.13. Fitting of a hypothetical resonance peak shift against G:H molar ratio to a theoretical binding isotherm 
represented by the red line. 
However, unlike commercial software packages like GraphPad34 or modified 
fitting programs running on generic mathematical programming software like Origin, 
Excel, Matlabs or Mathematicas, BindFit fits all the observable peak changes, hence 
Ka determination is based on more than one set of data. For example, following a 
1H-
NMR titration, more than one proton resonance is visible and will show noticeable 
shifts upon complexation of the host, therefore, all the visible protons have to be 
considered in the fitting. According to Thordarson,31 fitting more data of the same 
titration (named global analysis) will reduce error compared to single-experiment or 
local fitting.  
Once the peak shift data are obtained and the binding constant (Ka) determined, 
the free energy (G) changes can be calculated and used as a measure of affinity (along 
with the obtained Ka values) between the components, according to (Equation 2.5. 
Herein, G refers to the Gibb’s free energy, R corresponds to the universal gas 
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constant, 8.3147 J K-1 mol-1, T is the temperature in kelvin and K is the binding 
constant. 
(Equation 2.5)
G = -R T ln(Ka) 
The stoichiometry selection for the binding model is initially based on Job’s 
plot measurements. At the same time, all the data points are also fitted to all the 
available models (1:1, 2:1 and 1:2) in the BindFit software as the programme also gives 
an indication towards the best fitting interaction stoichiometry (fit which generated the 
least % error). Having a Job’s plot to support the selected fitting is always the best 
route, however, if multiple species are present in the test solution, Job’s plot result will 
not be reliable as the plot only considers one dominant species in its measurement.35  
2.4 Molecular dynamics (MD) simulations: Tetrazole/DMF system 
This simulation was performed by Dr. Antonella Ciancetta, a collaborator at 
QUB. MD simulation is a computer simulation of atoms and/or molecules interacting 
using basic laws of physics, e.g. Newton’s law of motion.36 MD allows for 
investigation into the kinetic and thermodynamic property of a system including 
macromolecular stability,37molecular recognition and the properties of complexes38,39 
as well as many others. MD is widely used in molecular design (e.g. drug and protein 
design40,41) and structure determination and refinement (e.g. X-ray and NMR).42,43 
The three basic steps are followed in any MD simulation, which is simplified 
as firstly setting up the initial state (system setup). In MD, atoms are typically 
represented as hard spheres which interact according to a van der Waals (Lennard-
Jones) potential.44 Partial charges are calculated by quantum methods to represent the 
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distribution of electronic charge on those molecules.45 Meanwhile, bonds and their 
respective angle of constraints are typically represented as e.g. Hooke’s Law,44 or 
harmonic and anharmonic oscillators.46 The second step is the introduction of the 
interaction potential in the system (system equilibration). Prior to starting the 
simulation, a range of velocities is chosen that matches the Boltzmann distribution for 
a temperature, and then those velocities are assigned randomly to each atom. Similar 
methods are then used to put energy into the bond angles and dihedrals. The last step 
is to run the prediction on molecule movement, typically via Newton’s equation of 
motion (system production) which allow structural fluctuations e.g. molecules 
transferring both energy and momentum to one another via electrostatics and van der 
Waals interactions, to be observed relative to time.44 The details of Dr. Antonella 
Ciancetta simulation work is as follows: 
System setup. Molecules were placed in a cubic box of 100 Å x 100 Å x 100 Å 
dimensions. The binary tetrazole/DMF mixture was set up by using packmol.47 Five 
different systems were simulated with increasing DMF concentration, as shown in 
Table 2.3. Water molecules were added to the mixture by means of HTMD (Acellera, 
Barcelona Spain, version 1.9.10).48 MD simulations with periodic boundary conditions 
were carried out with the ACEMD engine (Acellera, version 2017.11.30)49 and 
CHARMM364/CgenFF(3.0.1)50,51 force field for water and solute molecules, 
respectively.  
System equilibration. The systems were equilibrated by performing a 5000-step 
minimisation followed by 4 ns of MD simulation in the NPT ensemble by maintaining 
the temperature at 310 K using a Langevin thermostat with a low damping constant of 
1 ps–1, and the pressure at 1 atm using a Berendensen barostat. Bond lengths involving 
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hydrogen atoms were constrained using the M-SHAKE52 algorithm with an integration 
time step of 2 fs.  
System production. The equilibrated systems were subjected to 200 ns of unrestrained 
MD simulations (NVT ensemble, damping constant of 0.1 ps–1, single run). Long-
range Coulombic interactions were handled using the particle mesh Ewald summation 
method (PME)53 with grid size rounded to the approximate integer value of cell wall 
dimensions. A non-bonded cut off distance of 9 Å with a switching distance of 7.5 Å 
was used. The simulations were run on one 1080 Ti NVIDIA GPUs (Nvidia, Santa 
Clara, CA). 
Table 2.3. Details of the simulated TTZ/DMF systems 
System Number Tetrazole 
equivalents 
DMF 
equivaents 
Number of 
water 
molecules 
Total number 
of atoms in 
the system 
1 1 0 32013 96255 
2 1 5 31375 95061 
3 1 15 30193 92955 
4 1 25 28872 90432 
5 1 50 26083 85665 
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CHAPTER 3  
 THE COMPLEX SOLID-STATE LANDSCAPE OF SODIUM 
DIATRIZOATE HYDRATES 
3.1 Chapter overview 
Pharmaceutical sodium salts are hygroscopic,1 hence are prone to incorporate 
water into their crystal structures, forming hydrate.2,3 The screen of the sodium salt 
model compound, diatrizoic acid monosodium salt, yielded five hydrates and two 
solvate forms. The water content of the hydrates varies from 0.3 to 8 molar equivalents 
of water, showing interconvertibility, stoichiometric and non-stoichiometric 
behaviour, and potential of amorphisation during release of water. One of the solvates 
was also found to be a water mixed solvate. The complex system observed highlights 
the importance of having a comprehensive data on any pharmaceutical sodium salts 
solid-state phase transition and hydration behaviour as it provides a guide for better 
formulation and manufacturing, as well as ensuring dose uniformity and stability of 
the final formulation. This chapter emphasises on the importance of thorough hydrate 
screening for pharmaceutical sodium salts, as the probability of water incorporation 
into their crystal structures is high. Also, this chapter showcases the complexity of the 
resultant crystalline hydrate system, which interconverts with the varying condition. 
Consequently, this chapter points to the need for early detection and characterisation 
of hydrates. The findings from this research has been published in Chemistry - A 
European Journal, with the same title (DOI:10.1002/chem.201703658).4  
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3.2 Introduction 
3.2.1 Background  
Optimisation of the physical and chemical properties of a new active 
pharmaceutical ingredient (API), such as flowability, hardness, stability, and 
solubility, is a routine challenge in the pharmaceutical industry. Many compounds are 
often synthesised having non-optimal properties, whether for manufacturing or patient 
safety, or even both. Thus further steps are taken, e.g. change of crystal form, co-
crystallisation or salt formation, to improve the unwanted properties. Salt formation is 
common to improve the solubility for molecules showing low to very low solubility in 
water. However, the salt formation will undoubtedly affect other physicochemical 
properties of the compound such as melting point, chemical stability, hygroscopicity 
and etc.5 Traditionally, the salt-forming agents are chosen based on trial and error,6,7 
and the salt form selected by pharmaceutical chemists is based on a practical basis 
addressing cost and ease of production. However, in recent times intelligent design for 
the salt selection process is more favourable,5,8 with more than half of all drug 
molecules used in medicine marketed as salts.9 Overall, sodium salts are amongst the 
most abundant salt forms, second only to hydrochloride salts of basic APIs.10 The 
current European Pharmacopoeia 9.011 monographs 79 pharmaceutically active small 
organic compounds as their sodium salt, 13 of which is individually or solely 
monographed as the hydrate form due to the form’s high stability and/or prevalence.  
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3.2.2 Challenges due to sodium salt hydrates formation 
In general, water can interact with crystalline solids through surface moisture 
adsorption, deliquescence, capillary condensation, and crystal hydrate formation.12 
The latter is less apparent (hence more severe) as water is incorporated into the crystal 
lattice, making the physical state appearance similar to that of a dry powder. The 
likelihood of water inclusion increases with the presence of charged (e.g. sodium salt) 
or polar groups (e.g. carbonyl (C=O),13 which is a common feature for 
pharmaceuticals. Though not definite, the possibility of crystalline hydrate formation 
especially in sodium salts could potentially counteract the benefits of the initial salt 
formation. Also, to avoid hydration of a salt is difficult as water is ubiquitous, for 
instance, atmospheric water cannot be avoided, and aqueous processing solutions are 
needed. Consequently, unexpected transformation spells numerous challenges. 
Humidity levels variations which lead to crystalline hydrates transformation can occur 
throughout the manufacturing process, for example, upon transitioning between high 
humidity (e.g. wet granulation) to low humidity (e.g. drying) processes.14–16 Post-
production, a crystalline compound can face humidity variations during storage, 
mainly due to an inconsistent temperature of the environment (e.g. storage condition 
or climate)17,18 or upon consumption. Contact with body fluids or as the patient takes 
the medication with water, could initiate the salt-hydrate transformation.  
A third of pharmaceutical compound can potentially form a hydrate,19,20 hence 
the formation is particularly problematic for pharmaceuticals, as due to 
thermodynamic reasons, hydrates have the lowest solubility in water of all solid forms 
of a specific compound.2 Lower solubility means lower bioavailability as a compound 
needs to be in solution to be absorbed. There are three general classes of crystalline 
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hydrate, firstly is the isolated site hydrates, where a single water molecule is 
individually incorporated or trapped in small clusters. Secondly is channel hydrates, 
where the structure features water-filled pores or sheets. The third class is metal-
associated hydrates, which is particularly important for pharmaceutical sodium salts 
as the water molecules coordinate to metal centres in the crystal structure. On top of 
the reduced solubility, metal-associated hydrates can show high or very high stability 
against dehydration, which means that is harder to remove the bound water.   
Bound water molecules can be mobile and migrate within the crystal lattice, or 
along the solid surface.21 As a result, water absorption enhances the drug molecular 
mobility, which in turn enhances the chemical reactivity.12 Several studies have 
confirmed the correlation between increased molecular mobility caused by the 
plasticising effect of water and drug degradation,22 especially for amorphous 
material.23,24 This translates into the reduced stability of the drug compound and may 
lead to recalls. One such example is in the case of levothyroxine sodium pentahydrate 
which has been recalled due to stability failures which lead reduced potency earlier 
than the expiration date.25  
Sodium salts are hygroscopic and have an enhanced water interaction.1 It is 
also not uncommon to see both interactions of ion coordination and hydrogen bonding 
in a single sodium salt crystalline hydrate.26  Incorporation of the water molecules into 
the crystal lattice also produces a different unit cell than that of the anhydrate form, 
and along with the introduction of additional forces mentioned, alters the physical 
properties, including solubility and dissolution rate of the sodium salt. Such variation 
of interaction and hydrate formation capability from a singular sodium salt is shown 
here in the case of diclofenac sodium, which can exists in four hydrates forms namely 
a trihydrate, two tetrahydrate forms and a pentahydrate form.27,28 Similar attribute can 
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also be observed in nedocromil sodium, which is reported to be present as a 
hemiheptahydrate, a trihydrate, and a monohydrate.29 Sodium deoxycholate is another 
example, showing a variety of crystalline hydrate forms, ranging from dihydrate and a 
tetra- and even octahydrate,30,31 with a recent study suggesting that hydrate interaction 
is non-stoichiometric.32 Finally, in the report on naproxen sodium, this sodium salt has 
been characterised to exist as four hydrate forms; a monohydrate, two dihydrates and 
a tetrahydrate form.33 The various hydrate forms possibilities translates into more 
uncertainty towards aqueous solubility and the chemical stability of the drug. The 
variance in solubility is very likely to have an impact on the bioavailability and toxicity 
profiles of the drug,34,35 which would translate into content uniformity problems for 
patients and jeopardise their safety.  
Chances of sodium salt and water interaction is high as water is everywhere. 
Sodium salt affinity towards water, coupled with the effect of hydration level 
variations can not only trigger the transformation of sodium salts to hydrates but also 
cause the formed hydrates to dehydrate or change their hydration level, especially if 
they are in a metastable state. Such metastable hydrate-hydrate transformation is 
reported in the case of pantoprazole sodium, reported to exists as four hydrates (i.e. 
hemihydrate, monohydrate, sesquihydrate and dihydrate)- in which the hemihydrate 
and monohydrate are metastable and readily transform to the dihydrate (stable form) 
at high relative humidity (RH).36 In another case, anhydrate sodium naproxen (the 
metastable form), has been reported to change to the dihydrate form above 43% RH,17 
while a more recent publication highlights a more complex interchange between the 
hydrate forms of sodium naproxen.37 Here, it is reported that both temperature and RH 
affect the resultant sodium naproxen hydrate form. At 25 °C and 50% RH, anhydrous 
sodium naproxen (AH) transforms directly to one dihydrate polymorph (DH-II), while 
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at 50 °C and similar RH, AH transforms stepwise to a monohydrate (MH) then to the 
other dihydrate polymorph (DH-I). DH-II transforms to a tetrahydrate (TH) more 
readily following sorption than DH-I at respective temperature and humidities. Both 
dihydrate polymorphs transform to the same MH following desorption at respective 
humidities.37 In the case of amorphous sodium indomethacin, it is reported to be stable 
at 21% RH for two months, but, upon exposure to 56% RH and above, the amorphous 
form rapidly crystallises to the trihydrate.38 This goes to show that variation in 
hydration level, e.g. RH instability, can affect the solid’s profile significantly.  
Hydrate formation can have a positive impact from a formulation point of view. 
As the most thermodynamically stable form, crystalline hydrate with good 
bioavailability is often pursued as the form of choice. Celecoxib sodium salt is such a 
case in which the mixed propylene glycol/hydrate form was found to be the most stable 
form at low and high humidities compared to the anhydrous solvate form.39 In some 
cases, a hydrate form is pursued as it improves drug absorption, as demonstrated in the 
pentahydrate of the celecoxib sodium salt, which improves the oral drug absorption by 
breaking up the strong hydrogen bonding interactions present in crystals of the poorly 
soluble marketed anhydrous form of the drug.39 Hydrated sodium salts can also offer 
an advantage from a manufacturing point of view, as shown in the case of diclofenac 
sodium tetrahydrate having improved flowability within the powder bed than its 
anhydrous counterpart, which eases industrial processes such as mixing, tabletting and 
capsule filling.40 
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3.3 Aims  
Given the problems and challenges mentioned, it is astounding that much focus 
of the publications on the crystal structure of pharmaceutical sodium salt has been on 
the predominant phase of these compounds, crystallisation procedures in the case of 
patent literature, and solubility and dissolution rate.41–43 As a result, many of the 
pharmaceutical sodium salts have not been fully characterised, and thus their phase 
transition behaviour cannot inform processing and manufacturing steps. Hence, this 
chapter aims to characterise a monographed sodium salt thoroughly, focusing on solid-
state phase transition with regards to salt-hydrate transformation. Sodium diatrizoate 
is selected as the model compound as the solid-state landscape has not yet been 
investigated in depth with just a single hydrate form reported for this sodium salt.44 
3.3.1 The model compound: Sodium diatrizoate 
Sodium diatrizoate (DTS) is a radiocontrast agent containing iodine, and 
multiple proton donor and acceptor sites (Figure 3.1). The sodium salt along with the 
free acid form is monographed in the European, British as well as United States 
pharmacopoeias.11,45,46 The sodium salt is the optimisation product of diatrizoic acid 
(DTA), which has low aqueous solubility; reported to exists in three anhydrous 
modifications, two hydrates and nine solvate forms.47 The reported hydrate forms are 
the di- and tetarto (1⁄4) hydrate. Meanwhile, a single tetrahydrate form is reported for 
DTS, with an earlier report suggesting that the form contains 4 moles of water 
(tetrahydrate).44 Meanwhile, a recent report has found this form to incorporate 4.5 
molar equivalents of water per salt unit instead.47 The X-ray and neutron crystal 
structures show that, while most water is coordinated to the sodium cations, there are 
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channels in the structure through which the water can potentially freely diffuse in and 
out. Commercial preparations include the similarly monographed diatrizoate 
meglumine45 and/or sodium salt at various concentration, 30, 50, 60, and 76 % (w/v) 
solution.48 DTS salt has an advantage over the meglumine salts, as the later have a 
higher viscosity than the sodium salt. Higher viscosity formulation would require 
greater injection pressures to deliver the same amount of material, increasing the 
possibility of patient trauma and catheter damage. Moreover, meglumine salt usually 
has a lower iodine content as a result of the increased weight of the meglumine ion. 
Therefore, the amount of iodine delivered per second will be smaller.49 Trade names 
include Hypaque, Gastrografin and Urografin, the latter being a combination of the 
sodium and meglumine salts. Although marketed as a solution, information on the 
solid state can inform the manufacturing, ensuring the correct form is manufactured 
and along with the humidity studies, help to identify optimal conditions to generate 
bulk phases safely. Also, in-depth investigation of sodium salts used pharmaceutically 
would guarantee dose uniformity and stability of the final formulation.  
 
Figure 3.1. Sodium diatrizoate (DTS) structure. 
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3.4 Results and Discussion  
The screen reveals DTS to exist in at least five different hydrated crystal forms. 
Powder X-ray diffraction shows all of them to be distinctly different, with three (Hy8, 
Hy1 and Hy0.5-3.5) crystallise directly from solution, while the other two result from 
the conversion of another form induced either by humidity or heating. Also, a methanol 
trisolvate and a mixed DMSO/H2O monosolvate directly crystallise from the 
respective solvents. An unsolvated crystal form could not be identified.  
3.4.1 The octahydrate 
Initial dynamic vapour sorption (DVS) isotherm of the amorphous commercial 
sample shows that the sample takes up a maximum of 22.76% of its weight (Figure 
3.2) at the highest measured humidity, 90% RH. This amount corresponds well to a 
calculated stoichiometry of 8 moles of water per DTS unit (calculated weight change 
22.67%), and the crystal form present at high RH values will furtheron be called Hy8.  
 
Figure 3.2. Sorption/desorption isotherms of the commercial sample of DTS. The starting point is at 40% RH 
following a sorption step, then desorption to 0% RH, and finally sorption up to 90% RH again. 
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Hy8 could also be obtained by storing the commercial product in a water slurry, 
resulting in a crystalline sample consisting of thin diamond shaped plates (Figure 3.3). 
The observed habit corresponds well to the previously reported crystallisation 
behaviour from water.47  Heating up of the crystals using thermal microscopy (TM) 
revealed the low thermal stability of this crystal form. The dry powdered sample lost 
birefringence above 40 °C, while a sample containing mother liquor to avoid 
desolvation before heating, dissolved in the surplus solvent above 33 °C. 
 
 
Figure 3.3. Thermal microscopy (TM) photomicrograph of Hy8 at different temperature points. Top set (a to c) is 
dry powdered sample while bottom set (d to f) is in the mother liquor. 
The powder X-ray diffraction (PXRD) trace of these plates is different to the 
known tetrahydrate (Hy4), as compared to the calculated pattern of Hy4 which is based 
on the neutron structure.47 Humidity controlled PXRD also confirmed the octahydrate 
formation (Figure 3.4 (a)) starting from the amorphous commercial product. Coming 
from a low (Figure 3.4 (a) bottom trace) to higher humidity (Figure 3.4 (a) top trace) 
shows clear crystallisation process indicated by the sharp peaks appearing at 80% RH 
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coming from the amorphous sample, which is represented by the typical broad hump 
PXRD trace at the lower humidities. 
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Figure 3.4. Humidity controlled PXRD patterns starting from a) amorphous product at 30% RH forming Hy8 at 90% RH b) Hy8 at 90% RH and passing through the transition to Hy4 towards 35% 
RH c) continuation from 35% RH to 5% RH showing sample losing crystallinity (amorphisation). 
 
a)  b)  c)  
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Figure 3.5. The octahydrate (Hy8) PXRD trace comparison to the calculated powder pattern (black) of the 
tetrahydrate (Hy4). 
Thermogravimetric analysis (TGA) of Hy8 shows a dehydration step with the 
weight loss of 37.70% (Figure 3.6). Closer investigation of this dehydration up to 
150 °C (Figure 7) reveals a two-step desolvation profile, even though no intermediate 
equilibrium is reached. Weight loss starts immediately with a slope of -0.3% weight 
change per °C in the range from 22.6 °C to 63.9 °C. The weight loss between these 
temperatures sums up to 12.81%. After this first weight loss region, the slope changes 
slightly and becomes steeper (-0.5% per °C) between 63.9 °C to 110.1 °C. The second 
weight loss recorded equals 22.56%, which corresponds to 7.963 moles of water. DSC 
analysis confirms this two-step profile which shows two overlapping endothermic 
events corresponding to the events observed in the TGA trace (Figure 3.7). This high 
total weight loss value of nearly 37% for the whole run was due to the wetness of the 
sample, which was analysed in slurry to compensate its instability. In the first weight 
loss step, the surface attached and interstitial water evaporates leading to the intact 
Hy8 crystal form. The second endothermic event seen in the DSC and weight loss 
value from TGA of that event corresponds well to the data expected for Hy8.  
Desorption of Hy8 by reducing the humidity leads to the formation of the 
known tetrahydrate at RH values lower than 50% (Figure 3.2), as confirmed by PXRD 
(Figure 3.8). Hy4 could also be obtained by storing the commercial sample in an 
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aqueous slurry and drying the powder at room conditions. TGA analysis of the form 
from ambient temperature and humidity records 11.29% weight difference, which 
translates into 4.5 moles of water (Figure 3.6).   
 
Figure 3.6. TGA thermograms of tetra- vs octa- hydrate forms of DTS 
 
Figure 3.7. TGA (top) and corresponding DSC (bottom) thermograms of both recorded at 10 °C min-1. The 
measurement was conducted on the wet sample to ensure full hydration  
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The curve from the desorption cycle of the humidity controlled PXRD 
compliments the data, showing Hy4 formation from desorption of Hy8 (Figure 3.4 (b)) 
as the humidity reduces from 90 to 35%. The experimental powder pattern of this form 
shows some resemblance to the pattern calculated from the single crystal structure 
published earlier.47 However, due to the platy nature, this crystal form suffers from 
pronounced preferred orientation. The presence of a phase transition between the 
temperature of the powder and the single crystal measurements (300 vs 120 K) cannot 
be unambiguously ruled out.  
 
Figure 3.8. Hy4 PXRD comparison to the calculated powder pattern (black) and Hy8. 
 
 
Figure 3.9. Photomicrograph of Hy8 and Hy4 habit. 
 
Hy8 Hy4
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Due to it originating from Hy8, which is the initial crystallisation product from 
water, the crystal habit of Hy4 resembles that of Hy8 (Figure 3.9). Surprisingly, the 
crystals of Hy4 are perfectly translucent and do not show any signs of blackening of 
the particles or any sign of a change from the bright single coloured interference (in 
dark-field) to a dim-grey interference colour or pseudomorphosis in short. 
Pseudomorphosis typically follows crystal form changes and solvent loss from the 
crystals; the lack of it points to the close structural relationship of these two highly 
hydrated crystal forms.  
 
Figure 3.10. High-resolution dynamic vapour sorption (DVS) isotherm of the transition between Hy8 and Hy4. The 
grey line represents desorption curve, the black line sorption. 
The high-resolution DVS shows the reversibility of the transition between Hy8 
and Hy4 (Figure 3.10). Hy8 is stable with only minor weight change above 50% RH. 
The sample then continuously releases water beyond this point, which accumulates to 
2.280 moles of water upon reaching 40% RH. Following sorption of Hy4, it is clear 
that the phase transition to Hy8 starts above 55% RH, which follows a different path 
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to that of the desorption, suggesting different kinetics between the two processes, with 
both having a single step transition. 
 
Figure 3.11. High-resolution DVS of the dehydration of Hy4. Insert represents the mass change (dm), respective 
RH levels and mass change rate (dm/dt) of the steps below 5% RH. 
Hy4 is stable between 40 and 10% RH. (Figure 3.2). Storing Hy4 within this 
stability range shows a slight variation in water content of 0.5%, varying between 4.47 
and 3.97 molar equivalents of water incorporated, which corroborates earlier report 
that full occupancy of all water positions for Hy4 would result in a stoichiometry of 
4.5 water molecules per DTS unit.47 This result suggests that the variation in water 
content is connected to partial occupancy of the distinct water positions within the 
crystal form. It is thus likely that the structure of Tønnesen et al. has been measured at 
the lower end of this humidity spectrum and therefore resulted in four water molecules 
being refined. The DVS also corroborates the TGA data mentioned earlier; as the TGA 
liberates all incorporated water from the fresh sample, with 4.5 molar equivalent form 
Hy4 being also recorded (Figure 3.6). Below 10% RH, the remaining water is released 
(Figure 3.2). High-resolution DVS of this transition (Figure 3.11) shows that step-like 
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dehydration takes place below 4% RH, in which the sample loses 7.8% of its weight 
(2.76 molar equivalents of water). This mass loss leads to an intermediate 
monohydrate, which is stable at 2% RH but undergoes a further mass loss below this 
humidity. As the humidity controlled PXRD can only detect down to 5% RH, the 
existence of the transient monohydrate cannot be confirmed via this method. 
Following desorption (Figure 3.4 (c)) from 35% RH and lower, the sample undergoes 
amorphisation (loses crystallinity), which is evident from the trace losing its peaks and 
becoming broader, thus making the comparison to previous traces more difficult. From 
the DVS data, however, it is conclusive that this intermediate is indeed a crystalline 
phase, as the mass of the sample is in equilibrium at 2% RH, while this is not reached 
at 1% RH (Figure 3.11 insert). At the lower humidity, the sample is in the process of 
releasing the remaining incorporated water; however, the mass step is not at its final 
value, as clearly shown by the remaining slope in the dm/dt curve. Even though only 
existing at an extremely narrow humidity range, the monohydrate does not represent a 
kinetic intermediate, as the crystal form is evidently stable over six hours (potentially 
longer) under these conditions, which is the time that this step has taken in the 
measurement. 
3.4.2 The 0.3-1 hydrate 
Tracking the DVS sorption curve of the completely dehydrated sample up from 
0 to 1% RH, a weight gain of 0.95% (0.34 molar equivalence of water) is observed 
(Figure 3.11). The sample takes up another 0.72% in weight, (corresponding to 0.25 
moles of water) in a linear manner over the following nine steps up to 10% RH, and 
the trend continues upwards to 40% RH (Figure 3.15), at which further 1.07% uptake 
(0.38 molar equivalent of water), adding up to a total of 0.97 molar equivalence of 
109 
 
water is incorporated; hence this form is identified as Hy0.3-1.0. PXRD of Hy0.3-1.0 
is different from the previous traces (Figure 3.13). Two different experimental routes 
could reproduce this form; firstly, by mirroring the conditions of the DVS, through 
drying a sample of the Hy8 at 25 °C in dry nitrogen flow over ten hours using TGA. 
Secondly, the Hy8 was dehydrated by TGA at 150 °C for ten minutes. The resulting 
materials show similar PXRD patterns, and even though the peaks have low intensity, 
their positions are distinctly different to those of Hy8 and Hy4  (Figure 3.12 and Figure 
3.13). In comparison, the peaks are broader and less intense, which is in agreement 
with the fact that the sample undergoes amorphisation at low humidity as discussed 
earlier. 
 
Figure 3.12. PXRD patterns of nitrogen dried vs heated sample of Hy8 
TGA of both samples showed a comparable weight loss of approximately 1% 
corresponding to 0.4 molar equivalents of water after being exposed to environmental 
humidity (Figure 3.14).  
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Figure 3.13. Hydrate Hy0.3-1.0 (heated sample) PXRD comparison to Hy4 and Hy8 
 
Figure 3.14. TGA thermogram of Hy0.3-1.0 recorded at 10 °C min-1 
 
Figure 3.15. DVS isotherm of Hy0.3-1.0 showing slow conversion to Hy8 at higher humidities. Identical Hy8 
desorption curve observed afterwards.  
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Upon sorption above 40% RH, the form takes up water at a higher rate, then 
transforms into Hy8 from 70% RH onwards. The curve records only a small increase 
from 70% RH (19.93%) onwards to the highest point of saturation of 90% RH, which 
is 21.09%, (7.44 moles of water); gaining just 1.38 moles of water from the 70% RH 
mark. The final figure is less than the expected value for Hy8, and the slow transition 
is reminiscent of the transition of Hy4 to Hy8 and presumably hampered by the low 
crystallinity of the sample as shown by the humidity-dependent PXRD data, and 
potential amorphous fraction (Figure 3.4) introducing a kinetic component to the 
event.  
3.4.3 Crystal form from direct crystallisation: The monohydrate 
A full crystallisation screening was performed to attain the intermediate 
hydrated forms (following desorption of Hy4 at 2% RH). The screen resulted in two 
more hydrate forms, which one form is showing unique needle-shaped crystals habit 
(Figure 3.16). Two solvate forms were also found from methanol and DMSO 
respectively. Table 3.1 lists a summary of the crystal forms obtained from the 
screening process.  
 
Figure 3.16. Photomicrograph showcasing the unique needle habit, only observe in Hy1 form. 
Hy1
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The first of the two new hydrate forms is crystallised from evaporation and 
slow cooling experiments using acetone, acetonitrile, the higher alcohols, 
nitromethane, ethyl acetate, THF and 2-butanone under ambient conditions. As stated, 
microscopic observation revealed that this form appears to have needles habit in 
contrast to the previous platy forms.  PXRD analysis of this needle form shows 
different peak positions compared to Hy0.3-1.0, Hy4 and Hy8 (Figure 3.17), 
confirming that it was indeed a new form. 
Table 3.1. Summary of slow cooling, fast cooling, precipitation, and evaporation experiments 
Solvents Slow cooling Evaporation Fast cooling Precipitation 
Acetone Hy1 Amorphous x[a] x 
Acetonitrile Hy1 x Amorphous x 
Amylalcohol Hy1 x x x 
1-Butanol Hy1 x x x 
2-Butanol Hy1 Hy1 x x 
Chloroform Amorphous Amorphous x x 
Dichloromethane Amorphous x x x 
Diethyl ether Amorphous x x x 
Dimethylformamide Amorphous x Amorphous x 
Dimethylsulfoxide x x x Solvate 
Dioxane Hy1 Amorphous x x 
Ethyl acetate Hy1 x x x 
Ethyl-methyl-ketone Hy1 x x x 
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Ethanol Hy1 Hy1+Hy2 x x 
Hexane Amorphous x x x 
Methanol Solvate Hy1 x Amorphous 
Nitromethane Hy1 x x x 
1-Propanol Hy1 Hy1 Amorphous x 
2-Propanol Hy1 Hy1 Amorphous x 
Tetrahydrofuran Hy1 Amorphous x x 
Water Hy4/Hy8 x Hy4/Hy8 Hy4/Hy8 
[a]: indicating solvent did not evaporate/ crystal did not form/ experiment unable to be performed. 
 
  
Figure 3.17. Monohydrate (Hy1) PXRD along with the calculated pattern (black) in comparison to Hy4, Hy8, and 
Hy0.3-1.0. 
TGA analysis from ambient to 300 °C, shows 3.26% weight loss (Figure 3.18), 
which corresponds to 1.1 molar equivalents of water, hence this form in referred to as 
a monohydrate (Hy1). The TGA trace of Hy1 still share the continuous weight loss 
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feature when compared to the thermogram of Hy4 and Hy8 (Figure 3.6), with almost 
immediate, continuous weight loss observed even at lower temperature, however the 
dehydration slope of Hy 1 is less steep, with an apparent weight drop above 50 °C, 
hinting towards a more relatively stable hydrate compared to Hy4 and Hy8. A steeper 
slope would suggest that the volatile inclusion is not ‘held’ or bound as strong, hence 
liberated quicker at a similar heating rate.   
 
 
Figure 3.18. TGA thermogram of Hy1 recorded at 10 °C min-1 
 
Figure 3.19. DVS isotherm of Hy1 starting from room conditions down. Isotherm is normalised to the lowest point 
of the measurement. 
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The DVS isotherm of Hy1 (Figure 3.19) shows that the initial DVS value reads 
8% of volatile inclusion, a marked increase as compared to the water content of the 
same form (Hy1) as determined by Karl-Fischer titration which is just above 1 mole 
of water (3.75% corresponding to 1.375 molar equivalents of water. The reason for a 
higher DVS reading could be due to a low impurity of the material, potentially a higher 
hydrate, even though PXRD detected no impurities (Figure 3.17). Another possibility 
is that this hydrate shows non-stoichiometric characteristics, by having the ability to 
incorporate a higher amount of water at higher humidity. Desorption isotherm starting 
from 40% RH (room conditions) towards lower humidity shows a gradual release of 
the incorporated solvent with an increase in rate from 10% towards 0% RH. Following 
the sorption isotherm from 0 to 40% RH, the curve runs in parallel to the desorption, 
but at a lower weight. The increase in weight for the sorption run is due to the intake 
of water since the atmosphere in the instrument only contains water vapour. The 
difference in desorption and sorption curve would corroborate the assumption of a low 
fraction impurity containing either a considerable amount of water or a heavier solvent, 
e.g. ethanol from the solution crystallisation. Over the range from 10 to 60% RH, the 
sample shows an almost linear uptake of water, which agrees on the hypothesis of Hy1 
being a non-stoichiometric hydrate. Unfortunately, the sample amount of Hy1 
accessible by crystallisation is too low to perform humidity controlled PXRD 
measurements to prove this hypothesis. At humidity levels between 60 and 90% RH, 
the rate of weight gain increase as the sample converts to Hy8. A clear indication of 
Hy8 formation is that a similar curve to that of the octahydrate is observed following 
desorption. 
Hy1 single crystals are grown in a slowly cooled ethanol solution and 
crystallise out in tetragonal space group I4cm with half a molecular unit in the 
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asymmetric unit (Table 3.2). As expected, water is coordinated to the sodium cation 
(Figure 3.20). The packing shows both linear coordination polymeric strands as well 
as hydrogen bonding motifs running on parallel along the c axis (Figure 3.21). Similar 
to Hy4, the sodium cations coordinate to the deprotonated acid, however, the 
coordination scheme between Hy1 and Hy4 forms is different. The previous report 
mentions that the carboxylate in Hy4 coordinates to the sodium ion through one 
oxygen atom, while the other oxygen atom accepts a hydrogen bond from a water 
molecule. While Hy1 also shows one carboxylic atom coordinating to one sodium 
cation, but the other oxygen atom coordinates to two more sodium cation in the 
subsequent layer, along the c axis. This coordination pattern results in a square of 
alternating sodium and oxygen atoms, in which each carboxylic acid bonds to three 
sodium cations and each sodium bonds to three carboxylates. The water molecule 
finally bonds to a sodium cation, creating a fourth coordination bond. Remarkably, the 
incorporated water molecule does not donate any hydrogen bonds to the surrounding 
molecules and only acts as a filler for the coordination shell and space filler for the 
structure. The diatrizoate anions show the cis conformation in which the amide 
carbonyl moieties point towards one side of the central ring and the amino moieties 
are directed to the opposite side.47 The conformation allows chain-like or catemeric 
hydrogen bonding between the coordination polymeric strands along the c axis. 
Halogen bonds are not found in this structure. Overall, Hy1 packs more efficiently 
compared to Hy4 with a calculated density of 2.50 vs. 2.33 g cm-3 (Table 3.2). As most 
solution crystallisations resulted in Hy1 (Table 3.1), suggests that this form has lower 
energy, hence relatively more stable than the other forms. As mentioned earlier, TGA 
of the Hy1 also points to the form’s higher relative stability compared to Hy4 and Hy8 
due to a more gradual, less steep desolvation curve. 
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Figure 3.20. DTS Hy1 molecule showing water coordination towards the sodium cation (far left: blue arrow); 
sodium-acid (middle: yellow arrow) coordination observed towards a second DTA as the catameric strand grows; 
acid-sodium coordination (far right: green arrow) towards a third DTA. The colour code is carbon grey, nitrogen 
blue, oxygen red, iodine purple, sodium cyan and hydrogen light grey and this colour coding will be adapted for 
all following figures. 
Table 3.2: Crystallographic data of the crystal forms of DTS  
Crystal form Hy1 Hy0.5-3.5 Methanol 
solvate 
DMSO/H2O 
1:1 solvate 
Formula C11H8N2O4I3 
Na 
x H2O 
C11H8N2O4I3 
Na  
x 1.6 H2O 
C11H8N2O4I3 
Na  
x 3 CH4O 
C11H8N2O4I3 
Na  
x H2O x 
C2H6SO 
Mr [g mol-1] 653.92 660.90 732.01 732.05 
Crystal system Tetragonal Tetragonal Monoclinic Orthorhombic 
Space group I4cm I41/a P21/c Pca21 
T [K] 120 100 120 120 
a [Å] 19.965(1) 24.947(1) 7.9669(3) 16.9591(8) 
b [Å] 19.965(1) 24.947(1) 11.2998(3) 12.9735(6) 
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c [Å] 8.7022(7) 12.7382(7) 24.4405(7) 9.6080(4) 
α [°] 90 90 90 90 
β [°] 90 90 90.753(3) 90 
γ [°] 90 90 90 90 
V [Å3] 3468.5(4) 7927(8) 2200.1(1) 2113.9(2) 
Z 8 16 4 4 
ρcalcd [g cm-3] 2.5043 2.2147 2.210 2.300 
λ [Å] 0.71073 0.68890 0.71073 0.71073 
μ [mm-1] 5.453 4.774 4.317 4.585 
F(000) 2390 4823 1376 1364 
θ range for data collection 2.04 – 26.00 1.80 – 25.99 2.455 – 26.000 2.40 – 26.00 
Index ranges -26 > h > 24 
-25 > k > 25 
-12 > l > 12 
-40 > h > 40 
-40 > k > 40 
-20 > l > 20 
-9 > h > 7 
-13 > k > 13 
-30 > l > 30 
-21 > h > 21 
-16 > k > 16 
-12 > l > 12 
Reflections collected 24882 88103 16707 30704 
Independent reflections 1784 3894 4314 4131 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 1784/9/112 3894/0/210 4314/9/258 4131/0/239 
GOOF on F2 0.9375 1.0255 1.044 1.0536 
Final R indices (I>2σ(I)) R1 = 2.83 
wR2 = 8.22 
R1 = 7.32 
wR2 = 23.90 
R1 = 3.54 
wR2 = 7.09 
R1 = 1.69 
wR2 = 3.67 
R indices (all data) R1 = 4.19 
wR2 =8.89 
R1 = 7.52 
wR2 = 24.14 
R1 = 5.10 
wR2 = 7.82 
R1 = 1.84 
wR2 = 3.76 
Largest difference peak 
and hole [e Å-3] 
1.1572 and -
1.0746 
-3.0348 and 
3.8870 
1.313 and -
0.676 
0.8993 and -
0.9424 
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Figure 3.21. Packing representation of the single crystal structure of Hy1. For this and all following structural 
representations, anisotropic displacement parameters are drawn at 50% probability. 
3.4.4 The 0.5-3.5 hydrate 
Another hydrate form obtained from direct crystallisation is a platy form, 
which grows concomitantly with Hy1 from the evaporation of ethanol solution (Figure 
3.22). The platy crystal has a distinctly different PXRD trace compared to the other 
previously discussed forms (Figure 3.23). The platy form is then isolated and seeded 
using slow-cool experiment with ethanol as the solvent for subsequent analysis. TGA 
measurements reveal a water content of 6.83%, which correlates with 2.6 molar 
equivalents of water (Figure 3.24).  
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Figure 3.22. Photomicrograph of the platy second hydrate grows concomitantly with the needle habit of Hy1 
form.  
         
Figure 3.23. Hydrate 0.5-3.5 PXRD comparison to Hy1, Hy4, Hy8, and Hy0.3-1.0. 
Hy1+Hy0.5-3.5
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Figure 3.24. TGA thermogram of Hy0.5-3.5 recorded at 10 °C min-1. 
 
Figure 3.25. DVS isotherm of Hy0.5-3.5 starts from room condition, with initial desorption down the humidity 
range. Isotherm is normalised to the lowest point of the measurement. 
The DVS isotherm of this hydrate reveals that the sample contains 8.99% 
volatile component (3.2 molar equivalents of water), which is slightly higher weight 
percentage compare to the weight loss from TGA measurement when normalised to 
the lowest isotherm point of zero (Figure 3.25). Upon lowering the humidity, the 
sample loses weight in a continuous manner, which speeds up between 20 and 10% 
RH while stabilising again between 10 and 0% RH. Following desorption, the lowest 
water content of this hydrate is 0.5 molar equivalents, recorded at 0% RH. The sorption 
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isotherm follows an almost identical path to the desorption proving the non-
stoichiometric character of this hydrate. The highest water content of this form is 
9.75% (3.44 molar equivalents of water), as the humidity reaches 60% RH. Thus the 
ranges of this hydrate are between 0.5 and 3.5 molar equivalents of water, hence it is 
identified as Hy0.5-3.5. Above 60% RH, the sample takes up water at a higher rate 
and transforms to the octahydrate. Almost full hydration of Hy8 is reached indicating 
only minor traces of impurities. The second desorption isotherm trace is the same as 
that of Hy8. Diffraction data of Hy0.5-3.5 were collected on the synchrotron beamline 
I19 at Diamond Light Source, Oxfordshire, UK, due to the small size of the individual 
crystals. The structure solution shows that this hydrate crystallises in the tetragonal 
space group I41/a with one molecular unit in the asymmetric unit (Table 3.2). 
Surprisingly, only 1.6 molar equivalents of water can be refined, even though 
additional electron density points towards more disordered water in this structure. As 
in the other hydrates, the carboxylate moieties coordinate to the sodium cations; 
however, in Hy0.5-3.5 only one of the oxygen atoms is involved in the coordination. 
The resulting motif is a slightly twisted cube with alternating sodium and oxygen 
atoms at its corners (Figure 3.26). Each sodium cation furthermore coordinates to a 
water oxygen atom, whilst two half-occupied water positions bridge two faces of the 
cube. Comparable to Hy4, the second oxygen atom of the carboxylate moiety is 
involved in hydrogen bonding with a coordinate water molecule (donor-acceptor 
heavy atom distance: 2.74(2) Å). The hydrogen bonding motif found between the 
diatrizoate ions resembles that of Hy4: centrosymmetric dimers show hydrogen 
bonding between one amide N-H moiety to the non-coordinated oxygen atom of the 
carboxylate, whilst the N-H of the second amide hydrogen bonds to a third diatrizoate 
amide carbonyl. The latter hydrogen bond leads to spirals along the 41 axis. Halogen 
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bonds involving the iodine atoms are realised with both amide carbonyl oxygens as 
well as to the disordered water.  
The structure contains a 2-dimensional network of solvent-accessible channels, 
which run along the crystallographic a and b axes (Figure 3.27). These channels are 
the reason for the non-stoichiometric behaviour observed by DVS, as water from the 
environment can diffuse in and out of the structure without changing the overall 
scaffold. This hypothesis is corroborated by the remaining electron density, which is 
located within the channels and points towards additional disordered water molecules. 
Compared to Hy4 and Hy1, Hy0.5-3.5 has with 2.14 g cm-3 the lowest density, which 
may be due to missing modelled water. However, the low density points towards the 
highest energy and thus the lowest stability of this crystal form. This is corroborated 
by the occurrence of Hy0.5-3.5 in only one crystallisation experiment and even then 
only concomitantly with the more stable Hy1. 
 
Figure 3.26. A cluster of sodium cations, carboxylate moieties and water molecules of the Hy0.5-3.5 structure.  
124 
 
 
Figure 3.27. Packing of the crystal structure of Hy0.5-3.5 along the crystallographic a axis with clearly visible 
pores. 
 
3.4.5 The solvates 
In addition to the hydrated crystal forms, DTS was also found to exist as two 
solvates, of methanol and DMSO respectively, as confirmed by PXRD (Figure 3.28). 
The methanol solvate shows a weight loss of 13.03% by TGA, which corresponds to 
3 molar equivalents of methanol (calculated weight loss 13.113%, Figure 3.30). The 
methanol trisolvate grows as large blocks from the slow cooling experiment of 
methanol. As methanol is only slightly bigger than water and can comparably 
coordinate to the sodium cation, it is not surprising DTS takes up such a high number 
of methanol molecules, considering the complex hydration behaviour as discussed 
above. TGA of the methanol solvate suggests the form’s low stability as the weight 
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loss of starts at room temperature, and it is likely that desolvation occurs under dry 
conditions. The low stability is also apparent from the fact that Hy1 is crystallised from 
methanol by evaporation under ambient conditions (approximately 40% RH). 
 
Figure 3.28. PXRD patterns of the solvates of DTS with the calculated patterns of the crystal structures (grey). 
 
Figure 3.29. Photomicrograph of the methanol trisolvates habit. 
Methanol trisolvate DMSO:Water solvate
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Figure 3.30. TGA thermograms of the methanol and 1:1 DMSO/H2O solvates of DTS. 
Methanol solvate single crystal is grown in a slowly cooled methanol solution 
to a size suitable for X-ray diffraction. The resultant structure revealed to be indeed a 
trisolvate, with three solvent molecules coordinating to the sodium cation; along with 
carboxylate group and one amide carbonyl.  
 
Figure 3.31:1D coordination polymers of the (a) methanol and (b) DMSO/H2O solvates of DTS. 
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a  
 
b  
 
Figure 3.32: Packing of the crystal structure of DTS (a) methanol and (b) DMSO/H2O with the DMSO channels 
running along c. 
The structure crystallises in the monoclinic space group P21/c with one 
molecular unit in the asymmetric unit. The latter interaction is not realised in any of 
the hydrate structures and leads to 1D coordination polymeric chains along the 
crystallographic b axis. The second amide group accepts a hydrogen-bond from the 
amide N-H moiety of a neighbouring anion, which connects the polymeric chains with 
each other. Two of the methanol molecules are hydrogen-bonding to the carboxylate 
moiety of the anion, whilst the third methanol donates a hydrogen bond to a 
neighbouring methanol molecule. The solvate has relatively low stability despite 
having no clear channels which stop the solvent from diffusing through, coupled with 
the fact that the incorporated methanol being hydrogen-bonded.  
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Figure 3.33: Photomicrograph of the DMSO/water solvate habit. 
The second solvate is obtained from precipitation of DTS from DMSO solution 
with dichloromethane as the antisolvent. The small, irregularly shape (Figure 3.33), 
metastable solvate shows an experimental weight loss of by 24.8% TGA (Figure 3.30); 
which corresponds to one molecule of DMSO and water each per DTS. TGA 
observation also revealed although different, both solvent species are showing similar 
trace trend with immediate weight loss at a lower temperature. Both solvent species 
also release the incorporated solvents from the crystal lattice at about the same time, 
showing that the initial crystal structure is not stable without either of the guest 
components and collapses.  
DMSO/water mixed solvate crystallises in the orthorhombic space group Pca21 
with one molecular unit in the asymmetric unit. The sodium cation has the lowest 
coordination number with only four oxygen atoms (one from each solvent, two from 
diatrizoate) interacting with it. The coordination of two oxygen atoms of the anion 
through the carboxylate as well as one amide carbonyl leads to the presence of 1D 
coordination polymeric chains comparable to the methanol solvate. However, the 
geometry of the chain in this solvate is more open and linear due to the lack of 
hydrogen bonds, which in the case of the methanol solvate leads to a spiral with a short 
Methanol trisolvate DMSO:Water solvate
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pitch length. The open chains of the DMSO/H2O 1:1 solvate pack closely on top of 
each other leading to a herringbone packing. Whilst the incorporated water is donating 
hydrogen bonds to both the carboxylate and the amide moiety of the anion; the DMSO 
molecules are only coordinated to the sodium ion through their oxygen atoms and thus 
show higher motion around this hinge (detected as larger ADPs, Figure 3.32 (b)). Even 
though this mixed solvate is metastable, it gives another indication of the high 
attraction of DTS to water. 
3.5 Chapter summary and conclusion  
 
Figure 3.34: Schematic representation of the crystal forms and transformation pathways of DTS 
In-depth solid-state workup reveals that diatrizoic acid monosodium salt to 
exists in at least five hydrated crystal forms and two solvates (Figure 3.34). Overall, a 
wide range of water incorporation is observed, with three of them (Hy8, Hy1 and 
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Hy0.5-3.5) crystallise directly from solution while dehydration of Hy8 yields the 
remaining hydrates (Hy4 and Hy0.3-1)  along with one unconfirmed transient 
monohydrate. All the reported hydrate forms convert to Hy8 at high humidity levels. 
Meanwhile, the solvates contain three moles of methanol or one mole each of DMSO 
and water in a mixed solvate. 
Strong involvement of the sodium cation along with additional stabilising 
hydrogen bonding is observed from structural analysis of three hydrates and both 
solvates. The monohydrate and both solvates show 1D coordination polymers through 
interaction between the organic anion and the sodium ion. Coordination of all 
incorporated water is directed towards the cation and hydrogen bonds to other moieties 
of the crystal structure. However, Hy4 is reported to have a second water coordination 
motif, where water molecule acts as a bridge between the two amide carbonyl groups 
of the same molecule.47 No anhydrous crystal form of DTS could be identified. DTS 
complex solid-state behaviour highlights the importance of having a complete solid-
state landscape for any sodium salt under variable humidity conditions. The 
connection, as well as interconversion between the DTS hydrates, showcases the 
importance of humidity-controlled experiments to fully understand any 
pharmaceutical sodium salts, before formulation and manufacturing. 
As almost all of the structure of the crystalline form of DTS obtained contained 
water (except for the methanol solvate), it is a clear indication that water incorporation 
into the crystal lattice stabilises the structure. As the formed hydrates show a wide 
range of water content, consequently, such variety will be problematic in terms of 
measuring and maintaining dose, solubility and uniformity of any produced solid 
formulation. The instability and frequent phase changes with varying the humidity, 
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coupled with possible amorphisation upon dehydration or desolvation, presents an 
additional complication for manufacturing and stability of the final formulation. Even 
though DTS is not currently marketed as a solid, it is a good model compound to 
demonstrate the potential hazards of sodium salts in water-containing environments as 
well as highlighting the importance of a full and in-depth characterisation of other 
sodium salts used pharmaceutically. Furthermore, although it is common for most 
alkali and earth alkali salts to form hydrates by taking up water to complete their 
coordination shell, as well as for compound with charged or polar groups to 
incorporate water, in all cases, one cannot definitively say a hydrate has or will 
form.This uncertainty makes the screening for hydrates challenging and even more so 
when it comes to determining the stoichiometry (the compound: water ratio). Earlier 
prediction of hydrate formation would allow control over the emerging form; hence, 
investigating the interactions of drug and water in the solution-state is potentially 
useful as this allows observation to be done before the formation of the crystalline 
form.  
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CHAPTER 4  
 EXTENSIVE HYDRATE AND SOLVATE FORMATION OF THE 
ANTIALLERGIC COMPOUND TRANILAST  
4.1 Chapter overview 
Hydrate formation is a major problem in the pharmaceutical industry as it can 
reduce aqueous solubility and may impact drug stability. As part of our project to 
understand hydrate formation as well as the role which water plays, we investigate 
tranilast, an orally administered drug with poor aqueous solubility, reported to exists 
as an amorphous, five polymorphic monohydrates, three polymorphs and two solvates. 
However, data on the hydration behaviour is limited, with the monohydrate structures 
remaining unknown. Hence, a thorough polymorphism screening and a systemic 
investigation into the hydration behaviour were performed. Overall, we have observed 
22 forms, of which 18 are novel. In addition to six solvates and one solvent/water 
mixed solvate, we have found tranilast to exist as at least 11 hydrate forms: a trihydrate, 
a 2.3 hydrate, a 1.8 (transient) hydrate, three polymorphic monohydrates (one of which 
has been reported before), two 0.8 hydrates (exact water content are 0.8 and 0.7-0.8), 
a 0.6-0.7 hydrate, a hemihydrate and a 0.4 hydrate. Interestingly, gravimetric humidity 
variation analysis shows a stoichiometric hydrate to a non-stoichiometric interchange; 
also a complex hydrate interconversion coming from the methanol/water mixed 
solvate. Tranilast shows an unusually complex hydration behaviour for an uncharged 
drug molecule, highlighting the importance of a thorough understanding of the solid-
state landscape to ensure patients’ safety and efficient manufacturing process 
138 
 
4.2 Introduction 
4.2.1 Background and significance  
Hydrate formation is well-known issue in pharmaceuticals. It is estimated that 
one in three active pharmaceutical ingedients (APIs) can crystallise as the hydrate 
form.1 Water inclusion generally changes the intermolecular interactions within a 
crystal lattice. As a result, the hydrate is more thermodynamically stable in aqueous 
environments, having a lower free Gibbs energy than the anhydrous form, effectively 
lowering its solubility.2 A drug must be present in solution at the site of absorption to 
be absorbed. Unintentional hydrate formation which lead to the decrease in the 
aqueous solubility is problematic. Poor solubility is a longstanding and significant 
problem in pharmaceuticals, which is over-emphasised for oral solid dosage form. 
Considering that the oral route of drug administration is the most simple and 
convenient for patients,3 and solid, e.g. tablets, is the most popular oral dosage form 
(not only to patient, but also to manufacturer for various reasons, ranging from the ease 
of ingestion and production, to versatility in accommodating drug candidate),4 the 
problem will persist as the oral route and solid continues to be the route and dosage 
form of choice. To exacerbate, the number of new chemical entities in drug 
development having poor water solubility has significantly increased (to almost 90% 
in one report).5,6 As highlighted in chapter 3, API modification to improve aqueous 
solubility, e.g. salts formation, can backfire and lead to the formation of complex 
hydrate landscapes instead. For example, sodium diatrizoate is found to exist as five 
hydrate forms, with water content ranging from 0.3 to 8 molar equivalents, and 
showing complex transition profile between the forms (chapter 3).7 Another example 
is sodium naproxen which has been reported to exist as one monohydrate, two 
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polymorphic dihydrate and a tetrahydrate.8 The report revealed that the 
interconversion between the different sodium naproxen hydrate forms are centred 
around the polymorphic dihydrate form. Another salt form drug reported to have a 
complex solid form landscape is sitagliptin L-tartrate, which exist as a tetrahydrate and 
four hemihydrate forms.9 The controlling factor for the different hydrate formation is 
said to be the different solvent composition, making finding the relationship between 
the forms difficult. Other examples of salt drugs having complex hydrate landscape 
include pamidronate disodium (existing as mono-, tri-, tetra- and pentahydrate),10,11 
and pantoprazole sodium (existing as hemi-, mono, sesqui- and dihydrate).12 In 
contrast, the complex hydrate landscape is less familiar for the neutral or uncharged 
molecule. For example, paracetamol13–15 is reported to exist as three hydrate forms, 
cimetidine exist as three polymorphic monohydrates,16 while gabapentin exists as two 
polymorphic monohydrate17,18 and a heptahydrate.19   
Interestingly, the simple hydrate landscape property is not echoed for an 
antiallergic drug, tranilast (TRN). TRN has been reported to exist as five polymorphic 
monohydrates, two solvates, three polymorphs, and one amorphous form.20 However, 
the literature of the solid-state forms are ambiguous, with CCDC database search 
accounts for two dissimilar crystal structure of the anhydrous polymorph,21,22 two 
different chloroform (CHCl3) solvate structure,
22,23 and dichloromethane (DCM) 
solvate.22 In general, TRN is poorly water-soluble hence has low bioavailability. 
Interestingly, the solubilities of the monohydrate forms (I and II) surpass the 
anhydrous forms (α and )20. The monohydrate II solubility also reported matching 
that of the amorphous form. This unusual characteristic is also observed in 
erythromycin24 and norfloxacin.25 The reason for this unconventional behaviour is that 
both TRN and erythromycin hydrate forms have higher surface energy or lower 
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hydrophobicity; while the zwitterionic nature of norfloxacin, allows the hydrated form 
to generate more highly charged molecule and could be easily hydrated with water 
compared to the anhydrous form.  
TRN was approved in Japan and South Korea for the treatment of bronchial 
asthma since 1982,26,27 with indications for keloids and hypertrophic scar added in 
1993.28 A recent review on TRN therapeutic application summarises additional 
effectiveness in the management of a wide range of conditions, e.g., diabetes, 
cardiovascular complications and various cancer.29 Since the significance of TRN is 
increasing, the ambiguity surrounding the solid-state deserves clarification. A 
throrough understanding of the solid-state stability and phase transition of TRN can 
improve the chemical processes, suggest a more efficient formulation method, and lead 
to stronger patent for the compound. 
4.3 Results and discussion 
4.3.1 Initial screen and the resultant forms 
Our initial polymorph screen of TRN with 20 different solvents (as detailed in 
chapter 2), using thermodynamically and kinetically controlled experiments reveal one 
novel hydrate form, five new solvates with one being water mixed and one anhydrous 
form. We also found the reported polymorph I (α Form,20 Form I22), the monohydrate, 
and the two solvates. However, the DCM solvate from this study produces a different 
powder pattern compared to the previous report.22 The following nomenclature used 
is based on our finding, with reference to the reported forms mentioned if needed 
(Scheme 4.1)  
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Scheme 4.1.Initial polymorph screen with 20 different solvents 
KF of the anhydrous form I showed 1.4% of the analysed sample to be water. 
However, TG and DSC traces of form I in Figure 4.1 showed no dehydration curve 
confirming its respective anhydrous state. The dissimilar observation suggest that TRN 
reacts with KF reagent and generates the mentioned sum of water. Subsequent value 
from KF analysis is considered with caution. TG of polymorph II in Figure 4.2 shows 
minimal weight change of 1.30%, however due to the absent of a dehydration curve in 
both TG and DSC, the loss is potentially from the surface solvent as this form was 
crystallised from quench cooling of TRN from a hot acetone solution. Hence, it is most 
likely that traces of acetone still present on the surface, but not incorporated into the 
lattice. Also, an endothermic event was observed at 91 C, indicative of a polymorphic 
transition in enantiotropic system.30 The resultant crystal form above the transition 
temperature is polymorph I. Polymorph II is metastable as in the presence of the 
mother liquor, polymorph II transformed into polymorph I with simple agitation even 
at at ambient condition. The distinction between polymorph I and II is clear based on 
their respective PXRD patterns in Figure 4.3. 
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Figure 4.1. TGA (top) and corresponding DSC (bottom) thermograms of TRN polymorph I both recorded at 10 °C 
min-1.  
 
Figure 4.2. TG (top) and corresponding DSC (bottom) thermograms of TRN polymorph II both recorded at 10 °C 
min-1. 
4.4 Highlight on the TRN hydrate forms 
Overall, 11 hydrates forms were obtained from our extensive screening process 
and subsequent DVS analysis. Five hydrate forms having close to one mole of water 
incorporated into the lattice. They are three polymorphic monohydrates, a 0.8 and 0.7-
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0.8 hydrate respectively. One of the monohydrate has been reported before. As stated, 
the nomenclature used is based on the order of our finding, smaller roman numerals 
correspond to earlier, while larger number represent later discovery. The three 
polymorphic monohydrates are identified as Hydrate I, Hydrate VI, and Hydrate X, 
while the 0.8 hydrate is identified as Hydrate III, and the 0.7-0.8 hydrate is named 
Hydrate V. On top of that, we also found TRN to exist as three lower than one mole 
hydrates, and three larger than one mole hydrates. The lower hydrates are: a 0.6-0.7 
hydrate (Hydrate VII), a hemihydrate (Hydrate XI) and a 0.4 hydrate (Hydrate VIII). 
Meanwhile the larger hydrates are: a trihydrate (Hydrate IX), a 2.3 hydrate (Hydrate 
II), and a 1.5-1.8 (transient) hydrate (Hydrate IV). To sum up, the sorting of the hydrate 
forms based on the order of discovery and water content are as follows: 
Hydrate I = monohydrate I 
Hydrate II = 2.3 hydrate 
Hydrate III = 0.8 hydrate 
Hydrate IV = 1.5-1.8 hydrate 
Hydrate V = 0.7-0.8 hydrate 
Hydrate VI = monohydrate II 
Hydrate VII = 0.6-0.7 hydrate 
Hydrate VIII = 0.4 hydrate 
Hydrate IX = trihydrate 
Hydrate X = monohydrate III 
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Hydrate XI = hemihydrate 
4.5 Hydrate forms from direct re-crystallisation of TRN and pathways to forms 
derived from them 
4.5.1 Hydrate I (monohydrate I) 
Hydrate I (monohydrate I) was obtained by the evaporation of TRN from 
dioxane solution, with the PXRD pattern obtained was compared to the reported α20 
and Form I,22 and confirmed to be similar to the trace reported by Kawashima. 20 
 
Figure 4.3. PXRD of TRN polymorph I, II and hydrate I. Grey coloured trace is the calculated powder pattern of 
polymorph I (α Form,20 Form I22) 
TG trace of hydrate I (Figure 4.4) indicates that the onset for a typical 
dehydration curve was observed in the region of 65 C and ends at around 95C. The 
sample lost a total mass of 6.50% (corresponding to a calculated value of 1.2 moles of 
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water) up to this point and transforms into polymorph I, which is later confirmed via 
PXRD and FTIR. The calculated value for one (1) water molecule from the 
stoichiometry of TRN is 5.13%. The experimental value is slightly higher most likely 
due to the sample having some traces of crystallising solvent (dioxane) or water on its 
surface, evident from the immediate slope observed upon heating. The DVS isotherm 
of this form showed very little change across the different relative humidity (RH, 
Figure 4.5, (a)), varying only 0.80% (corresponding to 0.14 moles of water) between 
the two extreme RH. PXRD of hydrate I from before and after DVS analysis showed 
an identical pattern (Figure 4.5, (b)). The PXRD pattern and stable behaviour observed, 
even at lower RH is consistent with previous literature which state that this form could 
withstand drying as water is strongly bonded in the lattice.20 
 
Figure 4.4. TG (top) and corresponding DSC (bottom) thermograms of TRN hydrate I both recorded at 10 °C min-
1 
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Figure 4.5. TRN hydrate I DVS cycle (a) with PXRD the sample from before and after DVS analysis 
(b) 
4.5.2 Hydrate II (2.3 hydrate) polymorph III and hydrate III (0.8 hydrate) 
Hydrate II was obtained by evaporation of TRN from methanol or ethyl-
methyl-ketone solution under ambient condition. TG thermogram revealed 12.70% of 
weight change, corresponding to 2.64 moles of water (Figure 4.6). A single crystal of 
this form suitable for diffraction was grown by seeding and slowly cooling TRN from 
a hot acetone-water solution. This is the first time a crystal structure of a hydrate form 
for TRN is reported. 
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Figure 4.6. TGA of TRN hydrate II before and after DVS run (0% RH) both recorded at 10 °C min-1 
The structure crystallises in the triclinic space group P-1 with three molecular 
unit in the asymmetric unit (Figure 4.7). There is also intramolecular hydrogen bond 
between the amino and the acid group, with a distance of 1.963 Å between the donor 
and acceptor. The refined structure reveals 2.3 moles of water. One water molecule in 
the lattice acts as a proton acceptor (A) via the oxygen atom and coordinates to the 
acid. Following the water, two more hydrogen bonds were formed with two other TRN 
molecules by donating (D) the two protons to the acid and amide functional groups 
respectively (Figure 4.7 (a)). The two TRN molecules that are accepting the protons 
from water are in different planes, and oriented in a head-to-tail manner, hence 
accepting the protons at different functional group respectively. More importantly, 
there are two molecules of water in the channel, which formed from interlacing 
methoxy end of different TRN units (Figure 4.7 (b) and (c)). 
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Figure 4.7. (a) Water molecules are acting as DDA, bridging three TRN molecule. (b) The two molecules of water 
which are in the channels are highlighted in by the black circle. (c) Black arrow is highlighting the channels. The 
colour code is carbon grey, oxygen red, and hydrogen light grey. 
A follow up DVS isotherm of hydrate II showed comparable initial water 
content (to the TG) of 11.70%, corresponding to 2.41 moles of water at 40% RH, with 
little change in weight between 20-90% RH (Figure 4.8). Between these RH ranges, 
hydrate II shows a typical non-stoichiometric hydrate behaviour, where at the highest 
humidity range, hydrate II incorporates 12.93% (corresponding to 2.7 moles of water), 
a)  
b)   
 
c)  
149 
 
while at the lower end, the weight change recorded was 10.24% (corresponding to 2.1 
moles of water). The non-stoichiometric behaviour is expected the feature is 
commonly associated with the presence of a channel, which can accommodate in and 
out around 0.6 moles of water. However, unlike the channel normally linked with non-
stoichiometric hydrate, the channel structure here along with the water it occupies 
plays an integral role in stabilising the molecular structure, which role is further 
highlighted in the following DVS sorption-desorption curve, Figure 4.8.  
 
Figure 4.8. DVS isotherm of TRN hydrate II (2.3 hydrate) 
DVS isotherm of hydrate II (Figure 4.8) shows, below 20% RH, the form lost 
most of the incorporated water. TG of the sample after the DVS run suggest that at 
most, 1.0% water is present at this point (Figure 4.6). The post-DVS TGA trace also 
does not show any typical dehydration step, but rather a continuous loss which again 
most likely due to presence of surface water which the sample acquired in between the 
analysis or decomposition due to small particle sizes of the anhydrous form. The 
follow up FTIR analysis showed comparable spectra between the heat dried and the 
sample dried at 0% RH. The majority of the peaks aligned well, however subtle 
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differences between the spectra were detected in the form of additional peaks, which 
is most likely due to the impurity of the heated sample from decomposition (Figure 
4.9). 
 
Figure 4.9. FTIR of dehydrated hydrate II, via heat and 0% RH 
 
Figure 4.10. PXRD of TRN polymorph I, II and III. Grey coloured trace is the calculated powder pattern of 
polymorph I 
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PXRD of the anhydrous sample at 0% RH revealed a different pattern to the 
anhydrous polymorph I and II, hence named polymorph III (Figure 4.10). Comparison 
of polymorph III to the other reported anhydrous forms, e.g. Paneque et al.’s triclinic 
polymorph, and Kawashima’s  and  form) could not be made due to incomplete or 
ambiguous data.20,21 Following the DVS up the second sorption cycle, polymorph III 
gained mass steadily, with a maximum gain of 4.45% (corresponding to 0.8 moles of 
water) at 90% RH. Further probe with longer isotherm (16 hours) revealed that the 
weight gained never reached the initial sum lost (Figure 4.11).  
 
Figure 4.11. Hydrate II desorption to 0% RH  followed by prolonged isotherm at 90% RH. 
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Figure 4.12. FTIR of polymorph III exposed to 98% RH for 36 hours showed similar spectra to hydrate II 
FTIR of polymorph III exposed to 98% RH for 36 hours showed similar spectra 
to hydrate II (Figure 4.12). The reason for the comparable spectra is most likely due 
to similar vibrations and interactions present in both hydrate II and the re-hydrated 
polymorph III, potentially showing isostructural property between the two forms. 
Humidity-controlled PXRD confirms earlier assumption as the traces of hydrate II and 
the re-hydrated polymorph III, showed similar features as most of the major peaks 
aligned (grey dotted lines, Figure 4.13). Only subtle differences were observed and 
noted with * symbol (Figure 4.13). Complete dehydration or removal water from the 
crystal structure packing typically affect the structure in one three ways, first of which, 
the crystal lattice being broken and rearranged into a new anhydrous form as seen in 
here (hydrate II to polymorph III), as well as in aspartame hydrate.31 Secondly, 
isostructural or isomorphic dehydrate could be form, where the crystal structure retains 
its crystalline property and unchanged, e.g. erythromycin A dihydrate32,33 and 
cephalexin acetonitrile solvate34. The third and final effect of dehydration is a complete 
collapse of the crystalline framework, transforming into an amorphous phase, e.g. DTS 
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tetrahydrate (chapter 3), topotecan hydrochloride pentahydrate35 and cromolyn sodium 
hydrates.36 We proposed that, upon loss of all the water, hydrate II framework 
including the channel feature partially collapses and forms polymorph III (Figure 4.7 
(b) and (c)). However, the channel feature irreversibly broken down, and due to the 
absent of this feature, the sample could never gain similar water content. Polymorph 
III’s limited ability to accommodate water, lead to a new form upon exposure to high 
humidities. The new form bares similarities in the unit cells to its precursors, mainly 
hydrate II and part of polymorph III, which is come to known as 0.8 hydrate or hydrate 
III (Figure 4.13). Hydrate III and polymorph III interchanges in a nonstoichiometric 
manner, but along a different sorption-desorption pathway, attributed to the different 
sorption-desorption kinetics. 
 
Figure 4.13. Predicted (GREY) and experimental PXRD (BLACK) of TRN hydrate II, polymorph III and hydrate 
III. Humidity controlled PXRD sample was taken at 40% RH before being exposed to 3% RH and subsequently 
exposed to 90% RH for four (4) hours at each step respectively. 
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Scheme 4.2. Pathway showing the relationship between hydrate II and its related forms 
4.5.3 Hydrate IV (1.5-1.8 hydrate) 
Precipitation of TRN from acetone solution with water as the anti-solvent 
yields a metastable form. FTIR confirms that the spectrum is novel when compared to 
all other spectra. KF and TG of this form yields a value of 9.0% (Figure 4.14) 
corresponds to 1.8 moles of water. However, as stated KF analysis for TRN was 
considered with caution as the anhydrous compound was found to react with KF 
reagent, generating 1.4% during analysis, and if the value is subtracted from the KF 
measurement of this form, the remaining 7.6% would correspond for 1.5 moles of 
water. In addition, the immediate mass loss recorded suggests that the incorporated 
solvent is very weakly bonded in the lattice. We are confident that the solvent is indeed 
incorporated and not just trapped on the surface as FTIR spectrum of a dried sample 
of this form showed a broad peak vibration at 3413 cm-1 (Figure 4.15), indicative of 
water OH vibration. Further analysis of this form proved to be challenging as the 
unstable nature limits our analytical method. Nevertheless, this form was identified as 
hydrate IV based on the currently available data.  
< 20% RH > 20% RH 
0% RH
2.3 hydrate (Hydrate II )
Polymorph III (Form III)
0.8 hydrate (Hydrate III)
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Figure 4.14. TGA of hydrate IV recorded at 10 °C min-1. 
 
Figure 4.15. FTIR of hydrate I-IV, highlighting the vibration at 3413 cm-1 of hydrate IV 
4.6 Methanol/water solvate (solvate I) and pathways to forms derived from 
solvate I 
4.6.1 Solvate I (methanol/water solvate) and hydrate V (0.70-0.80 hydrate)  
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Solvate I is obtained by quench cooling of TRN from a hot methanol solution. 
The form was found to be metastable, transforming into polymorph I upon agitation in 
the presence of the mother liquor at ambient condition. NMR analysis of the fresh 
sample clearly showed the presence of methanol peak at 3.16 ppm, confirming that the 
crystal form indeed contains methanol.  
 
Figure 4.16. NMR spectra of the fresh solvate I sample  
KF from the batch yielded 6% of water inclusion corresponding to 1.1 moles 
of water, suggesting that solvate I to be mixed with water. TG of the freshly prepared 
sample showed four different thermogram slopes with a total weight loss of 8.2% 
(Figure 4.17). 
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Figure 4.17. TGA of the freshly prepared TRN solvate I and solvate I isotherm for 10 minutes. 
It is highly likely that the first steep slope (-0.65% °C-1) corresponds to the 
release of a more volatile inclusion i.e. methanol, which suggests that in addition to its 
volatile nature, methanol is loosely bound, hence rapidly liberated with heat as low as 
40 °C. The exact amount of methanol incorporated is a challenge to determine, with 
0.40 moles calculated from the 3.8% loss at ambient up to 40 °C. However, having a 
nonstoichiometric value is not a common trait for a solvate, hence is highly likely that 
the solvent liberation occurs much earlier at ambient humidity and temperature.  
To prove our hypothesis that the initial loss was from a weakly bounded 
volatile inclusion, the same sample is left at an isotherm, under dry nitrogen at 25 °C 
for 10 minutes. TG of the isotherm sample showed no initial steep slope, instead, a 
single typical dehydration curve is observed upon heating. The weight change recoded 
here 3.4% (corresponding to 0.64 moles of water). The following the TG slope at -
0.03% °C-1 of the fresh sample from 40-80 °C (Figure 4.17) a release of a less volatile 
inclusion, most likely water, with a loss of 1.4% (corresponding to 0.26 moles). Strong 
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indication that the inclusion liberated from this second slope is also weakly bound in 
the crystal lattice as this slope is also missing from the isotherm sample TGA curve. 
The third and fourth desolvation step from 80-200 °C, with a slope of -0.13% and -
0.014% °C-1 respectively records a weight sum loss of 2.9% (corresponding to 0.54 
moles of water). The value corresponds well to the isotherm sample value upon heated 
up to the same temperature, highlighting a strongly bounded inclusion, containing the 
respective sum in the lattice. The total loss recorded from 40-200 °C is 4.3%, which is 
equivalent to 0.82 moles of water. As mentioned, KF of the fresh sample yielded 6% 
of water, which is higher than the total loss recorded between 40-200 °C, however, the 
higher KF value is expected as stated before, the anhydrous compound was found to 
react with KF reagent, generating 1.4% during analysis. Therefore, if the sum recorded 
from the anhydrous form is accounted for, then, the actual KF for the fresh solvate I is 
4.6% (corresponding to 0.86 moles of water), which is comparable to the TG weight 
loss between 40-200 °C.  
Interestingly, the DVS curves in Figure 4.18 (a) and (b) show comparable 
values upon losing the incorporated methanol, as the sample equilibrates in both DVS 
run at 40% RH. The methanol deprived sample appeared to be stable between 10-80% 
RH, containing somewhere between 0.70-0.80 moles of water, hence identified as 
hydrate V.  
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Figure 4.18. DVS isotherm (initially to higher humidities) of hydrate V (formed from methanol desolvation of 
solvate I) The sample contain between 0.84-0.81moles of water upon exposure to RH between 40-80% going up 
the humidity range. Meanwhile (b) DVS isotherm (initially to lower humidities) of hydrate V. The sample is shown 
to contain between 0.72-0.70 moles of water upon exposure to RH between 40-10% up the humidity range. 
4.6.2 Hydrate VI (monohydrate), VII (0.60-0.70 hydrate) and VIII (0.40 hydrate) 
Due to instability of solvate I, the PXRD obtained thus far is that of hydrate V. 
Following the DVS (Figure 4.18 (a)) up the RH range to 90% RH, hydrate V gained a 
further 0.34 moles of water, forming a monohydrate which is later identified as hydrate 
VI. The step feature observed form hydrate V to VI was indicative of a stoichiometric 
hydrate transformation. Following desorption cycle, hydrate VI loses the incorporated 
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water below 70% RH and transition into another stable form which contain somewhere 
between 0.60-0.70 moles of water, which showed non-stoichiometric sorption-
desorption curve along 0-90% RH, Figure 4.18 (a). This stable 0.60-0.70 hydrate is 
identified as hydrate VII. 
 
Figure 4.19. Humidity controlled PXRD of hydrate V (formed from methanol desolvation of solvate I) BLACK 
traces corresponds to the first sorption-desorption cycle, GREY traces corresponds to the second sorption-
desorption cycle. Each step is left at isotherm for one hour before pattern is obtained 
Humidity controlled PXRD trace of hydrate V from 40 to 90% RH, supports 
the finding, with the trace (second trace from bottom, black trace labelled 90% RH in 
Figure 4.19) showing several peak splitting and new peak emerging (indicated by (*) 
in Figure 4.19). The new peak along with peak splits confirms the presence of hydrate 
VI, mixed together with hydrate V. Their nearly similar PXRD trace suggest a rigid 
framework, accommodating between 0.2-0.3 moles of water without affecting the 
trace much. Humidity controlled PXRD trace of hydrate VII (Figure 4.19), shows very 
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similar trace to the starting hydrate V. It is also plausible that hydrate VII and hydrate 
V is the same form, only that the initial sample prepared for hydrate V potentially 
contain seed of this new form. Evidently, the second 90% RH trace is does not show 
the additional peak/changes observed at the previous 90% RH (that of hydrate VI). 
The following traces of the sample exposed to 90% RH, then followed by 5% RH (grey 
colour traces, fourth and fifth traces from bottom respectively in Figure 4.19) show 
similar peak features as well. The absence of peaks traces indicative of hydrate VI 
reiterate that the monohydrate hydrate VI is indeed a metastable state, only forming 
from initial sorption of hydrate V, which contain its seeds. Furthermore, slight shift to 
higher diffraction angle is noted (by the dotted line in Figure 4.19) to the traces of 
hydrate VII exposed to lower % RH. This general peak shift position to higher 2 Theta 
(°) angle (right-shift), according to Braggs law, is due to a decrease to reduced d-
spacing, most likely due to the egress of water upon formation of hydrate VII at lower 
humidity. The high rigidity of the main structure persist through hydrate V and is 
drivative forms. The role of water in this hydrate set must have helped in maintaining 
the framework and stability, seen in the stable final form of hydrate VII. 
Meanwhile, following down the RH range (Figure 4.18 (b)) to 0% RH, hydrate 
V sample lost 1.9% (at 0% RH) from the initial mass of 3.8% (at 40% RH after 
gravimetric equilibrium acheived), hence forming a 0.40 hydrate (named hydrate 
VIII). Like hydrate VI, hydrate VIII appeared to be metastable, gaining 1.7% in weight 
(0.30 moles of water) above 10% RH as it form a stable form afterwards. Following 
the second DVS sorption-desorption cycle, similar trend and water content indicative 
of hydrate VII is observed. The second sorption-desorption cycle in both run (Figure 
4.18 A and B) saw 0.1 mole ingress and egress of water between the two RH extremes, 
typically observed in a non-stoichiometric hydrate. Comparison between the FTIR 
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spectra of the sample at the end of both DVS runs (initially going up vs. initially going 
down, Figure 4.20), shows very similar spectra, confirming that hydrate VIII also 
transition into hydrate VII following the second DVS sorption-desorption cycle. 
 
Figure 4.20. FTIR spectra of hydrate V at the end of DVS runs, initially going up vs. initially going down 
 
Scheme 4.3. Pathway showing the relationship between solvate I and its related forms thus far 
4.6.3 Hydrate IX (trihydrate) 
In order to compare the PXRD of hydrate VI (a monohydrate) to the four other 
reported monohydrate polymorphs,20 the freshly prepared methanol/water solvate was 
20% - 80% RH 
< 10% RH >80% RH 
> 20-90% RH <90-0% RH 
0.7-0.8 hydrate (Hydrate V)
0.6-0.7 hydrate (Hydrate VII)
Methanol/0.82 water solvate (Solvate I)
Monohydrate (Hydrate VI) 0.4 hydrate (Hydrate VIII)
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placed in a 98% RH chamber to replicate the DVS environment. Surprisingly, the 
follow-up TGA recorded a higher than expected weight loss of 14.5%, corresponding 
to three moles of water, with an initial weight loss following the steep slope from 
ambient to 40 °C accounting for 9.90%, which corresponds to two moles of water. 
(Figure 4.21). Since the only possible interaction is with water, it is most likely that as 
the sample loses the methanol, water molecule fill up the created void, incorporating 
a total of three moles of water instead, compared to the one mole of water seen in the 
prior DVS (Figure 4.18 (a)). The high hydrate form was then identified as hydrate IX. 
The thermogram trace observed for the hydrate IX, do share similar feature with TG 
trace of solvate I (Figure 4.17) in the form if an initial steep desolvation slope, however 
the trihydrate trace only show three distinct slopes, with a clear curve indicating the 
completion of the dehydration process, at above 100 C (Figure 4.21).  
  
Figure 4.21. TGA of TRN solvate I vs. the same form exposed to 98% RH chamber forming the trihydrate (hydrate 
IX)) 
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Figure 4.22. NMR of fresh TRN solvate I sample vs. sample exposed to 98% RH chamber or the trihydrate /hydrate 
IX) 
NMR spectra of the fresh solvate I vs. the sample exposed to 98% RH, clearly 
shows the presence of methanol, and not the latter, confirming the exchange (Figure 
4.22). It is most likely that as the two moles of water occupies the spaces that once 
occupied by methanol. Since similarly weak interactions are present in both, 
previously with methanol (solvate I), and now with water (hydrate IX), we suggest 
possible channel feature similar to hydrate II, and these exchanges occur within 
channels in the lattice. Similar solvent-water exchange feature was reported for 
cephalexin acetonitrile solvate, where reversible exchange between the solvent and 
water molecules can occur due to the a channel feature, without affecting crystalline 
structure much.34,37 
A single crystal X-ray diffraction would be needed to ascertain the theory. 
Also, the solvent exchange bares little effect to the unit cell, such that PXRD of the 
trihydrate showed similarities to the other forms (hydrate V-VIII) derived from solvate 
I- without being entirely the same. We note some unique feature of hydrate IX in the 
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form of additional or missing peaks which are highlighted with (+) symbol in Figure 
4.23. 
The stability and the solid-state transition of hydrate IX is difficult to ascertain 
due to the metastable nature. The thermogram (Figure 4.21) does suggest that once the 
weakly bounded water is lost (two moles), and a more stable form containing at least 
one mole of water emerges. Due to PXRD similarities observed for the whole solvate 
I-derived ‘family’, it is not surprising if the stable monohydrate bares similarities to 
the hydrate V-VIII. 
 
Figure 4.23. PXRD comparison of hydrate IX to other hydrate form derived from solvate I. Unique feature of this 
form is highlighted with (+) symbol. 
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Scheme 4.4. Pathway showing TRN solvate I relationship to TRN trihydrate 
4.7 Other solvate forms from direct re-crystallisation of TRN and forms derived 
from them 
The other solvates obtained by direct re-crystallisation of TRN from various 
solvent are pure solvate (not water mixed).  
4.7.1 Solvate II (2-propanol monosolvate) 
Quench cooling TRN from a hot 2-propanol yielded a novel solvate form which 
was confirmed via PXRD hence dubbed solvate II (Figure 4.24). TG analysis of this 
from indicated that 14.9% mass loss, calculated to 0.95 moles of 2-propanol 
incorporated into its crystal lattice (Figure 4.25). The high temperature for the onset of 
desolvation which is above 75 C, suggests that the solvate from is stable.  
>98% RH 
Methanol/0.82 water solvate (Solvate I)
Trihydrate (Hydrate IX)
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Figure 4.24. PXRD solvate II alongside the from which it transform to at higher RH, hydrate I.  
 
Figure 4.25. TGA of solvate II, showing the mass loss recorded before, and after DVS analysis (0% RH) 
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Figure 4.26. DVS isotherm of solvate II 
This stability feature was also reflected in the DVS analysis, where upon 
exposure to lower humidities (40 down to 0% RH), solvate II showed no weight loss 
(Figure 4.26). However, a significant weight change is observed upon sorption to 
above 50% RH (coming up from 0% RH). A mass loss of 15.2 % is recorded, which 
is comparable to the sum for the incorporated 2-propanol. This lead to the suggestion 
that at higher humidities, water molecules displaces the 2-propanol in the solvate 
crystal lattice. The resultant form showed good stability along the humidity ranges 
(low and high), showing barely any changes. Subsequent TG of the DVS sample after 
completion of the run revealed that, upon displacing the solvent, 4.5% of water 
(calculated to 0.82 moles of water) gets incorporated into the form, possibly occupying 
the space vacated by the 2-propanol. FTIR analysis of the sample shows similar spectra 
to that of Hydrate I (Figure 4.27). The DVS behaviour is also in agreement, matching 
with hydrate I which does not change at any humidity variation. The solvate hydrate 
interchange behaviour was also reported for bisfinasteride monohydrate 
monotetrahydrofuran and bisfinasteride monohydratemono-1,4-dioxane, which are 
water-mixed solvates.38 
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Figure 4.27. FTIR spectra of solvate II after DVS cycle, showing similarities to hydrate I spectra 
 
Scheme 4.5. Pathway showing the relationship between TRN solvate II and its related forms 
4.7.2 Solvate III (chloroform monosolvate), hydrate X (monohydrate) and hydrate XI 
(hemihydrate) 
All thermodynamically and kinetically controlled crystallisation experiment 
from chloroform solution yielded identical form, which suggest that this form is 
thermodynamically stable. This solvate form has been reported before and identified 
as TRN chloroform monosolvate (solvate III).22,23 TG of solvate III in Figure 4.28 
shows a weight loss of 27.3% (corresponding to one mole of chloroform).  
100 ℃
60% RH
2-Propanol solvate (Solvate II) 
Monohydrate (Hydrate I) 
Polymorph I
(α Form/ 
Form I)
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Figure 4.28. TGA of Solvate III before and after DVS analysis (weight loss as 0% RH) 
 
Figure 4.29. DVS isotherm of solvate III 
Interestingly, following the DVS analysis curve in Figure 4.29, similar 
behaviour to that of solvate II is observed, showing no change in mass with reduced 
RH, whilst significant loss recorded at higher humidities (>70% RH). At 90% RH, the 
recorded loss is 27.5%, suggesting that all the incorporated chloroform is displaced. 
Interestingly, unlike solvate II, following subsequent desorption, a further mass loss 
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of 2.8% (calculated to 0.5 moles of water) is recorded below 10% RH. Following 
sorption to >20% RH, the form recovered back the lost water. The water lost and gain 
observed follow a step-like curve, indicative of a stoichiometric hydrate. A follow-up 
TGA (Figure 4.28) of the sample at 0% RH shows a comparable mass loss of 2.3% 
(corresponding to 0.4 moles of water). Calibrated to the TGA value, means that at 90% 
RH, the sample contain 0.9 (~1.0) moles of water and later identified as monohydrate 
hydrate X, while for the 0% RH form is identified as hemihydrate hydrate XI. 
According to Vogt et al., the chloroform molecules form channels in the solvate crystal 
lattice.22 He suggest that due to this arrangement, there is a possibility for solvent 
removal without altering most of the packing interactions.  
 
 
 
Figure 4.30. Crystal packing of solvate III, showing channel of chloroform molecule (GREEN)8 
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Figure 4.31. Humidity controlled PXRD of Solvate III (TRN chloroform monosolvate), matching to the calculated 
powder pattern (GREY). Each scan interval is two (2) hours. 
However, the humidity controlled PXRD experiment done proved otherwise. 
As water displaces chloroform in the lattice, the pattern changes with new peak 
emerging after two hours, and after six hours, all peaks indicative of hydrate X appears 
(Figure 4.31). Eight hours of exposure shows no more changes. The following two-
hour exposure to 3% humidity confirms hydrate XI formation, with no change 
observed after longer exposure. 
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Scheme 4.6. Pathway showing the relationship between solvate III and its related forms 
4.7.3 Solvate IV (DCM ¾ solvate) 
Quench cooling TRN from a hot dicholoromethane (DCM) solution yielded a 
solvate, which subsequent TG (Figure 4.32) revealed to contain 0.76 moles of DCM 
from 16.5% mass loss, whilst DVS of the same sample recorded a continuous loss, 
regardless of humidity, to a final value of 17.2% (calculated to 0.8 moles of DCM, 
Figure 4.33). TG data showed that the onset of mass loss occur early on, at 25 C, 
which is supported by DVS isotherm (at 25 C) recording similar, immediate mass 
loss.  
150 ℃
> 20% RH 
> 90% RH 
< 10% RH 
Monohydrate (Hydrate X)
Solvate III (CHCl3 monosolvate)
Hemihydrate (Hydrate XI)
Polymorph I
(α Form/ 
Form I)
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Figure 4.32. TGA and DSC analysis of Solvate IV 
 
Figure 4.33. Desolvation of solvate IV (DCM ¾ solvate) at isotherm. 
PXRD trace of the TRN DCM solvate (named solvate IV) obtained is distinctly 
different to the one reported (Figure 4.34).22 The form obtained from this study is 
potentially different the reported form as the calculated weight loss of 16.5% 
corresponds to 0.76 moles of DCM which could be a ¾ DCM solvate. Our effort to 
obtain the reported form is unsuccessful. As mention, the immediate loss regardless of 
RH and temperature suggest the instability of this form. Interestingly, solvate IV 
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desolvates to a novel anhydrous polymorph. FTIR spectra suggest both desolvated 
form using heat and without heat(at 0% RH), TG and DVS samples respectively, 
produced identical form (Figure 4.35). PXRD trace also confirms the finding, even 
though the heated sample lost some crystallinity, distinctive feature is still observable 
(Figure 4.34). This polymorph is later named polymorph IV or form IV. DSC of 
solvate IV shows consistent desolvation trace, forming polymorph IV above 100C 
(confirmed via FTIR). Further heating to 300 C saw form IV transforms in an 
exothermic event (onset observed at 164 C) into the anhydrous form I or α form  
which was confirmed via FTIR and PXRD (Figure 4.35 and Figure 4.36 respectively). 
The two crystal forms are most likely monotropically related as indicated by the 
exothermic transitions (Figure 4.32).39,40  
 
Figure 4.34. PXRD of Solvate IV (TRN DCM ¾ solvate), the pattern did not match to the calculated powder 
pattern (GREY)22 
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Figure 4.35. FTIR spectra of desolvated solvate IV without heat (0% RH) and at different heating interval. 
Heating to 150 C yeilded polymorph IV while >170C forms polymorph I. 
 
Figure 4.36. PXRD spectra of solvate IV ad different heating interval. Heating to 150 C yeilded polymorph IV 
while >170C forms polymorph I 
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Scheme 4.7. Pathway showing the relationship between solvate IV and its related forms 
4.7.4 Solvate V, VI and VII  
Finally, three more novel solvates identified as acetonitrile hemisolvate: 
solvate V, ethanol monosolvate: solvate VI and 2-butanol monosolvate: solvate VII, 
which were crystallised by quench cooling of TRN from hot acetonitrile, ethanol and 
2-butanol respectively. All the novel three solvates desolvates to form I at ambient in 
similar manner to that solvate IV in Figure 4.33 or when heated to >150 C. 
4.8 Chapter summary and conclusion  
The search aiming towards understanding hydrate formation has led to an 
astonishing discovery of a plethora of novel solid form of TRN. TRN shows an 
unusually complex hydration behaviour for an uncharged drug molecule. In total, 11 
hydrate forms were discovered in this study. Kawashima reported five polymorphic 
monohydrate,20 however comparison can only be made to one of the PXRD pattern 
provided as the rest is ambiguous. Five crystal forms having water content close to one 
mole was found, which are, three polymorphic monohydrates (one of which has been 
reported by Kawashima), and two 0.8 hydrates (exact water content are 0.8, 0.7-0.8). 
>170 ℃
0-90% RH or     <150 ℃
DCM solvate (Solvate IV)
Polymorph IV (Form IV)
Polymorph I
(α Form/ 
Form I)
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In addition, three higher (a tri-, a 2.3 and a transient 1.5-1.8 hydrate) and three lower 
(a 0.6-0.7, a hemi, and a 0.4) hydrate forms were also found. a 0.4 hydrate. The 2.3 
hydrate crystal structure provides first insight to TRN–water interaction. The solvate 
to hydrate conversion pathway presents a new outlook in hydrate formation. All-in-
all, the study highlights the importance of thorough understanding of the solid-state 
landscape to ensure a safe and efficient manufacturing process. More importantly, the 
variety of role played by water, as a stabilising component and having crucial 
implication to the crystal structure e.g. the 2.3 hydrate to 0.8 hydrate transition. The 
multiple form observed here points to the dilemma of having multiple solid forms, 
acting as double-edged sword which can either hamper a drug true potential OR an 
opportunity for better or more process-able crystal form. 
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Scheme 4.8. Pathway showing the relationship between all screened TRN crystal forms 
180 
 
4.9 References 
1. Griesser, U. J. & Burger, A. The effect of water vapor pressure on desolvation 
kinetics of caffeine 4/5-hydrate. Int. J. Pharm. 120, 83–93 (1995). 
2. Khankari, R. & Grant, D. J. W. Pharmaceutical hydrates. Thermochim. Acta 
248, 61–79 (1995). 
3. Sastry, S. V., Nyshadham, J. R. & Fix, J. A. Recent technological advances in 
oral drug delivery – a review. Pharm. Sci. Technolo. Today 3, 138–145 (2000). 
4. Fasano, A. Novel Approaches for Oral Delivery of Macromolecules. J. Pharm. 
Sci. 87, 1351–1356 (1998). 
5. Hauss, D. J. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 59, 667–676 
(2007). 
6. Lipinski, C. Poor Aqueous Solubility – an Industry Wide Problem in Drug 
Discovery. Am. Pharm. Rev. 5, 82–85 (2002). 
7. Najib, M. N. M., Back, K. & Edkins, K. The Complex Solid-State Landscape 
of Sodium Diatrizoate Hydrates. Chem. - A Eur. J. 23, 17339–17347 (2017). 
8. Raijada, D. et al. Exploring the Solid-Form Landscape of Pharmaceutical 
Hydrates: Transformation Pathways of the Sodium Naproxen Anhydrate-
Hydrate System. Pharm. Res. 30, 280–289 (2013). 
9. Tieger, E., Kiss, V., Pokol, G. & Finta, Z. Crystallisation of a salt hydrate with 
a complex solid form landscape. CrystEngComm 19, 1912–1925 (2017). 
10. Stahl, K., Treppendahl, S. P., Preikschat, H. & Fischer, E. Sodium 3-ammonio-
1-hydroxypropylidene-1,1-bisphosphonate monohydrate. Acta Crystallogr. 
Sect. E Struct. Reports Online 61, 132–134 (2004). 
11. Vega, D., Fernández, D. & Ellena, J. A. Disodium pamidronate. Acta 
Crystallogr. Sect. C Cryst. Struct. Commun. 58, m77–m80 (2002). 
181 
 
12. Zupančič, V., Ograjšek, N., Kotar-Jordan, B. & Vrečer, F. Physical 
characterization of pantoprazole sodium hydrates. Int. J. Pharm. 291, 59–68 
(2005). 
13. Parkin, A., Parsons, S., Pulham, C. R. & IUCr. Paracetamol monohydrate at 150 
K. Acta Crystallogr. Sect. E Struct. Reports Online 58, 1345–1347 (2002). 
14. McGregor, P. A., Allan, D. R., Parsons, S. & Pulham, C. R. Preparation and 
crystal structure of a trihydrate of paracetamol. J. Pharm. Sci. 91, 1308–1311 
(2002). 
15. Fabbiani, F. P. A. et al. High-pressure recrystallisation—a route to new 
polymorphs and solvates. CrystEngComm 6, 504–511 (2004). 
16. Hegedüs, B. & Görög, S. The polymorphism of cimetidine. J. Pharm. Biomed. 
Anal. 3, 303–313 (1985). 
17. Ibers, J. A. & IUCr. Gabapentin and gabapentin monohydrate. Acta Crystallogr. 
Sect. C Cryst. Struct. Commun. 57, 641–643 (2001). 
18. Vasudev, P. G. et al. Crystal structures of a new polymorphic form of 
gabapentin monohydrate and the E and Z isomers of 4-tertiarybutylgabapentin. 
Chem. Biol. Drug Des. 73, 83–96 (2009). 
19. Fabbiani, F. P. A. et al. Searching for novel crystal forms by in situ high-
pressure crystallisation: the example of gabapentin heptahydrate. 
CrystEngComm 12, 2354 (2010). 
20. Kawashima, Y. et al. Characterization of polymorphs of tranilast anhydrate and 
tranilast monohydrate when crystallized by two solvent change spherical 
crystallization techniques. J. Pharm. Sci. 80, 472–478 (1991). 
21. Paneque, A., Duque, J. & Pomés, R. Caracterización cristalográfica y 
determinación precisa de los parámetros del Tranilast (C1sH17N05). 
22. Vogt, F. G. et al. Structural analysis of polymorphism and solvation in tranilast. 
J. Pharm. Sci. 94, 651–665 (2005). 
182 
 
23. Villa, A. C., Manfredotti, A. G. & Guastini, C. . Cryst. Struct. Commun. 8, 457 
(1979). 
24. Allen, P. V., Rahn, P. D., Sarapu, A. C. & Vanderwielens, A. J. Physical 
Characterization of Erythromycin: Anhydrate, Monohydrate, and Dihydrate 
Crystalline Solids. J. Pharm. Sci. 67, 1087–1093 (1978). 
25. Yuasa, R. et al. Pharmaceutical studies on hydrates of AM-715. Physical 
characteristics and intestinal absorption. Yakugaku Zasshi 102, 469–76 (1982). 
26. Koda, A., Nagai, H., Watanabe, S., Yanagihara, Y. & Sakamoto, K. Inhibition 
of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) 
anthranilic acid (N-5′). J. Allergy Clin. Immunol. 57, 396–407 (1976). 
27. Azuma, H., Banno, K. & Yoshimura, T. Pharmacological Properties Of N-
(3′,4′-Dimethoxycinnamoyl) Anthranilic Acid (N-5′), A New Anti-Atopic 
Agent. Br. J. Pharmacol. 58, 483–488 (1976). 
28. Isaji, M., Nakajoh, M. & Naito, J. Selective inhibition of collagen accumulation 
by N-(3, 4-dimethoxycinnamoyl)anthranilic acid (N-5’) in granulation tissue. 
Biochem. Pharmacol. 36, 469–474 (1987). 
29. Darakhshan, S. & Pour, A. B. Tranilast: A review of its therapeutic applications. 
Pharmacol. Res. 91, 15–28 (2015). 
30. Burger, A. Interpretation of polymorphism studies. Acta Pharm. Technol. 28, 
1–20 (1982). 
31. Leung, S. S., Padden, B. E., Munson, E. J. & Grant, D. J. W. Hydration and 
Dehydration Behavior of Aspartame Hemihydrate. J. Pharm. Sci. 87, 508–513 
(1998). 
32. Miroshnyk, I. et al. Insight into thermally induced phase transformations of 
erythromycin A dihydrate. Cryst. Growth Des. 6, 369–374 (2006). 
33. Mirza, S. et al. Influence of solvents on the variety of crystalline forms of 
erythromycin. AAPS PharmSci 5, E12 (2003). 
183 
 
34. Stephenson, G. A., Groleau, E. G., Kleemann, R. L., Xu, W. & Rigsbee, D. R. 
Formation of isomorphic desolvates: Creating a molecular vacuum. J. Pharm. 
Sci. 87, 536–542 (1998). 
35. Vogt, F. G. et al. A study of variable hydration states in topotecan 
hydrochloride. J. Pharm. Biomed. Anal. 40, 1080–1088 (2006). 
36. Chen, L. R., Young Jr., V. G., Lechuga-Ballesteros, D. & Grant, D. J. W. Solid-
state behavior of cromolyn sodium hydrates. J. Pharm. Sci. 88, 1191–1200 
(1999). 
37. Pfeiffer, R. R., Yang, K. S. & Tucker, M. A. Crystal Pseudopolymorphism of 
Cephaloglycin and Cephalexin. J. Pharm. Sci. 59, 1809–1814 (1970). 
38. Byard, S., Abraham, A., Paul, P. J., Harris, R. K. & Hodgkinson, P. A multi-
technique approach to the study of structural stability and desolvation of two 
unusual channel hydrate solvates of finasteride. J. Pharm. Sci. 101, 176–186 
(2012). 
39. Burger, A. & Ramberger, R. On the polymorphism of pharmaceuticals and other 
molecular crystals. II. Mikrochim. Acta 72, 273–316 (1979). 
40. Threlfall, T. L. Turning DSC Charts of Polymorphs into Phase Diagrams: A 
Tutorial Paper. Org. Process Res. Dev. 13, 1224–1230 (2009). 
 
184 
 
CHAPTER 5  
 INFLUENCE OF WATER TOWARDS PRE-NUCLEATION AGGREGATES 
LEADING TO THE FORMATION OF STABLE CRYSTALLINE 
HYDRATES  
5.1 Chapter overview 
This chapter discusses the solid- and solution-state analysis of drugs with the 
ability to form a stable hydrate in the solid state, with emphasize on method 
development and refinement for later the solution-state. As discussed in chapter 1, 3 
and 4, hydrates present constant challenges due to their low aqueous solubility. The 
poor aqueous solubility is due to the form’s improved thermodynamic stability,1 and 
having a lower free Gibbs energy than anhydrate form.2 Although water is ubiquitous, 
hydrate emergence remains unpredictable and uncertain, even for the types of 
molecules which are prone to form hydrates.3 The solution-state analysis thus presents 
a fast and early probe into hydrate formation, as the crystalline form does not need to 
be present or even known. Recent studies have reported that solution-state analysis has 
successfully shown intermolecular interaction reflective to the solid state,4,5 hence the 
technique is used here to quantify the intermolecular interactions between water and 
hydrate-forming drug in solution through titration experiment. Four drugs, diatrizoic 
acid (DTA), cimetidine (CIM), tranilast (TRN), and piroxicam (PXM) were analysed 
using two methods, NMR and FTIR spectroscopy. The two methods worked in 
complementary, where FTIR analysis allowed qualitative observation of all the 
available and affected vibrations, on a faster time scale compared to the NMR. On the 
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other hand, NMR allowed quantitative measurement of the physical changes in the 
spectra which were monitored in the form of peak shifts as water is titrated into the 
respective solution. The general aim of both analytical methods was to observe early 
influence and interaction of water towards the respective compounds in solution and 
to probe whether the said interactions were measurable. The strength of the 
interactions between the components was realised in the form of association constant 
based on the changes to the NMR resonance peak shifts and subsequent fitting to the 
respective models, which were then used to determine a prediction value for hydrate 
formation. 
5.2 Introduction 
5.2.1 Background  
The emergence of hydrate and the related problems in the pharmaceutical 
industry is an ongoing struggle. As discussed in chapter 1, 3 and 4, the fact is that while 
pharmaceutical solids are prone to hydrate formation,6 resulting in hydrate form that 
modifies the physicochemical properties of the drug, more importantly reduces 
solubility,7–10 which in effect will impact the drug efficacy11,12 and jeopardise patients’ 
safety, the phenomenon remains unpredictable and unclear,3,13 costing pharmaceutical 
companies a tremendous amount of time, money, and efforts geared toward screening 
for all the potential hydrate form.14 Active in-silico approach to computational solid 
form screening via e.g. crystal structure prediction using crystal energy landscapes and 
statistical models are slowly being extended to predict hydrate.15–20 However, as stated 
in chapter 1 (1.2), the approach still demands time, money and efforts, which were the 
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initial reasons to use the approach, leaving hydrates formation largely unpredictable 
and remains a challenge in crystal engineering.21 
5.2.2 The new approach towards understanding the role of water in hydrate-forming 
drug compounds 
With that in mind, we propose a probe of the solution-state, by observing 
compound-water interaction at pre-nucleation state. As mentioned in chapter 1, we 
suggest that there is some degree of molecular recognition between a hydrate-forming 
compound and water which would lead to the formation of pre-nucleation complexes 
in solution. The said interaction would yield a significant structural binding value 
rather than a random interaction, especially for a compound that can form a stable 
hydrate. Through the early observation and probe, we aim to find a general pattern of 
solid-water interaction for hydrate forming compounds, with the aim to develop a 
faster, more efficient and more focused prediction approach. We hypothesise that 
(stable) hydrate forming compounds will have the ability to form a compound-water 
complex or at the very least show significant interaction with water, in solution. The 
importance and relevance of solution-state analysis have been discussed 
comprehensively in chapter 1 (1.3 and 1.5), with emphasis on the successful 
connection to the solid-state. One of the common solution-state technique is titration, 
which is normally used in supramolecular chemistry to quantify an interaction.  
The principle behind FTIR analysis discussed in chapter 2 (2.2.5) and the 
method used in (2.3.2). FTIR analysis allowed observation on the effect of titration on 
all of the available and affected vibrations, especially on hydrogen bond sensitive 
vibrations, e.g. the carbonyl (C=O). The fast time scale of the method also made it 
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possible to monitor all of the formed species during the titration. On the other hand, 
NMR titration experiments were used primarily to determine the association constant 
between drug and water. The principle behind the method, along with the technique 
used was discussed in chapter 2 (2.3.3 and 2.3.7). The mentioned probes were initially 
done to drugs which have one common property, which is having the ability to form 
the stable hydrate. Stable hydrate was internally defined as water-incorporated crystals 
which have the ability to hold water in the crystal lattice at a low (less than 10%) 
relative humidity (RH) isotherm at 25C and upon heating to at least 60 C without 
being dehydrated and retaining the crystal form. Despite being seemingly simple, 
many criteria needed to be carefully considered to ensure that the final results were 
reliable. Among others are drug solubility, solvent selection, host and guest 
concentration, the physical changes detection method (i.e., NMR, infrared), choice of 
stoichiometric binding model and etc. The continuous variation method, or Job’s plot, 
was used in determining the stoichiometry of binding complexes, information later 
used to fit the binding models. 
5.2.3 The model/the host: diatrizoic acid (DTA), cimetidine (CIM), tranilast (TRN), 
and piroxicam (PXM) 
Four drugs were chosen for the initial probe due to their ability to exist as a 
stable hydrate based on earlier reports and in-house data. The probed drugs are, 
diatrizoic acid (DTA),22 tranilast (TRN, chapter 4),23 cimetidine (CIM)24, and 
piroxicam (PXM)25 
DTA is known to exist as two hydrated (dihydrate and tetartohydrate), three 
anhydrous and nine solvated solid forms.22,26 The dihydrate form has been reported to 
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be extremely stable, and the crystal structure shows extensive hydrogen bond 
interactions with water via the amide and carboxylic acid groups.22   
 
Figure 5.1. Chemical structure of DTA 
The DTA molecule has two amide NH groups and one carboxylic acid OH 
functionality as hydrogen-bond donors, as well as two amide and one carboxylic acid 
carbonyl groups as hydrogen-bond acceptors (Figure 5.1). The balanced ratio of 
donors and acceptors in the DTA molecule promotes extensive hydrogen-bonded 
networks in the crystalline structure. Also, the three iodo substituents offer additional 
possibility of halogen-bonding interactions.27 
The next pharmaceutical compound probed was cimetidine (CIM). CIM is 
made of three main functional units: a 4,5-disubstituted imidazole ring, a cysteine and 
an N-cyanoazamethine or guanidine derivative (Figure 5.2). The flexible guanidine 
chain and numerous hydrogen bonding sites (–NH groups and C≡N) can give rise to 
multiple crystal forms due to the ability of the molecule to adopt various 
conformations. CIM has been reported to exist as a polymorphic monohydrate (M1, 
M2 and M3) and four anhydrous polymorphs (Form A, B, C, and D).24 
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Figure 5.2. Chemical structure of CIM 
Details on tranilast (TRN) was mentioned in chapter 4. We have reported that 
TRN exists as at least 11 hydrate forms: a trihydrate, a 2.3 hydrate, a 1.5-1.8 (transient) 
hydrate, three polymorphic monohydrates (one of which has been reported before), 
two 0.8 hydrates (exact water content are 0.8 and 0.7-0.8), a 0.6-0.7 hydrate, a 
hemihydrate and a 0.4 hydrate. We also reported four polymorphs and seven solvates, 
one of which found to be water mixed. The previous report on the anti-allergic agent 
reported that compound to exist as three anhydrous polymorphs (form I was also found 
in our analysis) and five polymorphic monohydrates (monohydrate I was similar), 
along with two solvates (CHCl3 solvate was found as well).
23,28 However, the literature 
of solid-state forms are ambiguous, with CCDC database search accounts for two 
dissimilar crystal structure of the anhydrous polymorph, along with two different 
chloroform (CHCl3) solvate structure. The other submitted solvate form is 
dichloromethane (DCM) solvate.28 TRN structure consist of two proton donors and 
five acceptors site which are capable of forming hydrogen bond with water. 
 
Figure 5.3. Chemical structure of TRN 
190 
 
Piroxicam (PXM) is a nonsteroidal anti-inflammatory drug (NSAID). The 
compound has two hydrogen bond donor, and six acceptor site. PXM also posseses 
acidic enolic OH (Figure 5.4, (a))29 in its structure, a feature which gives PXM the 
ability to form inter- and intramolecular hydrogen bond allowing the structure to adopt 
different structures and various conformations depending on the surrounding 
condition, i.e. pH.30 For example, at the lowest possible energy levels or ground state, 
the closed enol structure (Figure 5.4, (b)) transform into the keto-type form (Figure 
5.4, (c)) upon electronic excitation in nonpolar solvents through an intramolecular 
proton transfer reaction.31 The anionic structure (Figure 5.4, (d)) is favourable 
following neutral pH and biologically favourable conditions,32 while in protic solvents, 
an open conformer or zwitterionic form (Figure 5.4, (e)) is formed, which consist of 
two intramolecular hydrogen bonds in the PXM molecule.33–35 
 
Figure 5.4. General chemical structure of PXM (a) and the different ionisation states modifications of PXM under 
various conditions (b)-(e). 
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5.3 Results and Discussion  
5.3.1 DTA solid-state preliminary analysis   
DTA starting compound was analysed to determine its state of form. PXRD in 
Figure 5.5 revealed that the trace is consistent with the dihydrate form. Dehydrating 
the sample (heating to above 100 ℃) produced a different PXRD trace (Figure 5.5, 
bottom trace) to the starting compound.  
 
Figure 5.5. PXRD of DTA dihydrate and the anhydrous form II. The small differences between the measured and 
predicted DTA dihydrate patterns are due to the platy habit of this crystalline form, hence highly preferred oriented. 
Also, the two measurements were taken at two different temperatures, i.e. ambient and 120 K.22 
TGA and DSC analysis in Figure 5.6 also revealed distinctly different traces 
between the two forms. The weight loss recorded from the TGA of the dihydrate was 
5.525% (corresponding to 1.993 molar equivalent of water, two molar equivalents is 
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calculated to 5.543% mass change). DSC shows an endothermic event parallel to the 
dehydration curve observe in the TGA. In addition, an exothermic event typical of 
enantiotropic phase transition of form II to III, was also observed, which is similar to 
the previously reported literature.22 A follow-up TGA of the anhydrous form exposed 
to the ambient environment for 30 minutes directly after dehydration highlights the 
compound’s affinity towards water. Within that exposure time, almost all water loss 
(4.8%, corresponding to 1.7 moles of water) was recovered (Figure 5.6). Subsequent 
DVS analysis of the dihydrate form revealed a stable behaviour, with very little mass 
change throughout the humidity cycle (0.02% between the two extreme RH), 
indicative of surface water (Figure 5.7). 
 
Figure 5.6. TGA (a) and DSC (b) of DTA dihydrate and anhydrous forms. Also, additional follow-up TGA of the 
anhydrous form, after ambient environment exposure for 30 minutes. 
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Figure 5.7. DVS isotherm of the DTA dihydrate. 
Similar to the PXRD, TGA, and DSC trace, the FTIR spectra also shows clear 
differences between the dihydrate and anhydrous form. Interpretation of the 
subsequent FTIR spectra were based on vibrational frequency assignment for DTA 
from the report by Lerner, assigning the NH stretch to 2985 cm-1, C=O of the acid 
to1700 cm-1 and amide to1661 cm-1, and finally the secondary amide and aromatic 
C=C stretch to1551 cm-1 wavenumbers respectively.36 In addition, the single-crystal 
neutron structure reported by Fucke et al. also guide our interpretation of the FTIR 
spectra.22 Based on the single-crystal neutron structure, water coordinates to DTA via 
the carbonyl of the acid and amide exclusively.22 Our in-house FTIR spectra of DTA 
showed comparable spectra to the reported data, with notable differences between the 
dihydrate and the anhydrous form especially on the respective carbonyl vibrations 
(Figure 5.8).36,37 
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Figure 5.8. DTA dihydrate and anhydrous form FTIR spectra 
At the higher wavenumber around 3000 cm-1, both forms showed a broad 
double peak, followed by a weak shoulder. The double peaks are consistent with the 
stretching vibration of the two NH group, while the shoulder appearing just below 
3000 cm-1 is consistent with the OH stretching vibration. Although the mentioned peak 
features are the same, the anhydrous peaks come at a much higher wavenumber, 
3180.5 cm-1 compared to 3156.5 cm-1 of the dihydrate form. The shoulder in the 
anhydrous spectra also appeared at a higher position of 2991.5 cm-1 compared to 2986 
cm-1 of the dihydrate.  
More importantly in the fingerprint region, the vibration indicative of a 
carbonyl of the acid functionality, showed a significant difference between the forms, 
appearing at 1716.5 cm-1 (anhydrous), and 1709 cm-1 (dihydrate). Meanwhile, the 
carbonyl of the amide at 1668 cm-1, did not change position. In principle, the dihydrate 
form would show more hydrogen bond due to the interactions with water and a direct 
effect of the formed hydrogen bond can often be observed on the acceptor side, DTA 
e.g. in X-H…O=C bonds, the carbonyl O=C bond is weakened leading to a lowering 
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of the stretching vibration frequency.38 The presence of hydrogen bond (to water) 
affects the position of already existing peaks by transferring charges by withdrawing 
electron density, effectively ‘pulling’ the C=O away from one another and stretching 
the respective covalent bond Numerous solid-state IR studies have shown that the 
carbonyl region is a very sensitive region towards hydrogen bond, shifting to lower 
wavenumber as hydrogen bond forms, with a stronger hydrogen bond tends to shift 
the carbonyl frequency more (lower).39–41 This observation follows the ‘ball and spring 
theory’, as discussed in chapter 2 where weakening or lengthening of the bond will 
decrease the vibrational frequency (and vice versa).42,43 Therefore, it is as expected 
that the highlighted peaks of the anhydrous form would appear at higher wavenumbers 
(and lower in the dihydrate), reflecting the absence of hydrogen bond to water of the 
respective functionalities or bands after desolvation. As water is released from the 
lattice. and as the bond of the existing functional group becomes less affected or less 
stretched by hydrogen bonding to water, the affected vibrations/peaks, will shift (back) 
to higher wavenumber. 
5.3.2 FTIR: DTA solution-state titration and kinetic study 
The solid-state analysis guides the interpretation of the spectrum of 1.54 M 
DTA in DMSO. Figure 5.9 shows the complete spectral range from 4000 to 400 cm-1 
with highlight on the regions of interest (inset) which are the NH and OH stretching 
region 3000-3600 cm-1 as well as the carbonyl region from 1750-1600 cm-1 of the acid 
and amide groups respectively.  
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Figure 5.9. DTA 1.54 M in DMSO solution FTIR spectrum with vibration range of interest are highlighted in the 
inserts. 
In solution, the DTA carbonyl region appears as a singular peak at 1683 cm-1, 
with a shoulder at 1710 cm-1. The distinction between the carbonyl of the acid and 
carbonyl of the amide group is difficult to ascertain. In the solid-state, carbonyl of the 
acid group appears at a higher wavenumber, followed by the amide.36 It is highly like 
that similar scheme is replicated in solution, suggesting that the shoulder represent the 
carbonyl of the acid, while the main peak observed is the amide carbonyl moiety. The 
use of anhydrous DMSO allows for clear observation of OH and NH stretching 
vibrations at 3430 and 3155 cm-1 respectively.  
Kinetics study to observe the ingress of water in the anhydrous DMSO-DTA 
solution mixture was done, in which the mixture is tested in an open setting where the 
system was left at ambient conditions (40% RH, 25 °C) and a time-dependent FTIR 
measurements were taken. The FTIR spectra were measured every six seconds for 150 
minutes (Figure 5.10, (a)). The influence of DMSO was also probed as DMSO is 
reported to be hygroscopic.44 Anhydrous DMSO-only preparation with a similar setup 
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was subjected to similar conditions for comparison (Figure 5.10, (b)). The experiment 
showed DTA propensity towards water in solution, based on the intensity of the OH 
vibrations (3400 cm-1, 85 vs.75% transmittance), which clearly shows that more water 
ingresses in the DMSO-DTA solution mixture as higher DTA concentration used 
allows for faster and stronger water ingress from the environment compared to only 
DMSO at a similar timescale. 
 
Figure 5.10. a) DMSO-DTA solution mix vs b): DMSO-only, exposed to ambient conditions for 150 minutes. 
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A water molecule has a broad symmetric (v1) and asymmetric OH stretching 
(v3) in the region of 3400 cm-1, a very weak OH bending (v2) and libration vibration 
at 2128 cm-1, as well as another v2, medium strength vibration in the region of 1644  
cm-1.45 In DMSO-water mixture, the second bending, v2 vibration can be observed at 
1660 cm-1 which in Figure 5.10 (b) clearly shows that as pure DMSO was left exposed 
to the environment, water stretching and bending vibrations peaks grew with time as 
more water was absorbed. The v2 vibration at 1644 cm-1 is weak, and in the DMSO-
DTA mixture, it is obstructed by the strong and intense carbonyl vibration. Influence 
form this vibration towards the carbonyl peak shift is minimal, but cannot be ruled out 
or overlooked. 
 
Figure 5.11. The FTIR spectra highlighting on the NH and OH stretching region of DTA in DMSO-DTA solution 
mixture following exposure to ambient conditions for 150 minutes.  
Observation of DMSO-DTA mixture, focusing on the NH and OH stretching 
region from 3000-3600 cm-1 (Figure 5.11), showed an increase to the OH vibration 
relative to the exposure time. The increase in absorbance (or reduction in % 
transmittance) of the OH vibration is most likely due to the increase in concentration 
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(Beer’s law, A = lc, A, absorbance, , absorptivity, l, pathlength, c, concentration )46, 
which is consistent with the ingress of water into the system as previously seen in 
DMSO-only experiment (Figure 5.10, (b)). Interestingly, the NH stretching does not 
change in shape or intensity, up to 40 minutes of exposure. After 55 minutes, the 
vibration is barely visible. The reason for this is most likely due to the overlapping of 
the OH vibration as more water is incorporated. As for the secondary amide and 
aromatic C=C at 1509 cm-1, no change in peak position was observed throughout the 
experiment. 
More importantly, observation of the carbonyl region in Figure 5.12, which is 
sensitive towards hydrogen bonding, 39–41 shows no immediate shift (from zero to five 
minutes), with the main carbonyl peak of the spectra remains constant at 1683 cm-1. 
The first shift of a single wavenumber to the carbonyl of the amide group was observed 
after 10 minutes. The single shift to lower wavenumber suggests hydrogen bond 
formation to this region. Continuous hydrogen bond formation due to the ingress of 
water with time, withdraws electron density from the bridging hydrogen atom, 
resulting in the stretching of C=O double bond leading to right-shift in the 
wavenumbers as more bonds are formed. At 60 minutes, the shift of the amide carbonyl 
peak is complete totalling 13 cm-1, from1683 to 1670 cm-1.  
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Figure 5.12. The FTIR spectra highlighting on the C=O stretching region of DTA in DMSO-DTA solution mixture 
following exposure to ambient conditions for 150 minutes. 
 
Figure 5.13. DMSO-DTA mixture vapour-sorption gravimetric experiment, where mixture sample was exposed to 
isotherm at 40% RH for 120 minutes 
Estimation of the amount of water which has ingresses from the environment 
in the kinetics experiment would allow investigation into DTA-water interaction with 
controlled water content. A vapour-sorption gravimetric experiment chamber was set 
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up to similar conditions of 25 °C and 40% RH. Similar DTA solution with 1.54 M 
concentration was loaded and exposed to the above conditions for 120 minutes, and 
the mass change was recorded (Figure 5.13). At 40 minutes, the amount of water taken 
up by DMSO-DTA mixture is 5.89% (calculated to 5.42 x 10-5 moles of water) which 
is approximately 4.33 molar ratio. At this point, the mass change slope is steep, 
suggesting a high rate of water ingress. At 60 minutes, the amount of water taken up 
by DMSO-DTA mixture is 6.86% (calculated to 6.32 x 10-5 moles of water) which is 
5.05 molar ratio. At this point, the slope is coming to a plateau (Figure 5.13). 
  
Figure 5.14. High concentration DTA-water FTIR spectra for the titration experiment with controlled water content 
in an open system 
Based on the data from the vapour-sorption gravimetric experiment, DMSO-
DTA solution titration with controlled amount of water was initially tested with four 
different water contents, namely 0, 0.825, 1.650, and 3.30 molar ratios. As expected, 
the observed shift occurs in the carbonyl region, shifting from 1683 to 1667 cm-1 
(Figure 5.14). The shift is more evident as all the solution are well mixed, allowing all 
possible interaction with the carbonyl group as they are in equilibrium, unlike the time-
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based the analysis where the surface area limits the interaction with water from the 
atmosphere. 
Titration of a high concentration DTA in a closed system allows for more 
precise water content to be incorporated as small water quantities can be used, also 
eliminating the influence of water from the environment. However, high concentration 
DTA study in liquid cell chamber proved to be problematic as the high concentration 
causes signal overload, even with the smallest spacer, as the method is very sensitive. 
The high concentration of DTA also limits the water content DMSO-DTA mixture can 
accommodate before precipitating out. A lower DTA concentration allows for liquid 
cell study with more water amount which can be titrated into the system. The downside 
is that at a lower drug concentration, background or noise vibration becomes more 
apparent, and may ‘interfere’ in the observation of the peak of interest, especially the 
bending (v2) OH vibration at 1643.5 cm-1 as water is introduced. To minimise the 
interference, deuterated water (D2O) and anhydrous DMSO, was used in the following 
titration.  
203 
 
 
Figure 5.15. The FTIR spectra highlighting on the C=O stretching region of DTA in DMSO-DTA solution 
mixture with high vs. low DTA concentration  
Figure 5.15 shows comparison between high (1.54 M) and lower (0.02 M) 
concentration DTA spectra, highlighting the carbonyl peak wavenumber range. The 
higher DTA concentration spectrum was from an open system, while the lower was 
from a closed system. Overall, the peak profile within the wavenumber range of 
interest shows that the main of the amide functionality still clear and consistent in both 
setup, with the peak observed in the lower DTA concentration appearing at four 
wavenumbers higher at 1687 cm-1 vs.1683 cm-1 in the high concentration DTA. 
However, the spectra comparison also shows the presence of a shoulder at 1624 
cm-1 at low DTA concentration (arrow pointing up, Figure 5.15). This shoulder is 
completely undetectable with the high concentration DTA analysis. Standard47 and in-
house FTIR spectrum of DMSO showed the mentioned shoulder as a very broad and 
weak peak with 96.5% transmittance. Closer examination revealed that this shoulder 
is coming off the OH v2 vibration in a wet DMSO, as DMSO-only does not possess 
any vibration at this wavenumber.48 Although the peak was marginal and weak, the 
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appearance of the water vibration was magnified with low concentration transmission 
cell analysis. The presence of water maybe to absorption from the environment during 
the transmission cell setup, or during transfer DMSO. The 1624 cm-1 shoulder does not 
shift but grows, comparable to the growth feature of the vibration at 1660 cm-1 
comparable to the observation of the DMSO-only exposed to the environment 
experiment (Figure 5.10). This growth is most likely due to the increase in the 
concentration of water, giving rise to the increase in the intensity of the absorbance in 
accordance with Beer’s law.46 A slightly lower wavenumber vibration position 
observed in this experiment is most likely due to DTA presence in the solution mixture.  
Another different feature in the spectra of the low concentration DTA analysis 
is the absence of the shoulder at 1710 cm-1 (arrow pointing down, Figure 5.15). As 
stated earlier, peak assignment based on the solid-state FTIR spectra of DTA suggests 
that this shoulder is most likely the carbonyl of the acid functionality. This shoulder 
was initially undetected at low D2O content but becomes more apparent once D2O was 
added to the system. As DTA concentration remained constant, the increase in the 
intensity of this carbonyl vibration (the C=O stretching) is generally due to the increase 
in dipole moment against distance. The said change could be caused by dimerisation 
involving carbonyl of the the acid group, giving rise to the shoulder. DTA dihydrate 
neutron diffraction study has reported DTA dimer formation through two hydrogen 
bonds from the amide (donor) to the carbonyl of the acid group in a centrosymmetric 
fashion.22 Based on the observation of the low concentration DTA FTIR titration 
experiment, which showed the emergence of the carbonyl shoulder with the 
introduction of D2O, it is possible that the dimerisation is induced or triggered by 
water. Also, in the high concentration DTA, this shoulder is present even at low water 
in the system. Since DTA molecule is abundant, it is very likely that the dimer is 
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present. Water could potentially induce the dimerisation here, as high DTA 
concentration generates a higher affinity towards water, in turn, facilitates water 
absorption from the environment, (inducing dimerisation) giving rise to the shoulder 
early on. Chemically inducing dimerisation is not a new concept as it has been in 
chemical sensor development49 as well as a tool in cell biology for nearly 20 years.50 
One example of the use of chemical induced dimerisation the report by Jiao et al., 
where the authors used carbazole derivative sa fluorescence carrier, which formed 
carbazole dimer in the present of iodine.49 In cell biology, the process is normally 
associated with the biological mechanism in which two proteins bind only in the 
presence of a certain small molecule, enzyme or other dimerising agent.51  
 
Figure 5.16. Low concentration DTA-water titration experiment with pre-determined water content in a closed 
system 
In the low concentration DTA-water titration experiment with controlled water 
content in a closed system (Figure 5.16) an immediate shift to lower wavenumber was 
observed from 0-5:1 G:H molar ratio. At 5:1 G:H molar ratio, the peak appeared 
slightly broader. It is most likely that the broadening is due to the presence of the D2O-
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carbonyl hydrogen-bonded and non-hydrogen-bonded species, as the FTIR spectra 
account for all the vibrations of the overlapping species. At the highest D2O content of 
500:1 G:H molar ratio, the shift observed was 12 wavenumbers, to 1675 cm-1. The 
value is comparable with values obtained from high DTA experiment, which shifts 
down 13 wavenumbers. DTA peaks observation above this range was challenging as 
D2O has a broad and intense OD v2 and libration vibration at 1555 cm
-1.45 
5.3.3 1H NMR: DTA-water titration 
Three chemical shift regions representing DTA protons were monitored in the 
initial 1H NMR spectrum in DMSO-d6 environment, with all peak aligned to TMS at 
0 pm. The signal at 13.9 ppm corresponds to the carboxylic acid (OH) proton which 
was identified as proton 1. At around 10 ppm the NH protons of the amide 
functionalities were observed. Closer observation of the spectrum revealed that the NH 
amide protons appeared as two separate peaks, even though both amides are equivalent 
due to the mirror plane down the molecule. The reason for having different chemical 
shifts is due to the influence of the huge iodine molecules, which affected the 
electronic distribution of the respective NH differently. The two peak were later 
identified as proton 2 at 10.04 ppm and proton 3 at 9.95 ppm respectively. Lastly a 
singlet representing two methyl group (CH3) was observed at around 2 ppm in the 
spectrum (Figure 5.17).  
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Figure 5.17. DTA 1H NMR spectrum in DMSO-d6 environment 
Integration of the peaks which were calibrated to the six protons of the two 
methyl group, accounts correctly to the sum of protons associated with DTA. Other 
visible peaks are of the reference, TMS (0 ppm), DMSO-d6 (2.5 ppm), water (3.3 ppm) 
and other impurities. The purity of DTA is calculated to 99.91% with 0.09% 
impurities, based on the initial NMR spectra. Potential decomposition was most likely 
the source of the impurity detected as the compound was purchased as a dihydrate, and 
require desolvation by heating the sample up to 150 ℃ prior to analysis.  
Dilution experiment initially was done to ensure that the peak shifts observed, 
if any were to occur, were indeed due to interaction with water and not the effect of 
dilution. An adequate amount of anhydrous DMSO was titrated in small aliquots into 
1.0 M DMSO-DTA mixture from 0-7:1 G:H molar ratios in 0.5 molar ratio gaps. The 
dilution experiment revealed that no significant peak shifts were observed to any of 
the protons, as highlighted in Figure 5.18 which followed proton 2 and 3 dilution 
towards higher dilution factor.  
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Figure 5.18. DMSO-DTA dilution experiment 
A detailed explanation of the fundamental and importance of binding constant 
measurement has been discussed in Chapter 1 and 2. A stable complex between the 
reactants, i.e. DTA (host, H) and water (guest, G) would correlate to a large binding 
constant. The finding would prove, or disprove quantitatively our main hypothesis 
which states that a compound with the ability to form a stable hydrate will show 
significant interaction with water in solution. As mentioned in chapter 1 and 2, 
measurement of the binding constants via NMR spectroscopy was performed by 
monitoring the changes in the chemical shift i.e. peak shifts, of one or more proton 
signals in the 1H NMR spectra of the receptor molecule at different guest 
concentrations.  
Examination of the DTA 1H-NMR spectrum revealed that the carboxylic acid 
OH proton peak appeared at 13.9 ppm as a single, broad peak. The broad shape is due 
to the peak being generated based on the average site of a fast exchanging proton on 
the NMR timescale. Monitoring of this peak was difficult as the peak became broader 
and barely visible above 5:1 G:H molar ratio mark. The methyl groups were also 
affected by water inclusion; however, the observed peak shift was not significant. The 
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strongest noticeable peak shift was to the NH of the amide groups. Monitoring of the 
NH chemical change is sensible since single-crystal neutron structure has also 
highlighted that the carbonyl of the amide functionality is one of the coordination point 
to water in the dihydrate structure,22 therefore, the NH moiety is closest to the 
interaction point to water, hence experiencing the biggest effect form the compound-
water complexation and the resultant electronic rearrangement. In addition, the NH 
moiety itself is capable of forming hydrogen bond to water by donating proton to the 
oxygen atom of the water molecule. Even though this motif is not observed in the 
solid-state, it is still highly possible in solution. 
a) 
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b) 
 
Figure 5.19. a) High vs. b) low DTA concentration of 1HNMR DTA-water titration experiment 
Similar to the FTIR probe, two constant DTA concentrations of high (1.0 M) 
and low (0.02 M) were used, titrated with varying concentrations of water as the guest. 
The method used was discussed in chapter 2, but basically closer guest (water) 
concentrations were introduced to the constant host (DTA) resulting in smaller G:H 
molar ratio gaps, which gradually followed by wider G:H molar ratio gaps with higher 
water concentration. The highest water content able to be titrated into the high 
concentration DTA experiment was eight molar ratios, with immediate precipitation 
211 
 
occurs above the value. Meanwhile, the low DTA concentration titration experiment 
was stable or remain in solution up to 1000 G:H molar ratio. From the observation of 
the amide NH protons at 10.04 and 9.95 ppm respectively in both runs, an immediate 
peak shift was observed, even at a very low molar ratio of water. High DTA 
concentration run (Figure 5.19 (a)) yielded a downfield shift (as a higher concentration 
of water is titrated in), while in the low DTA concentration experiment (Figure 5.19 
(b)), an upfield shift was initially observed up to 25:1 G:H molar ratio. Above this 
value as a higher concentration of water was titrated in, the peak shifts change 
direction, moving downfield instead. Above 130:1 G:H molar ratio, the NH proton on 
the lower chemical shift showed a larger peak shift magnitude compared to the other 
NH on the higher chemical shift, resulting in the two peaks to almost converge to one 
another at 1087:1 G:H molar ratio. Even though the observed peak shift magnitude is 
small, the value is significant with close to 0.1 ppm recorded at the highest water 
content of 8 molar ratios in the high concentration DTA experiment, while for the low 
concentration DTA experiment, an overall peak shift of 0.24 ppm was recorded at 
1087:1 G:H ratio. 
The shift to higher ppm suggests deshielding of a proton.52 In both DTA 
experiments the downfield shift observed were most likely due to one of these two 
explanations: 1) the NH acts as a proton donor and directly interact with water, 
resulting in loss of electron density (generated through-bond) around the bridging 
hydrogen atom as hydrogen bond is formed with water. Solid-state electron density 
redistribution study on α-oxalic acid and water of the dihydrate form showed similar 
electron density loss due to hydrogen bonding around the donor atom which was 
represented by topography contour change.53,54 Recent simulation study between 
various compounds and water best highlight the event, clearly showing in contrasting 
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colours that the bridging hydrogen atom loses density during complexation (Figure 
5.20).55–58  
a) 
 
b) 
 
Figure 5.20. a) Shows HC2O4 dimer where yellow-coloured isosurface represents electron loss and the blue colour 
suggests electron increase.57,58 b). Shows F2CCFH-water complexation resulting in shifts or rearrangement of 
electron density throughout the compound. Blue regions corresponds to electron density gain, and red regions 
represent loss.56 
In our titration experiments, following compound-water complexation in 
solution, the electron density shifted from H (of the NH) to O (in water) because of the 
higher electron affinity property of the oxygen atom. Therefore, the second 
explanation is more likely: 2) the shift observed is due to electron density 
reorganisations,56,57 an indirect effect from the hydrogen bond formation between the 
carbonyl of the amide and water as observed in the FTIR titration study, and reported 
as one of the interaction point to water.22 As the carbonyl of the amide and water form 
a complex, the DTA molecule underwent all-round electron density reorganisations, 
affecting bonds and electron density peripheral to the proton acceptor. The 
reorganisations of electron densities shown in the simulation of water dimer formation, 
and acetylene and the various fluorinated derivatives of acetylene complexation with 
water,56 suggest that while proton acceptor (in this case O atom) which forms the 
hydrogen bond gains electron density from the hydrogen atom, a ‘see-saw’ or ‘ripple’ 
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effect is seen, causing atoms to lose-and-gain electron density.56  The ‘ripple’ or ‘see-
saw’ effect is thus though to be a through-space effect- as reported by Wheeler, 59 
which in our study was initiated by the polarisation of the C=O bond by hydrogen 
bonding to water and affecting bonds closer to the interaction site. The electrostatic 
nature carries through, resulting in a final partial positive charge on the observed N-H 
bond, hence deshielding H leading to the observed downfield shift. 
In the low DTA concentration experiment, the monitored peak initially moved 
upfield which was observed form 1-25:1 G:H ratio. Even though the peak shift was 
marginal, the upfield peak shift movement, the consistent shape and magnitude was 
significant, indicative of ‘real’ interaction with a maximum shift of 0.005 ppm at 25:1 
G:H molar ratio. The slight chemical shift recorded suggests shielding of the observed 
nuclei due to a small gain in electron density. We believe that this interaction is the 
early hydrogen bonding interaction involving the acid group, indicated by the small 
magnitude of the chemical shift due to the interaction point being ‘further’ bond 
distance away from the monitored proton 2 and 3. Williamson reported similar 
inductive effect to the observed proton relative to its neighbours. The author mentioned 
that a proton may protons experience considerable secondary chemical shift due to 
neighbouring atoms’ interaction, either by pulling the electron density away, or 
pushing it towards the proton.60 This observation is also in line with the statement on 
the regioselectivity for guest binding, where location of the nuclei most affected by the 
complex typically show the biggest peak shift.61 This theory is also in line with the 
earlier observation of the low DTA concentration FTIR titration (Figure 5.16), which 
showed the initial absence of carbonyl acid shoulder, before becoming clearer with 
D2O introduction leading to hydrogen bonding or dimerisation.  
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As explained in detail in Chapter 2, the common method to determine the 
stoichiometry of the binding event is through Job’s plot measurement, which requires 
for the total number of moles of reactants to be kept constant for a series of 
measurements, done at different mole ratio or mole fraction of reactants.62,63 The right-
skewed (Xmax=0.7) Job’s plot in Figure 5.21 indicated that DTA and water interact in 
a 2:1 stoichiometry at equilibria. 
 
Figure 5.21. Job plot showing the 2:1 stoichiometry of the complexation between DTA and water in DMSO-d6 
using 1H NMR. ([DTA] + [H2O] = 0.1 M) 
The binding constant was determined by monitoring the changes in the 
chemical shift following DTA–water 1H-NMR titration. Figure 5.22 shows a scatter 
plot corresponding to the amide proton peaks, proton 2 or NH-A =10 ppm, proton 3 or 
NH-B = 9.94 ppm, at 0:1 G:H molar ratio. The scatter plot shifts were created for both, 
high and low DTA concentration titration experiments, and fitted to the host-guest 2:1 
binding model to obtain the K11 and K21 values. The fitting for the high DTA 
concentration titration experiments yielded a high K21 versus K11 value (Figure 5.22 
(a)). The calculated K11 value is 1.95 x 10
-5 M-1 (4.4% error) while K21 value is 1128 
M-1(10% error). The calculated errors are asymptotic error64,65 calculated based on 
Levie approach.66 Unlike standard error which is calculated at 95% confidence 
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interval, asymptotic error informs how far off a fitting to the 95% confidence interval 
level.65 Based on the considerably smaller K11 compared to the K21, and the speciation 
plot, two scenarios are likely, 1) the DTA-water complex is immediately transformed 
to DTA dimer-water complex or 2) DTA dimerisation is instantaneous in solution 
contributing to the low K11. 
 
Figure 5.22. a) Scatter plot of the amide proton peaks, NH-A =10 ppm, NH-B = 9.9 ppm, from 0-7:1 G:H molar 
ratio of high DTA concentration 1HNMR titration experiments, fitted to the 2:1 binding model, and b) shows the 
host, H guest G, speciation plot. 
A similar trend of high K21 vs. K11 is also observed in the low DTA 
concentration titration experiments. From the fitting, the K11 is calculated to 2.94 x 10
-
4 M-1 ( 2.3%.error) while K21 value is 3005 M-1( 8.1%.error, Figure 5.23). The 
fitting, however, failed to consider the upfield shift from 0-25:1 G:H (Figure 5.23 (a)), 
with the fitted line missed the set of points below 25 molar ratios. However, since the 
up-field shift was small, the points were still within the error range of 0.2% of the fitted 
line.  
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Figure 5.23. a) Scatter plot of the amide proton peaks, NH-A =10 ppm, NH-B = 9.9 ppm, from 0-1087:1 G:H molar 
ratio of low DTA concentration 1HNMR titration experiments, fitted to the 2:1 binding model. The inset in a) shows 
the fitting overlooking the upfield points b) shows the host-guest, speciation plot. 
If the peak shifts positions are broken into two sections, the initial up-field 
followed by the downfield shift, different K values are obtained. The best fitting for 
data from 0-25:1 G:H molar ratio generates a negative K11 value of -1.03 x 10
-2 M-1, 
with an error of 12%. The high error is most likely due to a low number of data point 
as only six are available. Meanwhile, K21 value is calculated to be 875 M
-1 ( 
2.5%.error). Due to the negative cooperativity in K11, the Gibbs free energy could not 
be calculated. 
The fitting for DTA titration at low concentration which generated the lowest 
error was for the titration points from 25-1087:1 G:H molar ratio, which generated the 
following K values, K11 = 0.05 M
-1 ( 7.4%.error), while K21 =619 M-1( 7.9%.error, 
Figure 5.24). Based on the speciation plot, it is suggested that the dimer-water complex 
is favourable upwards from 25 molar ratios of water, with H2G complex saturation at 
around 400 molar ratios (plateau observed in speciation plot). The DTA-water 1:1 
complex is also seen increasing in concentration with more water titration, most likely 
due to an abundance of water molecules in the system.  
217 
 
 
Figure 5.24 a) Scatter plot of the amide proton NH-A =10 ppm, NH-B = 9.9 ppm, at 25-1087:1 G:H molar ratio 
of low DTA concentration 1HNMR titration experiments, fitted to the 2:1 binding model, and b) shows the host, 
H guest G, speciation plot. 
Observation of the solution-state FTIR spectra, 1HNMR chemical shift and the 
obtained K values suggest firstly, the carbonyl is the most likely water interaction 
point, corresponding well to interaction present in the solid-state i.e. the difference in 
spectra of the anhydrous and hydrate form, as well as the bonding reported in the 
crystal structure. The FTIR showed the carbonyl vibrations to shift to lower 
wavenumber consistently, regardless of DTA concentration following water 
introduction. In the 1H-NMR, the amide functionalities shifted the most, suggesting 
that this region is most sensitive to water interaction. The sensitivity is most likely due 
to the close proximity of the group to the true interaction point, i.e. carbonyl of the 
amide, complementing FTIR data. Next, based on the K21 value, there is a strong 
interaction between DTA and water, following a 2:1 stoichiometry. Since the 
complexation processes are viewed in steps, the low K11 values suggest the initial 1:1 
complex changes into DTA dimer-water complex very quickly, almost instantaneous 
with water introduction. Dimer species are present in both low and high 
concentrations.  
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However, the interpretation above is only valid if there are only two species, 
the DTA-water complex and the dimer-water complex, present in solution in 
equilibrium. In a dilute solution, DTA can form dimers via several possible 
configurations; an acid dimer (acid-OH…O- acid), an amide-acid dimer (amide -
NH…O- acid), or an amide dimer (amide -NH…O- amide). Two of these interactions 
(amide-acid and amide-amide) can be observed in the crystal structure.22  
The FTIR data suggests that dimerisation are indeed present in solution, 
however, it is unclear which dimer variation is present at which titration point. Also, 
it is highly likely that there are multiple dimer variations, giving rise to multiple dimer-
water complexes or even a tetramer species. Furthermore, unlike the anion binding 
experiment which uses binding constant to measure the association strength, the 
magnitude of shift observed in this iteration (between an uncharged compound and 
water) is much smaller. From the first compound-water titration experiment, we 
learned that the dilute method is the way forward, as it allows for more water 
incorporation into the evaluated system, without precipitating out.  
We believe that the K values obtained from fitting of the chemical shift is an 
apparent fit, instead of a true association. The main reason for this assumption is that 
thermodynamically, a dilute solution would have greater the entropy, and thus the 
smaller the free energy (Equation 1.1). The greater entropy would reflect on the 
increase randomness of a system, hence generating more activities and species 
possibilities for the components interactions in a dilute solution. Therefore, it is highly 
unlikely that in a dilute setup, only one species exists and predominates others. 
However, the used model does still represent the binding interaction, albeit an 
‘apparent’ one as the peak shift data plotted do still ‘fit’ the mathematical model in 
219 
 
hand. The obtained binding constant, K is a thermodynamic parameter, hence it can be 
used to determine the free energy of association (in equilibrium, ΔG = 0) based on the 
Gibbs equation, G= -RT ln K. (R is the universal gas constant, which has the value 
8.31447 J·K-1·mol-1, T is temperature in Kelvin). The calculated K21 binding energies 
based on the different fitting scenario are listed below. Note that calculation on the 
magnitude of the overall binding process (21) is not calculated as the value of K11 is 
negligible ~0. We stress that since the process is considered as stepwise, it is unlikely 
that no HG (1:1) complexation occur in solution. However, this ‘apparent’ absence is 
due to the fitting of the model, as well as the very small magnitude of proton shift 
involving water titration. Hence, the G calculated is specifically used as a guide and 
reference for water binding in solution. 
Table 5.1. Calculated G of DTA-water binding based on 2:1 binding model 
[H]:[G] binding model K11 (±% error) K21 (±% error) Gfor K21 
2DTA:H2O (High [DTA]) 1.95 x 10
-5 M-1 
( 4.4%.error) 
1128 M-1 
( 10%.error) 
-17.41 kJ mol-1 
2DTA:H2O (Low [H2O]0-1087/ 
[DTA]1) 
2.94 x 10-4 M-1 
(2.3%.error) 
3005 M-1 
(8.1%.error) 
-19.84 kJ mol-1 
2DTA:H2O (Low [H2O]0-25/ 
[DTA]1) 
-1.03 x 10-2 M-1 
(12% error) 
875 M-1 
( 2.5%.error) 
-16.78 kJ mol-1 
2DTA:H2O (Low [H2O]25-
1087/ [DTA]1) 
0.05 M-1 
( 7.4%.error) 
619 M-1 
( 7.9%.error) 
-15.93 kJ mol-1 
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5.3.4 CIM solid-state preliminary analysis  
The starting compound was analysed to determine its state of form, which 
PXRD and FTIR later revealed that it was the anhydrous Form A (Figure 5.25).24,67 
Following the method reported by Hegedüs and Görög, CIM monohydrate (M1) was 
obtained by quench cooling a hot 15% w/w CIM aqueous solution with (five times the 
volume) ice-cold water.24 PXRD and FTIR spectra confirm the precipitated form to be 
the monohydrate M1 (Figure 5.25).9 
 
Figure 5.25. FTIR spectra (LEFT)and PXRD traces of CIM anhydrous Form A and monohydrate M1 
TGA of the monohydrate M1 showed a mass loss of 6.32%, corresponding to 
0.945 moles of water (the calculated value for a monohydrate is 6.67%, Figure 5.26). 
Meanwhile, the DSC trace ( Figure 5.26 (a)) shows an endothermic event at 73 ℃, 
indicative of a dehydration process (comparable to the M1 TGA trace). Also, the 
melting event revealed to be at 140-142 ℃ (Figure 5.26), the slight variation between 
the two TG runs was most likely due to sample preparation. The obtained melting point 
was comparable to the earlier report of 143 ℃.9 Following dehydration, the 
monohydrate M1 transforms spontaneously to Form A, as previously reported by 
Calvo et.al.68 
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a)      b)  
Figure 5.26. TGA (a) and DSC (b) traces of CIM Form A and monohydrate M1 
DVS of the anhydrous Form A and the monohydrate M1 (Figure 5.27) 
indicates that both forms are stable, with very little mass change throughout the 
humidity cycle, 0.06% (Form A) and 0.12% (M1) difference between the two extreme 
RH, indicative of surface water. 
 
Figure 5.27. DVS of the anhydrous Form A and the monohydrate M1 
The FTIR spectra show a clear difference between the anhydrous Form A and 
M1, especially in the nitrile vibration (C≡N, Figure 5.25). Kanumfre et al. reported the 
FTIR assignment for the C≡N stretch vibration to be at 2187 cm-1, without stating the 
identity of the polymorph.69 A more in-depth comparison by Hegedüs and Görög also 
provided FTIR peak assignment, with emphasis on difference to the C≡N peak position 
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for all four anhydrous forms A,B,C and D. Our in-house spectra are comparable to 
Hegedüs’s assignment, with the C≡N stretch vibration emerging at 2174 cm-1for the 
anhydrous Form A. A substantial shift of the C≡N is observed in the monohydrate M1 
spectra as this band shifts 24 wavenumbers lower to 2150 cm-1. It is evident from the 
shift to lower wavenumber that hydrogen bond to water takes place in the nitrile region 
as the C≡N is a strong hydrogen bond acceptor, comparable that of water.70 Reasons 
relating a lower wavenumber shift to hydrogen bonding has been discussed in the DTA 
section above. This region will henceforth be a probe in the following FTIR solution-
state titration experiments.  
5.3.5 FTIR: CIM solution-state titration  
Following the result from low DTA concentration analysis, solution-state FTIR 
titration for CIM was performed using a concentration of 0.05 M in DMSO solution, 
and titrated with different D2O contents. Initial titration gap of five molar ratios was 
used up to 20:1 G:H molar ratios. Larger G:H molar ratios were later used namely 
30:1, 40:1, 70:1, 100:1, 125:1, 150:1, 300:1, 400:1, 500:1 with the highest D2O 
introduced was in 600:1 G:H molar ratios. The initial nitrile peak position at 0:1 G:H 
molar ratio was 2165 cm-1. No shift was initially observed, up to 30:1 G:H molar ratios 
incorporated. At 40:1 G:H molar ratios, a single wavenumber shift was observed. 
Unexpectedly, the shift observed was to the higher wavenumber (Figure 5.28, (b)), 
suggesting hydrogen bond breaking, as more D2O was introduced. The higher 
wavenumber shift trend continues, with the next two wavenumber shifts observed at 
300:1 G:H molar ratios. The following 100 molar ratios gap onwards to 600 molar 
ratio saw the peak shift steadily, from 2168 to 2171cm-1. The FTIR probe of the other 
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CIM vibrations was complicated as most CIM peaks in solution were covered either 
by the D2O or the DMSO vibrations (Figure 5.28, (a)).  
 
Figure 5.28. 0.05 M CIM in DMSO solution (a) showing unobstructed view of the vibration of interest. (b) shows 
the solution-state FTIR titration of CIM from 0-600 G:H ratios. 
In the CIM Form A, the amino functionality on the guanidine part of the 
compound is involved in inter- and intramolecular hydrogen bonds.71 The reported 
dimer motif in the structure of CIM Form A is between the NH+…:N≡C.71 One of 
the slightly positive (+) hydrogen atom in the amide molecule is attracted to the lone 
pair on the nitrogen atom (-) in the nitrile, forming a hydrogen bond. It is unconfirmed 
whether the dimer motif persists in solution. However, the observed to shift to higher 
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wavenumber potentially due to the said motif being broken in the presence of large 
quantities of water in the system. Water OH is a stronger hydrogen bond donor 
compared to the guanidine,70 therefore, as more D2O titrated into the system, the dimer 
motif began to break as a strong acceptor i.e. C≡N is more likely to favour interaction 
with a strong donor i.e. OH. The effect of the intermolecular hydrogen bond breaking 
of the dimer offsets the change due to hydrogen bond formation between C≡N…DOD 
resulting in the delayed observed to shift to higher wavenumber.  
5.3.6 1H NMR: CIM-water titration 
Preliminary 1H-NMR spectra of CIM in DMSO-d6 and acetone-d6 were 
obtained, integrated and assigned accordingly (Figure 5.29).72 The proton were 
identified as proton 1-8 based on their position, from higher to lower ppm as they 
appear in the respective spectra (Figure 5.29). CIM peaks positions differ slightly 
between the two solvents, however, they do appear generally within the comparable 
region. 
 
Figure 5.29. CIM proton 1-8 assignment form higher to lower ppm as they appear in the spectra along with their 
respective symbols. a) shows CIM spectrum in DMSO-d6 environment, and b) in acetone-d6 respectively. 
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1H NMR dilution experiment with 40 molar ratios of DMSO, and 500 molar 
ratios of acetone respectively were done to ensure that the shifts, if any recorded were 
indeed due to interaction with water not the effect of dilution (Figure 5.30). As 
mentioned in chapter 2, 1H NMR dilution experiments were carried out by preparing 
sufficient amount stock solutions of the CIM in DMSO-d6 or acetone-d6 at 
concentrations of 0.05 and 0.02 M, and diluting the main stock with sufficient molar 
ratio aliquots of the main solvent. In both experiments, no significant shifts were 
observed (Figure 5.30)  
a)  b)  
Figure 5.30. Peak shift in CIM dilution experiment. a) in DMSO-d6 environment, while b) in acetone-d6 
environment  
1H NMR titration experiments were carried out at a constant concentration of 
CIM, 0.05 M in DMSO-d6 and 0.02 M in acetone-d6, titrated with varying 
concentrations of water. Similar to the DTA titration, a closer G:H concentration gaps 
were initially used, followed by wider G:H gaps containing higher water concentration 
introduced into the mixture. The amount of water titrated in was from 1-35: G:H molar 
ratio in DMSO-d6 environment while in acetone-d6, the guest introduced was from 1-
450 G:H molar ratios.  
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Figure 5.31. TOP form LEFT to RIGHT: Proton 1-4 peak shifts, while BOTTOM, from LEFT to RIGHT: Proton 5-8 peak shift in DMSO environment 
Table 5.2. 1H NMR chemical shift (ppm) of free cimetidine and complexed with water in deuterated DMSO at titration endpoint. 
 
 Proton 1 Proton 2 Proton 3 Proton 4 Proton 5 Proton 6 Proton 7 Proton 8 
Free CIM in DMSO 11.851 7.4643 7.1685 3.629 3.29 2.687 2.551 2.119 
35:1 G:H  in DMSO-d6  11.87* 7.4154 6.9601 3.578 3.243 2.638 2.50 2.059 
 0.019 -0.0489 -0.2084 -0.051 -0.047 -0.049 -0.051 -0.06 
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In the titration in DMSO-d6 environment (Figure 5.31), all protons showed 
upfield shift, except for the NH on the imidazole ring (proton 1). Proton 1 was clearly 
visible up to 4:1 G:H molar ratio. There was no significant shift observed to proton 1 
from one to four molar ratios of water, before shifting by 0.02 ppm downfield at five 
molar ratios of water inclusion. However, the peak of proton 1 then broadens 
significantly above the mark due to the fast exchanging of the NH with the 
incorporated water, making it hardly visible, hence difficult to interpret further (Figure 
5.31). Next is the proton CH of the imidazole ring (proton 2), which shifted to a lower 
ppm from five molar ratios of water upwards. Upon reaching 35 molar ratios, the peak 
shift recorded was almost 0.05 ppm (Figure 5.31). Next proton shift observed was in 
the NH peaks of the guanidine group (proton 3), with subsequent splitting at higher 
water concentration. The observed splitting started as a shoulder at 20:1 G:H molar 
ratios, before complete separation at 25:1 G:H molar ratios. At 35:1 G:H ratio, the 
peak which has separated out of the initial chemical shift has shifted by a total of 0.2 
ppm (Figure 5.31). Since the observed peak and broad base was the actually 
representing two NH protons, the split observe was most likely due to the influence or 
effect of hydrogen bonding to the electronic environment of each of the NH protons. 
One of the protons is receiving more electron density from a neighbouring atom, due 
to CIM-water interaction, causing the proton to be more shielded than the other. Even 
though the nitrile CN region showed significant shift in wavenumber between the 
anhydrous and hydrate form in the solid-state, our solution-state FTIR titration 
experiment did not share similar feature. Significant shift was only observed at very 
high G:H molar ratio. Therefore, it is most likely that the NH proton 3 which was 
shifting the most is interacting directly to water through hydrogen bond between the 
NH…OH. The splitting could also be caused by the presence of a CIM-water complex, 
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having a slow exchange (between complex and reactant) on the NMR time scale at 
equilibria. A lower temperature 1H-NMR run of the sample from 0-25:1 G:H ratio 
would slow-down the reaction even more, and cause the split peak to appear as a 
sharper more define peak, confirming the existence of the complex.  
The upfield shifts trend continues with the protons of CH2 connecting the 
imidazole ring and the thiol-S group (proton 4, Figure 5.31), which have shifted by 
0.05 ppm. Interestingly, the peak profile of the following protons which were close to 
the secondary amine changes with water titration. The proton of the CH2 linked to the 
secondary amine (proton 5) changes from a quartet to a triplet between 20-25: G:H 
molar ratios, while CH3 linked to the secondary amine (proton 6) changes form a 
doublet to a singlet between 10-15:1 G:H molar ratios, again shifting upfield at higher 
water molar ratios. The signal splitting and convergence observed were most likely 
due to changes to electronic environments of the said protons, which were most likely 
attributed to the hydrogen bond formation from CIM-water complexation. 
The final two protons, CH2 connecting the guanidine and the thiol-S group 
(proton 7), and CH3 on the imidazole ring (proton 8) shifted by 0.05 and 0.06 
respectively (Figure 5.31). In fact, all the proton shifted by a similar value of around 
0.05 ppm, apart from the NH group (Table 5.2). Therefore, a follow-up titration in 
acetone-d6 was done as acetone allows for the observation of the labile protons e.g. 
the. NH group of. proton 1 and 3, at higher water molar ratios. Monitoring of the NH 
group were important because they are potentially the point of complexation 
themselves or they at close proximity to the true interaction point as the NH chemical 
shift were being affected the most.  
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In acetone-d6 environment, significant chemical shifts were observed in all the 
protons of CIM following water titration up to 450:1 G:H molar ratio. All protons 
showed an upfield shift, apart from three protons showing downfield shifts which are, 
the proton of the NH on the imidazole ring structure (proton 1, ), the proton of the 
CH2, connecting the imidazole ring and the thiol-S group (proton 4, ), and  the proton 
of the secondary amine –NH protons of the guanidine group (proton 3,  Figure 5.33, 
Figure 5.32).  
 
Figure 5.32. Point of reference, the structure of CIM, with their corresponding symbols and numbering scheme. 
For most of the protons, their significant shifts were observed only after high 
water incorporation (> 50 molar ratios). Therefore, the focus of the titration analysis 
was more on the immediate shifting protons, even at lower water contents i.e. proton 
1,2, and 3. The biggest shifts are observed in the protons of NH groups on the 
imidazole ring and the guanidine (proton 1 and 3). However, due to the fast exchanging 
nature NH proton with water in the acetone environment, which was also observed in 
DMSO-d6 environment, the peak appeared very broad especially on the ring structure, 
and although visible, the exact peak position is difficult to ascertain and monitor 
(Figure 5.33). The proton 3 of the amide of the guanidine were visible at 450:1 G:H 
ratio while the NH on the imidazole ring is vaguely visible at 300:1 G:H ration. Proton 
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1 and 3 peaks has shifted downfield by 0.279 and 0.477 ppm at the respective water 
ratios, in relation to free CIM, the overall shift of all protons are listed in Table 5.3. 
Since the shifts of proton 4-8 are only apparent at higher water content, these small 
shifts are most likely electronic rearrangement effect from the main interaction points 
as more CIM-water aggregate are present in solution. 
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Figure 5.33. TOP form LEFT to RIGHT: Proton 1-4 peak shifts, while BOTTOM, from LEFT to RIGHT: Proton 5-8 peak shift in acetone-d6 environment 
Table 5.3. 1H-NMR chemical shift (ppm) of free cimetidine and complexed with water in deuterated acetone. 
 Proton 1 Proton 2 Proton 3 Proton 4 Proton 5 Proton 6 Proton 7 Proton 8 
Free CIM in ACO 11.1685 7.6256 6.7968 3.7192 3.5285 2.8797 2.6753 2.2294 
450:1 G:H in  acetone-d6 11.6457* 7.5542 7.0753 3.7336 3.4361 2.8634 2.6659 2.2197 
 0.4772 -0.0714 0.2785 0.0144 -0.0924 -0.0163 -0.0094 -0.0097 
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Figure 5.34. CIM Job plot experiment.in a) DMSO-d6 environment, b) acetone-d6 environment Job plot showing 
the 1:1 stoichiometry of the complexation between CIM and water in DMSO-d6 while a 2:1 stoichiometry of the 
complexation in acetone using 1H NMR. ([CIM] + [H2O] = 0.1 M) 
Job’s plot indicated that CIM and water interact in a 1:1 stoichiometry at 
equilibria in DMSO, while in acetone a right-skewed plot (Xmax=0.9) observed 
suggests a strong 2:1 stoichiometry (Figure 5.34). However, due to the shape and small 
value of the shift, similar assumption to DTA is taken here where we believe that more 
than one species exists in the dilute solution of each solvent. Therefore, the Job’s plot 
does not necessarily show a true interaction stoichiometry. Nevertheless, the fittings 
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were done according to the respective stoichiometries indicated by the Job’s plots. The 
stoichiometries, as well as the eventual fitting, are considered as apparent values which 
provide K information, and used as comparison to DTA K values. 
 
Figure 5.35. Proton 1-8 peak shift scatter plot form 0-35 G:H molar ratio in DMSO 
The scatter plot of the protons shifts shows barely noticeable change (Figure 
5.35). Binding constant fitting based on 1:1 stoichiometry for the titration experiment 
in DMSO environment yielded a very small K value of 1.5 x 10-5 M-1 (error ±1.3%) 
which translates into a positive Gibbs free energy of 27.5 kJ mol-1, favouring 
dissociation event. The K and Gibbs free energy values suggest that 1:1 CIM-water 
complex simply does not form. The reason is most likely that the shift observed is 
small, in addition to the fact that the complexation reaction was still ongoing due to 
the lack of plateau curve observed in the scatter plot of the protons. Plus, the change 
in the peak profile, from a singlet to a doublet, a quartet to a triplet, and a doublet to a 
singlet, in consequence making the monitoring of the peak more challenging. Using 
acetone as the bulk solvent allows for more water inclusion, without changing the peak 
profiles. Plus, as mentioned earlier, the solvent change allows for the observation of 
proton 1 at higher water content. The modified experiment also showed an end to the 
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complexation reaction, with plateau observed on the scatter plot of proton 2 and proton 
3 form 200 molar ratios upwards. (Figure 5.36 and Figure 5.37) 
 
Figure 5.36. Proton 1-8 peak shift scatter plot form 0-450:1 G:H molar ratio in acetone environment 
 
Figure 5.37. Example of fitting for binding constant determination to 2:1 model for proton 2 (a), and proton 3 (b). 
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Figure 5.38. CIM speciation plot following 2:1 binding stoichiometry 
The 2:1 fitting of all the protons up to 300 molar ratio as the final point where 
proton 1 is visible in the acetone environment yielded the following K values: K11 = 
0.007 M-1 (error ±1.9%), and K21 =203 M
-1 (error ±0.3%). Similar to DTA, the 
speciation plot which was based on the Job plot’s 2:1 fitting (Figure 5.38) suggests an 
instantaneous H2G complexation from the very low K11 value obtained in both DMSO 
and acetone environment titration. However, since the Job’s plot only consider a single 
species is present at a time in equilibria, the fitting and 2:1 stoichiometry relationship 
in the respective solvents is only an apparent on, as we assume that more than one 
species are present in equilibria. The calculated Gibbs free energy value of -13.16 kJ 
mol-1 is weaker compared to the DTA values, which was between -16 to 20 kJ mol-1. 
Nevertheless, the value does reflect a significant CIM-water interaction, comparable 
to that of the DTA.  
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5.3.7 TRN-water preliminary data and FTIR titration 
The solid-state forms of tranilast (TRN) have been extensively characterised in 
chapter 4. To recap, the anhydrous alpha form and monohydrate I are the predominant 
forms. A novel 2.3 hydrate was discovered, with the crystal structure of a hydrate form 
reported for the first time. One water molecule coordinates to three TRN molecules 
via the acid and amino functionalities (Figure 5.39). The remaining two water 
molecules are located in the channel at the methoxy end (not shown).  
 
Figure 5.39. The solved structure of TRN 2.3 hydrate. Water molecules are acting as DDA, bridging three TRN 
molecule. The colour code is carbon grey, oxygen red, and hydrogen light grey. 
In the following solution-state FTIR, the related vibrations are probed. The 
FTIR titration was done in anhydrous DMSO environment. Surprisingly, no changes 
to the peak position were observed. The second titration in acetonitrile environment 
was also done to check the whether DMSO hindered the compound-water interaction, 
however, no peak shift was observed as well. Both FTIR experiments suggest that 
TRN-water interaction was not ‘visible’ or ‘observable’ using FTIR spectroscopy. 
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5.3.8 1H NMR: TRN-water titration 
Initial TRN proton 1H-NMR spectrum was obtained in DMSO-d6 environment. 
Overall, 13 proton regions could be observed, which integrates to the 18 protons of 
TRN. The obvious protons are the OH of the acid group, the NH, and the two methoxy 
functional groups which come at 13.61, 11.29, 3.84 and 3.81 ppm respectively (Figure 
5.40, (a)). The protons were identified based on their chemical shift position, from 
higher to lower ppm on the spectra and labelled as proton 1-13 with their respective 
symbols to show their individual location on the spectra in (Figure 5.40). 
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Figure 5.40. Peak assignment, a) the OH of the acid group, the NH, and the two methoxy groups identified as 
Proton 1, 2, 12 and 13, with their respective symbols. b) Proton 3-11 and their respective symbols. 
Dilution with anhydrous DMSO up to 500 molar ratios did not show any 
significant shift, as indicated in Figure 5.41 which is the NH proton (proton 2) plotted 
at a similar scale as in Figure 5.43 (a) (from 11.4-11.2 ppm). Dilution experiment 
however did not show any significant peak shifts.  
 
Figure 5.41. Proton 2 (NH) of TRN in a dilution experiment with anhydrous DMSO up to 500 molar ratios 
Following the titration of water into the system, the OH (proton 1) was 
observed form 0-2:1 G:H molar ratio (Figure 5.41). Again, due to the fast exchanging 
OH proton with water, the peak was unobservable above 2:1 G:H molar ratio.  
 
Figure 5.42. The spectra of proton 1 from zero to five molar ratios of water 
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The next proton observed was the NH proton (proton 2, ), which shifted 
downfield by 0.044 ppm at 400:1 G:H molar ratios. The downfield shift observed in 
Figure 5.43 (a) is consistent with the deshielding effect of bridging proton which 
involved in hydrogen bonding, losing electron density as hydrogen bond is formed. 
Interestingly, scatter plot of proton 2 showed a steep increase from 0-30: G:H molar 
ratio, followed by a plateau effect after the 30:1 molar ration mark (Figure 5.43, (b)). 
The magnitude of the peak shift at the plateau is significant with 0.02 ppm recorded. 
It is highly likely that from 0-30 G:H molar ratio, direct hydrogen bonding between 
the NH and water occurred, resulting in the initial plateau. This plateau curve persists 
to up to 70 molar ratio of water, then slightly shifting upfield from 80 to 150, before 
continuing to shift downfield above 150 molar ratios of water. It is possible that the 
slight upfield shift observed was instrument sensitivity limitation as the standard 
deviation for the peak position of the chemical shift observed for the NH from 30 to 
150 mark is 0.0009 ppm which is not significant. If this is the case, then the plateau 
observed was actually from 30 to 150, instead of to 70 water molar ratios.  
 
Figure 5.43. a) Shows the spectra of NH proton (proton 2) from 0-400 G:H molar ratios. b) shows the scatter plot 
of the peak position chemical shift. 
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Figure 5.44. Spectra and chemical shift of TRN proton 3 to 11 from 0-400 G:H molar ratios. 
Since they appear close to each other, observation on the chemical shift of the 
subsequent protons was based on Figure 5.44 above, which depicts the chemical shift 
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of proton 3 to 11, within chemical shift range of 8.7 to 6.7 ppm. The peaks were 
identified based on the assigned symbol indicated in Figure 5.40. The biggest shift in 
TRN-water titration came from proton 3 ( , ortho position on the anthranilic acid 
ring), which has shifted upfield by 0.082 ppm. Proton 3 is the closest neighbouring 
proton to the carbonyl of the acid functionality. This large and significant shift suggests 
that this proton was most affected by the complexation interactions, confirming the 
involvement of the acid group in TRN-water interaction. Scatter plot of this proton 
revealed a linear shift upfield, with no plateau observed (Figure 5.45). 
 
Figure 5.45. Scatter plot of proton 3 showing a linear upfield shift. 
Proton 4 ( ) and 5 ( ) showed shift significant downfield by 0.013 and 0.014 
ppm respectively. Though the magnitude of the shifts is comparable at 400 molar water 
incorporation, their scatter plot revealed distinctly different shift profile, and it is 
expected as both protons are located at different rings. Proton 4 is located at the ortho 
position on the methoxy attached benzene ring, while proton 5 is at the para position 
on the anthranilic acid ring. Proton 4 showed linear shift downfield (Figure 5.46, (a)), 
while proton 5 shifted upfield first (0-10:1 G:H), before shifting downfield above 10 
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molar ratios of water. After this value, proton 5 shifts downfield linearly as well 
(Figure 5.46, (b)). 
 
Figure 5.46. Scatter plot of proton 4 (a) showing a linear downfield shift and proton 5 (b) with the initial upfield, 
followed by a downfield shift. 
Meanwhile, proton on the carbon which is connected to the 1’ position the 
benzene ring (proton 6), shifted upfield by a mere 0.006 ppm after 400 molar ratios of 
water introduced. Significant shift (0.002 ppm) was only observed after 20:1 G:H 
molar ratio. On the other hand, proton 7 which is the H on the ortho position on the 
benzene ring, neighbouring the methoxy group, shifted significantly early on at 5:1 
G:H molar ratio, and has a total shift upfield by 0.04 ppm. Both scatter plots of proton 
6 and 7 showed a similar linear trend upwards to 400 molar ratios of water as seen in 
Figure 5.47. 
 
Figure 5.47. Scatter plot of proton 6 (a) and proton 7 (b), both showing upfield shifts. 
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The scatter plot for proton 8 (H on the meta position, next to the NH of the 
anthranilic acid ring) showed a plateau feature, observed from 30 to 70 water molar 
ratios (Figure 5.48). The only other proton which share similar plateau feature is proton 
2, however, the plateau is a result of an upfield shift, the opposite direction to the one 
observed in NH of proton 2. The magnitude of the shift experienced by proton 8 at the 
plateau between 50-70:1 G:H ratio is 0.003 ppm, which is significantly smaller than 
the shift of the NH at the similar interval, 0.02 ppm. There is no doubt that the shift 
experienced by proton 8 is an indirect effect from the interaction of the NH. 
Interestingly, as more water is introduced, proton 8 shift changed direction, moving 
downfield from 200 water molar ratios upwards. At 400 molar ratios, the peak position 
is similar to the starting position. Misinterpretation of the peak shift might occur if just 
the two extreme ranges were to analysed in isolation. 
 
Figure 5.48. Scatter plot of proton 8 showing initial upfield, followed by a plateau curve, and subsequent downfield 
shift.  
Proton 9 ( ), the H on the meta position of the anthranilic acid ring, shifted 
downfield by 0.042 ppm after 400 molar ratios of water in the system. Meanwhile, 
proton 10 ( ) which is the H on the meta position on the benzene ring, next to the 
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methoxy group, also shifted downfield, but only by 0.025 ppm at similar water ratios. 
Both proton 9 and 10 are located far apart from one another but do share similar linear 
trend from their respective scatter plot, shifting steadily as more water is titrated in 
(Figure 5.49). 
 
Figure 5.49. Scatter plot of proton 9 (a) and proton 10 (b), both showing downfield shifts 
 
Figure 5.50. Scatter plot of proton 11 showing an upfield shift. 
The proton on the carbon neighbouring the carbonyl (proton 11, ) shifted 
upfield by 0.025 ppm. Similar to proton 9 and 10, an overall linear trend of the scatter 
plot can be observed. Meanwhile, the methoxy groups (proton 12 and 13) did not shift 
much throughout the titrations (Figure 5.51, (a)). The protons shift at the different 
magnitude, proton 12 did not show any significant shift from 0-100:1 G:H molar ratio 
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(+0.0004 ppm), while proton 13 shifted 0.002 ppm at similar water ratios. Scatter plot 
of both protons showed almost a straight line for proton 12 and a linear curve for proton 
13 (Figure 5.51, (b)). At the end of the titration, the total shift downfield recorded were 
just 0.003 and 0.008 ppm for proton 12 and 13 respectively. 
 
Figure 5.51. a) shows chemical shifts of proton 12 and 13, showing a non significant peak shift with water titration. 
b) shows the scatter plot of the peaks positions. 
 
Figure 5.52. Job plot showing unclear complexation between TRN and water in DMSO-d6 using 1H-NMR. ([TRN] 
+ [H2O] = 0.1 M) 
Job’s plot indicated that TRN and water interact in a 1:1 stoichiometry at 
equilibria in DMSO (Xmax=0.5). However, as mentioned before, there are potentially 
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more than one species present, and if that is the case, then the stoichiometry suggested 
is definitely off as Job plot is not capable of considering the two species in the same 
equilibrium. Therefore, a subsequent fitting is done to all available stoichiometry, 1:1, 
1:2, and 2:1 (Table 5.4). The best fitting considered would be the ones with the least 
error when fitted to the mathematical model. Based on the fact that a plateau was 
observed form 30-70 molar ratios of water, the binding constant fitting is done up to 
this titration point. The following K values are obtained from the fitting of all TRN 
protons to the respective binding stoichiometry models. 
Table 5.4. Calculated G of TRN-water binding based on three (3) different binding models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
TRN:H2O 10.6 M
-1 
(±14%) 
N/A N/A -5.9 kJ mol-1 
2TRN:H2O 2.01 M
-1 
(±3.2%) 
60.22 M-1 
(±2.3%) 
N/A -10.2 kJ mol-1 
TRN:2H2O 13.86 M
-1 
(±5.3%) 
N/A 0.51 M-1 
(±3.9%) 
-6.5 kJ mol-1 
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Figure 5.53. Example of fitting for binding constant determination for proton 2. 
 
Figure 5.54. TRN speciation plot following 2:1 binding stoichiometry 
Comparison based on the fitting errors clearly indicate that the best fitting of 
the three is the 2:1, with just 3% and 2% error in K11 and K21 values respectively. The 
speciation plot (Figure 5.54) indicated that the 2:1 complex reached a plateau at 10:1 
G:H molar ratio, while 1:1 complexation continues to form with higher water titration. 
In fact, at 20:1 G:H molar ratio, the H2G complex reached its critical point and started 
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to reduce in number or mole fraction value gradually, and more HG formation 
afterwards. 
The 2:1 stoichiometry fitting also allow for direct comparison to the two 
previous titration values of DTA and CIM. The K21 of 60 M
-1 is considerably lower 
than DTA’s K21 of 3005 M-1 (full titration point) or 615 M-1 (from 25-1087:1 G:H), 
and CIM’s value of 203 M-1. However, upon conversion to Gibb free energy (G), the 
values are quite comparable. G for K21 of TRN corresponds to -10.2 kJ mol-1, while 
as mentioned in the section above, while the value for CIM corresponds to -13.16 kJ 
mol-1, and DTA values was between -16 to -20 kJ mol-1. Even though the obtained 
binding constant and the calculated G only represent an ‘apparent’ binding, it is still 
useful as the values show some degree of molecular recognition, implying significant 
interaction between the tested compounds and water. Results from the solution-state 
analysis of the three compounds thus far, led us to believe that whilst FTIR probe is 
good initial approach as the method allows for qualitative observation of compound-
water complexation, 1H-NMR method is the best method to move forwards as from 
the experiment we are able to quantify the ‘apparent’ binding interaction to water. 
Moving forward, 1H-NMR titration method with water as the guest will be the focus, 
with FTIR titration probe acting as a preliminary screen. 
5.3.9 Preliminary FTIR solid and solution-state analysis of PXM 
Observation of the FTIR for PXM anhydrous and monohydrate reveals two 
distinctly different spectra (Figure 5.55).  The assignment for vibrations obtained from 
the FTIR of the anhydrous PXM (Form I) was based on the common vibrations of the 
available functional groups. The assignment to the functional groups (in descending 
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order) are as follows; N-H stretching intense single peak at 3392 cm-1, amide C=O 
stretch at 1638 cm-1, N-H bending 1528 cm-1, S=O asymmetric stretch I and II at 1437 
and 1353 cm-1 respectively, and finally the S=O symmetric stretch at 1179 cm-1. 
 
Figure 5.55. FTIR spectra of PXM anhydrous and monohydrate form with labelling of relevant peaks. 
As for the monohydrate form, the mentioned peaks showed clear changes 
compared to the anhydrous form, for example in the N-H stretching region, the initially 
in the anhydrous form, a sharp and strong single peak was observed, however, in the 
hydrate form, this region is occupied by three broad peaks, at 3538, 3447 and 3372 
cm-1. The other two latter vibrations at 3447 and 3372 cm-1 are most likely from the 
N-H and N+-H. The N
+-H vibration is present as the monohydrate structure is in the 
zwitterionic form (as shown in Figure 5.4 (d)).34 The peak at 3538 and 3098 cm-1 is 
most likely the OH stretching vibration coming from the incorporated water. There is 
no significant change observed to the carbonyl vibration of the two forms with just 
two wavenumber difference, to higher wavenumber recorded in the monohydrate. 
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Next, the NH-bending vibration, which vibrates at 1528 cm-1 in the anhydrous form I, 
appeared shifted by nine wavenumbers lower to 1519 cm-1 in the monohydrate spectra. 
The only unclear vibration change was for the S=O symmetric stretch which appeared 
at 1179 cm-1 in the anhydrous form, as two closely related peak position present in 
close proximity of the peak in the monohydrate. Summary of the mention changes as 
well as other assigned peaks shifts are indicated in Table 5.5. 
Table 5.5. Vibration assignments for PXM anhydrous Form I and the monohydrate 
PXM functional group 
vibration 
Anhydrous Form I Monohydrate 
N-H stretching 3392 cm-1 broad peak at 3447 and 
3470 cm-1 
amide C=O stretch 1638 cm-1 1640 cm-1 
N-H bending 1528 cm-1 1519 cm-1 
S=O asymmetric stretch 1437 and 1353 cm-1 1429 and 1326 cm-1 
S=O symmetric stretch 1179 cm-1 1185 or 1158 cm-1 
Based on these differences, it is safe to assume that the observed shifts are the 
result of both hydrogen bonding to water as well as different packing of the two forms. 
PXM monohydrate single crystal X-ray diffraction data revealed that the asymmetric 
unit of the monohydrate consists of two discrete PXM molecules, and two water 
molecules.73 Two host molecules are bridged by one water molecule, hydrogen bonded 
to the deprotonated hydroxyl oxygen atom and the amide carbonyl. Plus, a second 
unbound water molecule is connected to the main motif, which hydrogen bonds to the 
first water molecule. This second, independent water molecule also act as bridge to a 
second core motif (two PXM and one water), and thus forms a water tetramer in 
between four PXM molecules.34 Based on the reported hydrogen bond interactions in 
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the monohydrate, it is essential for the mentioned interaction points (carbonyl, sulfones 
and amide functionalities) to be observed in the following solution-state analysis. 
Solution-state FTIR titration analysis of PXM was done in acetonitrile 
environment to avoid overlapping of the targeted interaction points as the compound 
consist of functional group of the two previously used solvents, i.e. the C=O in acetone 
and the S=O in DMSO. Although in PXM the functional group is sulfones (O=S=O), 
the asymmetric and symmetric S=O stretching still overlaps with the DMSO S=O 
vibration. A dilute solution containing 0.1 M PXM in acetonitrile was used in the initial 
titration, with one D2O molar ratio gaps (up to three), followed by a larger gap to 50 
molar ratios of D2O. The observation of the relevant vibrations is as indicated in Figure 
5.56.  
In the higher wavenumber region, N-H stretching is observable at 0:1 G:H 
molar ratio, however as D2O is introduced into the solution, the vibration became 
obstructed. Although D2O do not possess any vibration above 3000 cm
-1, it is possible 
that the D2O used has reacted with ambient water forming HOD species,
74 thus having 
vibration which covers the N-H stretch. From 1700 to 450 cm-1, most of PXM 
vibrations can be observed. Surprisingly, the carbonyl vibration at 1636 cm-1 did not 
change nor shift, even at the highest D2O content. The region between 1550 to 1350 
cm-1, which N-H bending S=O asymmetric stretch was observed in the solid-state is 
overlapped with the OD v2 and combination of v2+ libration vibrations.45 However 
the vibrations at 1305, 1183 and 1157 cm-1 have the distinct feature similar to that of 
the S=O asymmetric stretch which was observed at 1437 and 1353 cm-1, and 
symmetric stretch at 1173 cm-1 in the anhydrous solid-state FTIR spectra. Similar to 
the carbonyl observation, no significant shift was detected as the difference between 
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the two D2O molar ratio extremes with just one wavenumber higher for 1305 cm
-1 
vibration, and one wavenumber lower for 1157 cm-1 vibration. Also, the vibration at 
1204 cm-1, coming from the D2O, overlaps with the monitoring of the vibration at 1183 
cm-1. Overall, the observation for PXM-D2O titration also did not show any significant 
changes, similar to the earlier FTIR titration experiment for TRN-D2O. 
 
Figure 5.56. Solution-state FTIR titration analysis of PXM focusing on the region from 1350 to 1100 cm-1. 
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5.3.10 1H NMR PXM-water titration 
Initial 1H-NMR spectrum a deuterated acetonitrile environment revealed 11 
proton regions could be observed (Figure 5.57), which integrates well to the 13 protons 
of PXM. The obvious protons are the N+ Hat 13.52 ppm, the NH proton at 9.07 ppm, 
and the methyl groups 2.90 ppm (Figure 5.57, (a)).  
 
Figure 5.57. Peak assignment, a) the N+H, the NH, and the methyl group identified as Proton 1, 2 and 11, with their 
respective symbols. b) shows proton 3-10 and their respective symbols. 
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Figure 5.58. PXM dilution experiment with anhydrous acetonitrile from 0-40:1 G:H molar ratios with five molar 
ratios gap. a) highlight proton 2, while b) shows proton 3-10 chemical shift regions. 
Dilution with anhydrous acetonitrile from 0-40:1 G:H molar ratios with five 
molar ratios gap did not show any significant shift, as shown in the NH proton (proton 
2) plot (Figure 5.58 (a)) and the remaining proton 3-10 chemical shift regions, showing 
no observable peak change  
The 1H-NMR PXM-water titration was proceeded and observation of proton 1, 
the protonated N+H on the benzene ring, revealed that it can only be monitored up to 
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10:1 G:H molar ratios, with no observable chemical shift afterwards This feature is 
similar to previous observations of the fast exchange protons, which would make the 
peak appear too broad with water inclusion, hence difficult to monitor the peak shift 
(Figure 5.59).  
 
Figure 5.59. Spectra of proton 1 from zero to 617 molar ratios of water 
Next observation was on proton 2, which is NH of the amide. This chemical 
shift was observable until the end of the titration, even though it is broad. The peak 
shifted downfield, indicative of hydrogen bond formation, with the NH acting as a 
donor. The proton which involve in hydrogen bonding or the bridging proton is 
associated with losing electron density, shifting downfield as a result of the 
deshielding.56 Interestingly, the peak is quite clear from 1-10:1 G:H and 101-617:1 
G:H molar ratios, however, between 15 to 90, the peak appeared broader (but still 
visible, Figure 5.60, (a)). The peak shifts linearly with more water titrated into the 
system, with a distinct slope change in the shift observed at above 90 molar ratios 
(Figure 5.60, (b)). This step is most likely a direct result of saturation of the NH binding 
site or interaction point in forming the PXM-water complex. Less active site results in 
a more gradual slope. Overall, the shift observed to proton 2 is the largest, with 2.2 
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ppm change recorded at the end of the titration. It is obvious that the NH is indeed one 
of the interaction point for water-PXM complexation in dilute solution. In the 
crystalline monohydrate, water coordinate to the deprotonated OH and the carbonyl, 
which is unobservable in this analysis.  
 
Figure 5.60.a) Spectra of proton 2 (NH), showing a downfield shift with water titration. b) scatter plot of the 
peaks positions. 
The observation of proton 3, which is the proton at meta position on the 
protonated benzene ring, neighbouring the N+H, revealed a broad single peak. (Figure 
5.61). While the shift upfield observed is quite minimal, the change in peak profile is 
clear (Figure 5.61 (a)). The peak becomes broader as more water is introduced, and 
start to split at 4:1 G:H molar ratios, and completely split as 8 molar ratios of water is 
titrated into the system. The clear split peak can be distinctly observed from 15:1 G:H 
molar ratio onwards. The split observed suggest that there was significant interaction 
around proton 3, most likely by the N+H interaction with water, which caused 
significant electronic environment rearrangement and changes leading to the split. 
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Figure 5.61. a) The spectra of proton 3, showing an upfield shift with water titration. b) shows scatter plot of the 
peaks positions. 
 
Figure 5.62. Spectra of proton 4-9, showing complex spectra shift and peak profile changes with water titration 
A more complex observation of proton 4 ( ) and 5 ( ), both located at around 
8 ppm on the spectra, and on the structure are at an opposite position on the first 
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benzene ring, appearing as a shoulder (higher ppm) and a split peak. The two protons 
somewhat overlap, and it is hard to distinguish one from the other. Interestingly, as 
water is added into the system, the shoulder (initially on the left side of the split peak) 
at the higher ppm began to disappear, and at around 10-15 G:H molar ratio, the 
shoulder re-appeared, this time on the lower ppm, on the right-hand side of the split 
peak. At 22:1 G:H molar ratios, this shoulder began to grow, and at 34:1 G:H molar 
ratios, a clear split peak is observed. This new split peak grows and shifts upfield as 
more water is added. At 78:1 G:H molar ratios, the new split peak is completely 
separated from the original peak, continuing to shift upfield up to 217:1 G:H molar 
ratio. However, 277:1 G:H molar ratio, it overlaps with another peak, proton 6, which 
was shifting downfield. Between 250-404:1 G:H molar ratio an overlapping of the 
peaks occurred where proton 5 and 6 are seen ‘jumbled’ together and identification of 
the individual peak is difficult. Above 404 molar ratios of water, the combined peaks 
are separated as both peaks continue to shift in their respective directions. Even though 
the magnitude of the shift is small (0.045 ppm), clear water influence toward the 
chemical shift of the compound can be observed. Also, towards the end of the titration, 
the curve seems to level off, most likely achieving plateau > 617:1 G:H molar ratio. 
 
Figure 5.63. Scatter plot of the peaks positions of proton 4 or 5 (the initial split peak) showing a downfield shift. 
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Simulation spectra pattern for proton 6-9,75–78 suggest that the peaks should 
appear as a triplet, a doublet, a triplet and a triplet, however these four protons peaks 
appeared overlapped together in the region of 7.8-7.9 ppm in the initial spectra at 
0:1G:H molar ratio (Figure 5.62). Of the four protons, proton 6 shifts downfield, while 
the other three showed no significant shift. Due to the shift of proton 6, the overall 
peak profile changes from the initial spectra. At 617:1 G:H molar ration, when the 
peak has shifted furthest downfield from the original position, it is clear that proton 6 
is a triplet, just as the prediction suggested. Note that monitoring of peak 5 to 9 is 
difficult due to the no profile change hence the peaks remained overlapped. 
Proton 10, which is the proton at the para position on the protonated benzene 
ring, shifted downfield. Peak profile change was observed at 339:1 G:H molar ratio, 
before changing back to the original shape at 473:1 G:H molar ratio. The shift only 
becomes clear at higher water molar ratio with just 0.06 ppm difference between 0 and 
617:1 G:H molar ratio (Figure 5.64).  
 
Figure 5.64.a) Spectra of proton 10, showing a downfield shift with water titration. b) shows the scatter plot of the 
peaks positions. 
Likewise, proton 11which is the methyl functionality do not show any shift at 
lower water content (0-10:1 G:H molar ratios), then shifted downfield (15-159:1 G:H 
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molar ratios), followed by an upfield shift at higher water content 217-617:1 G:H 
molar ratios. The overall magnitude of the shift observed is 0.003 ppm, which means 
that the initial downfield shift was not significant (Figure 5.65). 
 
Figure 5.65. a) Spectra of proton 11, showing initial downfield followed by a subsequent upfield shift with water 
titration. b): scatter plot of the peaks positions. 
The Job plot of PXM showed a 1:1 binding stoichiometry in solution, with 
Xmax=0.5 (Figure 5.66). The curve obtained is not the typical  of a Job plot, which is a 
result of the small . Plus, the broad nature of the observed NH peak did not help as 
the exact peak point is difficult to ascertain. All in all, the Job plot does reflect the 
stoichiometry of the crystalline state, consistent with neutron diffraction data which 
reported that the monohydrate stoichiometry to be a 2:2.34 
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Figure 5.66. Job plot showing the 1:1 stoichiometry of the complexation between PXM and water in acetonitriled3 
using 1H NMR. ([PXM] + [H2O] = 0.1 M) 
Overall, the fitting to the available stoichiometry interaction models of 1:1, 2:1 
and 1:2, for the chemical shift of all protons which are able to be monitored (proton 2, 
3, 4, 10 and 11) is poor (Figure 5.67, (a)) as not all protons are being analysed. The 
best fitting, with the least error when the line fitted to the mathematical model, is 1:1 
with a K value of 0.3 M-1. This K value translates into G of 2.98 kJ mol-1, which 
directly indicate that the complexation to water does not occur. However, we do 
believe that the complexation does take place, evident from the various changes to the 
chemical shift observed e.g. the peaks shifts and the peak profile changes. If direct 
comparison were to be made to the three previous compounds, DTA, CIM, and TRN, 
then the 2:1 binding need to be calculated. From the 2:1 binding model, the generated 
K11 value is 1.7 M
-1 while K21 obtained is 336 M
-1. The calculated Gfor K21 is -14.4 
kJ mol-1. Summary of all PXM fitting to all available binding models are listed in Table 
5.6. 
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Figure 5.67.a) Example of fitting of proton 2 for binding constant determination fitted to 1:1 binding model. b) 
PXM speciation plot following 1:1 binding stoichiometry 
Table 5.6. Calculated G of PXM-water binding based on three (3) different binding models 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
PXM:H2O 0.3 M-1 
(±2.5%) 
N/A N/A 2.98 kJ mol-1 
2PXM:H2O 1.7 M
-1  
(±16.7%) 
336 M-1 (±18%) N/A -14.4 kJ mol-1 
PXM:2H2O 0.37 M
-1 
(±1.7%) 
N/A -0.08 M-1 (± -
7.8%) 
NA-kJ mol-1 
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5.4 Conclusion  
Results from the analysis thus far reveals that titration using FTIR allows for 
qualitative observation of potential interaction points. The method’s fast timescale 
compared to 1H-NMR would also allow observation of multiple species at play 
Gaussian fits to spectra were to be used.79 Hydrogen bond sensitive vibrations i.e. 
carbonyl is a good region to focus on as shown in the case of DTA. Limited sensitivity 
of the method saw small changes to the remaining three model compounds FTIR 
spectra. However, shifts or changes are not guaranteed upon water introduction as seen 
in the solution-state FTIR water titration of TRN and PXM. Other drawbacks to this 
method include 1) tested compounds and selected solvent having overlapping 
vibrations, 2) for a solvent which do not share the same vibration, the solubility of the 
compound limits their selection, 3) problem with water/D2O vibrations, where the 
broad OH/OD vibrations potentially overlaps with the vibration of interest i.e. NH 
stretch. Even though the probe using FTIR are only limited to qualitative analysis, it 
was still useful to narrow down a specific region in the follow-up analysis. The best 
example for a successful FTIR titration is the DTA-water titration where a shift 
totalling 13 wavenumbers was observed to the carbonyl region, and the shift started 
even at low water incorporation, highlighting the compound’s high affinity towards 
water. Also, the FTIR method allows for observation of the interactions between drug 
and water through a carbonyl, which is not possible through 1H-NMR method.  
We found that 1H-NMR was able to detect and monitor the changes to the 
electronic environment of the monitored nuclei in the form of peak shifts, represented 
by  which resulted from the compound-water titration. The location of the nuclei 
most affected by water inclusion also gives qualitative information about the 
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regioselectivity for guest binding.61 Unlike anion/cation binding or other host-guest 
titration (enzyme-substrate) experiments where a large shift is commonly observed, 
and the active/binding site is charged and known, our water titration experiment 
involved neutral compound (except for PXM, which is zwitterionic) which all result 
in a small shift even at very high water content (>400 molar ratios). For example, the 
observed form anion binding experiment between 1,4-dimethoxypillar[5]arene 
(DMP5) and the guest molecule n-octylpyrazinium hexafuorophosphate (G) showing 
clear shift of around 3 ppm form the addition of 4.3 molar ratios of G,80 while titration 
on various indolocarbazole- and urea-based synthetic receptors (33 in total) toward 
acetate ion showed of the NH protons of the free receptor and the receptor−anion 
complex somewhere between 3.26 to 3.69 ppm, obtained from the various 
compounds.81  
On the other hand, the shift observed in our analysis normally is less than one 
ppm even at the highest water content of >400 molar ratios, apart from one peak, 
proton 2 (NH) in PXM titration which has yielded 2.2 ppm at 617:1 G:H molar ratio. 
The value is reasonable since PXM is zwitterionic in solution, having both negative 
and positive charge, hence more attracting force to the polar guest. Due the small 
shifts, chemical shift plot to obtain the binding constant is done against all protons 
which can be monitored, and help minimises the fitting error. However, for peaks that 
undergone profile changes and showed complex peak transformation i.e. in PXM 
proton 4-9, monitoring was hindered.  
The direction of the resonance peak shift usually gives an indication whether a 
proton is forming or breaking hydrogen bond, however, since the overall proton peak 
shifts and their respective electronic rearrangement were observed in determining the 
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binding constant (K), the shift direction is irrelevant as any shift, upfield or downfield 
would still reflect the water-compound complex (Figure 5.20). The difficulty to 
determine the strength of the observed shift or interaction is underlined with the fact 
that in a dilute water-solvent binary system, most likely more than one species form, 
hence the Job’s plot along with the traditional binding stoichiometry model has to be 
used with caution. All the K values obtained from the experiments thus only represent 
an ‘apparent’ binding constant, fitted against their respective binding models.  
Table 5.7. Calculated G of all compound-water binding based on 2:1 binding model. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
2DTA:H2O 2.94 x 10
-4 M-1 
(2.3%) 
3005 M-1 
(8.1%) 
N/A -19.8 kJ mol-1 
2CIM:H2O 7 x 10
-3M-1 
(±1.9%) 
203 M-1    
(±0.3%) 
N/A -16.1 kJ mol-1 
2TRN:H2O 2.01 M
-1 
(±3.2%) 
60.22 M-1 
(±2.3%) 
N/A -10.2 kJ mol-1 
2PXM:H2O 1.7 M
-1  
(±16.7%) 
336 M-1 (±18%) N/A -14.4 kJ mol-1 
Interestingly, all K21 fitting values suggest a significant binding constant (>60 
M-1), which still support previous notion stating that the ‘apparent’ binding values do 
represent some degree of molecular recognition by suggesting a significant interaction 
between the tested compounds and water. A large K lead to a large G, and the smaller 
or more negative G generally result in the formation of stronger complexes.61 The 
G values of < -10.2 kJ mol-1 are comparable to the cation binding, K+ to 18-Crown-
6 (or 1,4,7,10,13,16-hexaoxacyclooctadecane), which were reported to be between -
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11.4 to -12.1 kJ mol-1.61,82 To conclude, in this investigation on stable hydrate, the 
‘apparent’ significant values of K21 and G, could potentially be a reflection of their 
superior hydrate forming ability.  
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CHAPTER 6  
 THE AFFINITY AND SELECTIVITY OF METASTABLE, ELUSIVE, AND 
NON-HYDRATE FORMING COMPOUNDS TOWARDS WATER AND PRE-
NUCLEATION AGGREGATE FORMATION 
6.1 Introduction 
In chapter 5, a potential commonality is discovered in the form of the apparent 
significant values of K21 and G obtained from the 1H-NMR water titration, which 
could aid in crystalline hydrate prediction as the values reflect on the tested 
compound’s superior hydrate forming ability. In short, the K values obtained from the 
titration experiment of the compounds which are able to form stable hydrate are 
between 60-3000 M-1 which corresponds to G values of -20 to -10 kJ mol-1. In this 
chapter we are applying the new methodology in systems where no strong hydrated 
crystal forms known. This chapter highlights the 1H-NMR water titration analysis on 
naproxen, a compound which has yet to be reported to exists as crystalline hydrate or 
exist as an elusive hydrate form. In addition, analysis is also done on paracetamol, a 
compound which is known to exist as metastable or weak crystalline hydrate. The 
results from these two compounds would guide interpretation of the two mentioned 
categories of hydrate. G values obtained from the two model compound will serve as 
a gauge and determine the grey areas for weak hydrates prediction as well as provide 
cut offs for non-hydrate-forming compounds. To further scrutinise the method, a ‘blind 
test’ on five other compounds is performed, during which information on the existence 
of crystalline hydrates is blocked. This validation will determine whether the 
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procedure is robust enough to predict the hydrate, as well as sensitive enough to 
distinguish between the different hydrate forming abilities of selected the compounds. 
This is the final proof whether the observed changes are true or only serendipity at 
play. 
6.2 The tested compounds and results 
6.2.1 The elusive or non-hydrate forming drug: Naproxen 
Naproxen (NAP, Figure 6.1) or (2S)-2-(6-Methoxy-2-naphthyl) propanoic acid 
is a non-steroidal anti-inflammatory drug (NSAID), commonly used to treat mild to 
moderate pain, which includes relieve for arthritic pain,1 dysmenorrhoea,2 as well as 
prophylactic treatment and acute attack of migraine.3 
 
Figure 6.1. Two-dimensional chemical structure (A) and three-dimensional arrangement (B) of Naproxen. The 
colour code is carbon grey, oxygen red, and hydrogen light grey. 
NAP has been reported to exists four polymorphs,4 with a patent suggesting 
the existence of a hydrate form. However, no hydrate form has yet been reported for 
NAP in a scientific literature. The patent which is aimed for the Chinese market, claims 
the existence of a NAP 1.5 hydrate form by providing PXRD pattern along with TGA 
of the crystalline hydrate as means of identification.5  Based on the TGA curve 
provided by the patent, water appeared to be weakly bound as heating from 50 to just 
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below 100 ℃ effectively dehydrates the sample completely. The hydrate form appears 
to be elusive as all our effort to obtain the hydrate form, or any hydrate form for that 
matter have yet to be successful. Among the methods used were, thorough polymorph 
screening with 20 different solvents, recrystallisation using mixed water-solvent 
system, as well as using aqueous slurry with temperature cycling. Our efforts 
replicating the reported method in the patent was also unsuccessful in reproducing the 
hydrate form, suggesting that the hydrate either doesn’t exist or is very elusive.  
6.2.1.1 Preliminary 1H-NMR spectrum of NAP  
Ten chemical shift peaks regions representing the 14 protons of NAP were 
monitored in the 1H-NMR spectrum in acetonitrile-d3 environment, highlighted in 
Figure 6.2A and B. Integration of the peaks which were calibrated to the three protons 
of the methyl group, accounts correctly to the sum of the protons associated with NAP. 
The peaks are identified as proton 1-10 based on the position, in descending order, on 
the spectra. The first easily recognisable chemical shift region is the signal at 9 ppm, 
which corresponds to the carboxylic acid (OH) proton, named proton 1 (Figure 6.2A). 
Proton 2-7 are located on the two aromatic benzene rings, which is highlighted in 
Figure 6.2B. Next is the signal at 3.9 ppm which correspond to the one of the two 
methyl groups (CH3), and named proton 8. The signal at 3.84 ppm in the spectra 
corresponds to the protons of CH2, connecting the methyl and the carbonyl and named 
proton 9. Finally, the signal at 1.5 ppm corresponds to the final methyl group named 
proton 10. Other visible peaks are of the reference, TMS (0 ppm), acetonitrile-d3 (1.9 
ppm) and water (2.15ppm). 
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Figure 6.2. 1H-NMR spectrum of NAP in acetonitrile-d3 environment. Specific chemical shift regions on the spectra 
which are identified as proton 1-10 are highlighted with the respective symbols and correspond to inset chemical 
structure. Figure 3 A highlights proton 1, 8-10 and B highlights proton 2-7. 
6.2.1.2 1H-NMR dilution experiment of NAP 
1H-NMR dilution of 0.02 M NAP in acetonitrile-d3 environment with non-
deuterated acetonitrile saw all the peaks shifted downfield, with the biggest shift 
recorded was +0.0009 ppm, experienced by the proton at the chemical shift position 
of 7.4 ppm (Figure 6.3). Since all shift occurred at fourth decimal place, it is confirmed 
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that no significant effect from dilution is observable for NAP upon dilution to up to 
450:1 G:H ratio, ensuring that any shift observed during the titrations is due to the 
addition of water as guest.  
 
Figure 6.3. Dilution of 0.02 M NAP with non-deuterated acetonitrile. Dilution is done in a single tube, with the 
highest dilution factor used is 450 molar ratios. 
6.2.1.3 1H-NMR titration experiment of NAP 
1H-NMR titration experiment of 0.02 M NAP in acetonitrile-d3 solvent 
environment saw most of the observed protons to have small shifts. The overall peak 
shift peak shifts for all the protons, bar proton 1, at the end of the titration at 450:1 
G:H is summarised in Table 6.1. Similar to previous measurements in chapter 5, we 
only consider any peak shift as significant when the value exceeds 0.002 ppm of the 
measurement error mark, for reasons mentioned in chapter 2. With respect to 1H-NMR 
titration of NAP with water, a consistent shift trend is observed for all protons of NAP, 
however, the magnitude is small and significant shift is only observed above 30-40:1 
G:H ratio mark.  
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Table 6.1. Peak shift difference between the start, and the last titration point of 450:1 G:H molar ratio. 
 Proton 2 Proton 3 Proton 4 Proton 5 Proton 6 Proton 7 Proton 8 Proton 9 Proton 10 
 0.02 0.02 0.017 0.022 0.021 0.015 0.008 0.009 0.006 
Proton 1 (Figure 6.4) appearing as a single, broad peak, due to the peak being 
generated based on the average site of a fast exchanging OH proton on NMR timescale. 
Monitoring of this peak is difficult as the peak becomes too broad to observe as soon 
as water is introduced into the system. 
 
Figure 6.4. 1H-NMR chemical shift region for proton 1, showing the broad nature of the peak, and its disappearance 
once water is introduced into the system 
Meanwhile, observation of all the other protons (Figure 6.5, 6.6, and 6.7), saw 
downfield shifts, apart from proton 9 (Figure 6.6, * symbol, CH connecting the methyl 
and the carbonyl), which saw an initial upfield shift from 0-50:1 G:H ratio. The scatter 
plot also show that the curve is almost at plateau between 50-70:1 G:H ratio (Figure 
6.6). From 80:1 G:H ratio onwards, proton 9 shifted downfield. Since proton 9 is the 
closest visible proton on 1H-NMR to the acid, the effect observed would reflect the 
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interaction involving the acid group. However, all the mentioned shift to proton 9 is 
small, with a total shift magnitude of just 0.009 ppm at 450:1 G:H ratio. The peak shift 
only become apparent when proton 9 is plotted independently, hence the mentioned 
interaction is very weak, even for a secondary effect. Overall, the biggest peak shift 
observed for NAP-water titration is recorded for proton 5, with just 0.022 ppm 
difference from 0-450:1 G:H ratio. 
 
Figure 6.5. A showing 1H-NMR chemical shift region for Proton 2-7 and their respective peak shifts. B shows the 
scatter plot to the respective peaks. 
 
Figure 6.6. A shows 1H-NMR chemical shift region for proton 8 and 9, with their respective peak shifts. B shows 
the scatter plot to the respective peaks. 
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Figure 6.7. A showing 1H-NMR chemical shift region for Proton 10 and their respective peak shifts. B shows the 
scatter plot to the respective peaks  
 
Figure 6.8. Job plot of NAP showing the stoichiometry of interaction as 1:1, with Xmax= 0.5. 
The Job plot of NAP reveals that the stoichiometry of interaction is 1:1, with 
Xmax= 0.5 (Figure 6.8). Fitting of all the proton to 1:1 binding model yielded a K value 
of 0.1 M-1. K values for fitting to other available binding models, 2:1 and 1:2 
stoichiometries are listed in Table 6.2. 
Table 6.2. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
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NAP:H2O 0.10 M-1 (±0.5%) N/A N/A 
2NAP:H2O 0.20 M-1 (±0.5%) 9.88 M-1 (±0.5%) N/A 
NAP:2H2O 0.53 M-1 (±1.2%) N/A 0.10 M-1 (±0.6%) 
However, all the obtained K values suggested a non-significant interaction 
between water and NAP molecules. The highest K value was form the K21 (2:1), with 
9.88 M-1, which is calculated to -5.7 kJ mol-1, which accounts for about half of the sum 
obtained for the lowest G for stable hydrate probe. We believe that any compound 
showing G > -6 kJ mol-1 following our titration method will not exist as a crystalline 
hydrate form or that the hydrate form is very elusive. As it stands, the proposed G 
values for the hydrate prediction gauge is as illustrated in Figure 6.9. 
 
Figure 6.9. Proposed G values for the hydrate prediction gauge 
 
6.2.2 The metastable or weak hydrate forming drugs: Paracetamol 
Paracetamol (PCM, Figure 6.10) is the most common over-the-counter (OTC) 
drug and used as a mild analgesic and antipyretic. The structure contains a balanced 
number of proton donor and acceptor, with two of each.6 However, PCM structure can 
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change due to resonance of the free electron pair of the nitrogen atom. These resonance 
structures of PCM causes the nitrogen role to change from proton acceptor to donor. 7 
 
Figure 6.10. Two-dimensional chemical structure (A) and three-dimensional arrangement (B) of Paracetamol. The 
colour code is carbon grey, oxygen red, nitrogen blue, and hydrogen light grey.  
 
Table 6.3. Resonance structures of a paracetamol molecule. Figure was adapted from Bernal et al.7 
PCM has been reported to exists as five polymorphs, three of which have been 
structurally characterised as the monoclinic Form I,8 orthorhombic Form II,9 and the 
unstable orthorhombic Form III.9–11 New evidence of additional forms IV and V at 
high pressure has been reported.12 In 2002, Pulham’s group from Edinburgh reported 
two metastable PCM hydrate forms, identified as the monohydrate and trihydrate.13,14 
The monohydrate was obtained by quench cooling (60 to -0.15C) a mixture of PCM 
and disodium terephthalate,14 while trihydrate was obtained by slow cooling a hot 
PCM aqueous solution (4 g dm-3) for 12 hours to 0 C.13 Peterson et al. later reported 
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that the trihydrate crystal is stable in temperature up to 5 C at ambient pressure.15 
Both forms dehydrates at ambient temperature into Form I. Two years later, Pulham’s 
group reported a third hydrate form, a dihydrate, which was recrystallise from water 
at a pressure of 1.1 GPa.16 All reports suggest that the hydrate forms are indeed 
metastable under ambient condition. 
6.2.2.1 Preliminary 1H-NMR spectrum of PCM  
1H-NMR spectrum of PCM in the acetonitrile-d3 saw five chemical shift 
regions on the spectra (Figure 6.11), first of which is observed at 8.08 ppm, which 
corresponds to the OH and named proton 1. Proton 2 the peak at 7.34 ppm 
corresponding to the two protons on the benzene ring, facing the NH group. Proton 3 
at 6.758 ppm corresponds to the NH and next to the peak, at 6.746 ppm proton 4 is 
present as a split peak which corresponds to the two protons on the benzene ring, facing 
the OH group. Finally, proton 5 is the methyl group, which appear at 2.0 ppm on the 
spectrum. 
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Figure 6.11. 1H-NMR spectra of PCM in acetonitrile-d3 environment. Specific chemical shift regions on the spectra 
which are identified as proton 1-5 are highlighted with the respective symbols and corresponds to inset chemical 
structure.  
6.2.2.2 1H-NMR dilution experiment of PCM 
Dilution of 0.02 M PCM was done to just 10:1 G:H ratio of acetonitrile (Figure 
6.12). At the end of the dilution, proton 1 ( ) saw +0.0017 ppm shift downfield, while 
the proton 2 ( ) has also shifted downfield by +0.0004 ppm. The biggest shift recorded 
in the dilution experiment is to the proton 3 ( ), which shows a downfield shift of 
+0.0095 ppm. Proton 4 ( ) and 5 ( , not shown in Figure 6.12) did not shift at all 
(0.0000 ppm) throughout the dilution experiment. As the peak shifts observed here are 
not significant, any peak shifts observed following PCM-water titration, if any does 
occur, will be due to interaction with water, and not the effect of dilution. 
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Figure 6.12. 1H-NMR spectra of the dilution experiment of 0.02 M PCM with non-deuterated acetonitrile up to 
10:1 G:H ratio. 
6.2.2.3 1H-NMR titration experiment of PCM 
Following titration of water into PCM-acetonitrile-d3 solution, it is quite 
surprising to be able to observe the phenol -OH peak throughout the titration 
experiment. Normally, the OH undergo fast exchange with water, and would appear 
as a broad and eventually unobservable peak following water incorporation. Typically, 
1H-NMR resonance peak for phenol -OH group is broad at room temperature, and 
susceptible to fast exchange with protons of the protic solvents or with protons of the 
residual water in aprotic solvents.17 Further broadening of the peak is also contributed 
exchange between various –OH and –COOH groups which may be present in a 
particular molecule, especially in low polarity and dielectric constant organic solvents 
environments.17 Charisiadis et al. reported three factors which influence the exchange 
rates for phenol -OH peak and in turn the peak broadness, which are pH, temperature 
and solvent environment effect.17 As the former two reasons are kept constant in our 
experiment, it is highly likely that the reason for the proton 1 (OH) peak preservation 
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is due the slowing down of the intermolecular proton exchanges contributed by non-
protic nature of acetonitrile environment. In addition, Charisiadis et al. also reported 
that the use of dry non-protic solvents with strong hydrogen bonding ability e.g. 
DMSO, significantly reduces the –OH exchange rate in majority of their polyphenol 
model compounds. 
The biggest peak shift is observed on the NH (proton 3, ) at 6.75 ppm, which 
shifted significantly as soon as water is introduced (Figure 6.13). The peak becomes 
broader as more water is added, and completely unobservable above 390 molar ratios 
of water. The scatter plot also highlights the peak shift for the NH proton ( ), showing 
unexpectedly strong shift compared to other protons, and reaching plateau at around 
390:1 G:H ratio. The overall shift from zero to 390:1 G:H ratio is 1.78 ppm, which is 
very big in terms of water-compound interaction. Direction of the shift downfield 
signals direct hydrogen bond to water.18 It is surprising to see such strong interaction, 
for compound only reported to exist as three metastable hydrate forms.13,14,16  
 
Figure 6.13. A 1H-NMR chemical shift for PCM proton 1-4 showing peak shift, while B shows the scatter plot of 
the peak shift for respective protons.  
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Meanwhile peaks of proton 2 ( ) has shifted upfield by 0.024 ppm while 
proton 4 ( ) has downfield shifted by 0.029 ppm. Finally, proton 5 ( ) at 2.0 ppm 
has recorded a total shift of 0.038 ppm at the end of the titration (Figure 6.14) 
 
Figure 6.14. A showing the final 1H-NMR peak shift for PCM, which is proton 5- corresponding to the CH3, with 
B showing the scatter plot of the peak shift.  
The Job’s plot measurement showed that the interaction favours the 2:1 H:G 
binding based on the right-skewed plot with Xmax=0.6 (Figure 6.15).  
 
Figure 6.15. The job plot of PCM revealed that the stoichiometry of interaction is favouring the 2:1 binding with 
Xmax=0.6. 
 289 
 
Since we are confident that the NH is the coordination site for PCM-water 
complexation, the binding constant fit is initially based on just the NH peak shifts 
values, which generated a K21 value of 157.4 M
-1 (Table 6.4), calculated to Gof -12.5 
kJ mol-1. In order to make a more comparable comparison to the previous data where 
we do not normally see such a strong interaction, fitting to the binding model is done 
on all protons bar the labile OH and NH (* values in Table 6.4). Interestingly, the 
fitting of the said protons which only generally show secondary effect form the PCM-
water complexation has resulted in a K21 value of 80 M
-1, calculated to G of -10.9 kJ 
mol-1. This placed PCM on the hydrate side of our hydrate gauge, again confirming 
the method’s ability to predict hydrate formation (Figure 6.16). However, the result 
also suggest that the method used is not sensitive enough to differentiate metastable 
and strong hydrate-forming compound, or PCM do possess a strong undiscovered 
hydrate form, though the latter assumption is unlikely.  
Table 6.4. K values based on the fitting of NH proton (Proton 3) to all available binding model, the 1:1, 2:1 and 1:2 
H:G ratios. * Generated K values based on the fitting of non-labile protons (Proton 2, 4, and 5)  
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
PCM:H2O 0.36 M-1 (±0.7%) N/A N/A 
2PCM:H2O 0.024M-1 (±2.2%) 157.4 M-1 (±1.3%) N/A 
PCM:2H2O 0.23M-1 (±0.17%) N/A -0.17M-1 (±-0.17%) 
PCM:H2O* 0.13 M-1 (±5%) N/A N/A 
2PCM:H2O* 0.11M-1 (±0.7%) 80 M-1 (±0.9%) N/A 
PCM:2H2O* 0.83M-1 (±1.8%) N/A 0.07M-1 (±-0.8%) 
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Figure 6.16. PCM G position on the hydrate prediction gauge favouring hydrate formation 
6.2.3 The blind test 
A blind test was done to further scrutinise the procedure and ensure that the 
resultant K and G distinguishing hydrate and non-hydrate obtained thus far is not just 
serendipity at play. By keeping the information on the hydrate state of the compounds 
away throughout the duration of the experiment and K determination, avoids any bias 
in the subsequent K determination. Five compounds were analysed in the blind test, 
namely pyrazine, acetozalamide, dapsone and flurbiprofen. Prediction is done after G 
has been calculated. Correct match between the predictions and actual state of 
hydration will indicate the % reliability of the predictive tool. The only information 
given is the chemical structure of the respective compounds. 
6.2.3.1 Pyrazine 
 
Figure 6.17. Chemical structure of Pyrazine 
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Pyrazine (PYZ, Figure 6.17) is a heterocyclic aromatic organic compound with 
the chemical formula C4H4N2. The compound contains two hydrogen-bond acceptors 
but are devoid of any strong hydrogen-bond donors. PYZ is the simplest compound 
tested thus far. The preliminary 1H-NMR spectrum shows a single peak at 8.579 ppm, 
which is integrated to its four protons (Figure 6.18). Other observed peaks are the 
marker (TMS), acetonitrile-d3 and water, of which positions have been mentioned 
before. 
 
Figure 6.18. 1H-NMR spectrum of PYZ in acetonitrile-d3 environment. Specific chemical shift region on the spectra 
appears as a single peak corresponding to the four protons in the inset chemical structure. 
6.2.3.2 1H-NMR dilution experiment of PYZ 
PYZ 0.02 M dilution experiment saw the singular peak which corresponds to 
all four of PYZ protons, shifts downfield by 0.0002 ppm upon dilution to up to 500:1 
G:H molar ratios of acetonitrile (Figure 6.19). The shift is very small and confirms that 
dilution of the compound bares little to non-significant shift and effect. In addition, 
any peak shift observed following titration will be due to interaction with water. 
 292 
 
 
Figure 6.19. Dilution of 0.02 M PYZ with non-deuterated acetonitrile. Dilution is done in a single tube, with the 
highest dilution factor used is 500:1 G:H molar ratios. 
 
6.2.3.3 1H-NMR titration experiment of PYZ 
Titration from 0-10:1 G:H ratio saw no shift, however above the 10 molar ratio 
mark, a downfield shift trend emerges with significant shift (0.002 ppm) detected 
after 20:1 G:H ratio. At the end of the titration of 593:1 G:H ratio, a total peak shift of 
0.04 ppm was observed, which is much larger than the shift observed in the dilution 
experiment (+0.0002 ppm at 500:1 acetonitrile:H ratio). Looking at the compound 
structure without the influence from water, the N atoms would have an effect to the 
electron circulation of the ring as the N atom is more electronegative than carbon. We 
know that the compound contains two hydrogen-bond acceptors but are devoid of 
strong hydrogen-bond donors. Therefore, the only possible interaction with water, if 
any is indeed present, will be via the N atom, accepting the proton from water in order 
to form hydrogen bond. As water is introduced, the weak affinity to water is clear as 
delayed interaction is observed (Figure 6.20A). Significant interaction only occurs at 
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higher water content, >20:1 G:H ratios, where PYZ and water starts to form hydrogen 
bond via the N atoms (O-H…N). The N atoms gain electron density from the bridging 
protons of water,18 the additional electron density obtained would cause the N atoms 
to become less -, having a lesser affinity and influence towards the electron 
circulation of the benzene ring at both ends.  
 
Figure 6.20. A shows the 1H-NMR peak shift for PYZ, showing the initial delayed shift from 0-10, G:H ratio, while 
B. shows the scatter plot, with a larger shift is observed once more water is introduced into the system. 
The job plot revealed that the stoichiometry of interaction is 1:1, with Xmax=0.5 
(Figure 6.21). We consider the result from the job plot of PYZ with caution as the peak 
shift occurred on the fourth decimal place. Factoring against the host fraction 
accentuates the peak shift at a particular host fraction, however, as the magnitude is 
non-significant, it is still difficult to ascertain whether the shift is truly due to water 
interaction. Plus, since PYZ only showed as a single peak, no other peak can be used 
as reference or comparison. 
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Figure 6.21. Job plot of PYZ showing the stoichiometry of interaction as 1:1, with Xmax= 0.5. 
Fitting of the peak shift data for PYZ protons to 1:1 binding model yielded a K 
value of 0.1 M-1. The 1:1 fitting also yielded the least error (0.5%) to the fitted model 
compared to other available binding models, with the K values for fitting to other 
available binding models, 2:1 and 1:2 stoichiometries are listed in Table 6.5. For 
comparison purposes, the K21 obtained would translate into G of -7.1 kJ mol-1. 
Table 6.5. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
PYZ:H2O 0.1 M-1 (±0.5%) N/A N/A 
2PYZ:H2O 0.03 M-1 (±2.9%) 18 M-1 (±2.3%) N/A 
PYZ:2H2O 0.05 M-1 (±0.7%) N/A -0.1 M-1 (±1.7%) 
Based on the calculated G from the K21 value, which places PYZ on the grey 
zone, closer to NAP by +1.4 kJ mol-1 and thus closer to the NO hydrate region on the 
hydrate gauge (Figure 6.22). In contrast, PYZ is -3.1 kJ mol-1 away from the hydrate-
forming zone. Therefore, based on the placement on our gauge, and comparison to 
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other G values obtained thus far, we predict that PYZ do not exist as a crystalline 
hydrate form or that if the hydrate form does exist, it is very elusive. 
 
Figure 6.22. G position of PYZ on the hydrate prediction gauge does not favour hydrate formation 
After our prediction is done, the hydrate-forming capability of PYZ was 
revealed. Screening effort by Bajpai et al. using water slurry at ambient temperature; 
subjecting PYZ humid conditions (75% RH), and solvent drop grinding, all yielded 
the anhydrous form.19 To date, no hydrate form for this compound has been reported 
which correspond well to our titration data, which suggest weak binding to water from 
the K21. The high G, with just 1.4 kJ mol-1 different from NAP value reflect on the 
low stability of the PYZ-water aggregate in solution. 
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6.2.3.4 Acetazolamide  
 
Figure 6.23. Chemical structure of Acetazolamide 
Acetazolamide (ACT, Figure 6.23), is a monographed,20 potent carbonic 
anhydrase inhibitor, which is mainly use in the therapy of glaucoma and epilepsy.21 
Based on the chemical structure, ACT possesses several sites of hydrogen bond 
donors, i.e. the NH, NH2 and acceptors, i.e. the carbonyl, the sulfonyl, all of which 
could potentially hydrogen bond with water. The preliminary 1-H NMR of ACT is 
done in DMSO-d6 environment since ACT is sparingly soluble in acetonitrile. 
 
Figure 6.24. 1H-NMR spectrum of ACT in DMSO-d6 environment. Specific chemical shift regions on the spectra 
which are identified as proton 1 ( ), 2 ( ) and 3 ( ) are highlighted with the respective symbols and corresponds 
to inset chemical structure. 
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The three observable regions for 1H-NMR spectra of ACT are the NH, NH2, 
CH3, all of which appear as single peak, at 13.0, 8.3, and 2.2 ppm, which are then 
identified as proton 1 ( ), 2 ( ) and 3 ( ) respectively (Figure 6.24). The peak 
which appear at chemical shift 13.0 ppm, corresponds to the NH proton while the peak 
at chemical shift 8.3 ppm, corresponding to the NH2. Finally, at 2.2 ppm, we observe 
the peak corresponding to the methyl group. Other visible peaks are of the reference, 
TMS (0 ppm), DMSO-d6 (2.5 ppm) and water (3.3 ppm). 
6.2.3.5 1H-NMR dilution experiment of ACT 
 
Figure 6.25. Dilution of 0.02 M ACT with non-deuterated anhydrous DMSO. Dilution is done in a single tube, with 
the highest dilution factor used is 500:1 G:H molar ratios. 
Dilution of 0.02 M ACT with non-deuterated anhydrous DMSO up to 500:1 
G:H in DMSO-d6 environment (Figure 6.25) saw an overall downfield shift to proton 
1 and 2 peaks. The magnitude of the downfield shifts is 0.0032 and 0.0019 ppm 
respectively. The methyl peak at 2.2 ppm did not shift at all following dilution. We 
note that the DMSO is hygroscopic,22 even though anhydrous DMSO was used, there 
 298 
 
is possibility for water to be absorbed by DMSO and influence the dilution. However, 
we do take the shifted peak values as part of the error for ACT titration measurement.  
6.2.3.6 1H-NMR titration experiment of ACT 
Firstly, proton 1 NH peak is very broad, which is typical for a labile proton, 
hence the peak is vaguely visible from 0-10:1 G:H molar ratio (Figure 6.26). The NH 
is connected to the 1,3,4-thiadiazole group, which is an unsaturated heterocyclic 
compounds, which leads to a faster proton exchange between the NH and water 
molecule. The nature of proton 1 makes the monitoring of this proton difficult.  
 
Figure 6.26. 1H-NMR chemical shift region for proton 1, showing the broad nature of the peak, and its broadening 
and eventual disappearance once 20 molar ratios of water are introduced into the system 
The remaining two protons are easier to be monitored as both showed 
downfield shift, which becomes more apparent as more water is titrated into the system 
(Figure 6.27 and 28). Overall, at 500:1 G:H molar ratio, the NH2 peak (proton 2, Figure 
6.27) has shifted by 0.065 ppm while the CH3 (proton 3, Figure 6.28) has shifted by 
only 0.018 ppm. Compared to the dilution data, proton 2 shifted by 0.0019 ppm while 
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proton 3 saw no detectable shift, which suggest that following water titration there is 
some interaction with water - only that they are weak. Even though both of the 
monitored protons are at close proximity to functional groups which are most likely to 
form hydrogen bond to water i.e. the C=O (O-H…O=C) and O=S (O-H…O=S), 
delayed interaction with water is observed. Significant peak shifts were only detected 
after 30:1 G:H ratio for the NH2 and after 70:1 G:H ratio for CH3 peak respectively. 
This delayed shifts are similar to the events observed in PYZ. 
 
Figure 6.27. A depicts the 1H-NMR peak shift for ACT proton 2, showing the initial delayed shift from 0-10, G:H 
ratio. B shows the scatter plot showing a larger shift observed once more water is introduced into the system as 
compared to data points at the lower water content (inset, 0-10 G:H ratio). 
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Figure 6.28. A shows 1H-NMR peak shift for ACT proton 3, showing the initial delayed shift from 0-10, G:H ratio. 
Scatter plot showed a larger shift is observed once more water is introduced into the system as compared to data 
points at the lower water content (inset, 0-10 G:H ratio). 
The Job plot of ACT revealed that the stoichiometry of interaction is 1:1, with 
Xmax=0.5 (Figure 6.29). Similar to PYZ, we consider the result from the job plot of 
ACT with caution as the peak shift occurred on the fourth decimal place, hence it is 
difficult to ascertain whether the shift is truly due to water interaction. 
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Figure 6.29. Job plot of ACT showing the stoichiometry of interaction as 1:1, with Xmax= 0.5 
Subsequent binding constant fitting to all available binding model yielded non-
significant K values. Whichever the model is fitted against the data, all the obtained K 
value is small, which the summary of the fitting is listed in Table 6.6. The best fitting 
with the least error to the fitted line is the 1:1 model - as suggested by the Job’s plot. 
The 2:1 binding stoichiometry yielded 8% in fitting error while the 1:2 model fits the 
worst with >10% error. Conversion to G based ok K21 for comparison purposes is not 
possible as negative ln value would generate error (not mathematically possible). 
Therefore, the lowest G is used for comparison, which is calculated based on the 
largest K that we obtained, 0.32 M-1. The calculated G is 3.2 kJ mol-1. 
Table 6.6. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12  (±% error) 
ACT:H2O 0.04 M-1 (±3.7%) N/A N/A 
2ACT:H2O 0.32 M-1 (± 8%) -6.4 M-1 (±8%) N/A 
ACT:2H2O 0.3 M-1 (±30%) N/A 0.2 M-1 (±13%) 
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Based on the calculated G, ACT is placed in the far end of our NO hydrate 
zone on our hydrate gauge. Therefore, based on the placement on our gauge, and 
comparison to other G values obtained thus far, we predict that ACT do not exist as 
a crystalline hydrate form. 
 
Figure 6.30. G position of ACT on the hydrate prediction gauge which is in the NO hydrate zone. 
Literature search afterwards revealed that ACT exists as two polymorphic 
forms, which were identified and characterised as Mod. I and Mod. II,23 with no 
reported hydrate form. The lack of hydrate form does correspond well to our titration 
data, highlighting the method’s ability to discriminate non-hydrate forming 
compounds. We can state with high certainty a compound which show positive G 
from our titration will definitely do not exist as a hydrate form.  
6.2.3.7 Dapsone  
Dapsone (DAP, Figure 6.31) or 4,4′-diaminodiphenyl sulfone is a 
monographed drug,20 which belongs to a class of drugs known as sulfones. DAP is 
primarily used to treat skin disorder i.e. dermatitis herpetiformis (in combination with 
trimethoprim).24 It is also used in combination with rifampicin and clofazimine for the 
treatment of leprosy.24 Based on the chemical structure, DAP have a balanced proton 
donors and acceptors, and could potentially hydrogen bond to water.  
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Figure 6.31. Chemical structure of Dapsone 
 
Figure 6.32. 1H-NMR spectrum of DAP in acetonitrile-d3 environment. Specific chemical shift regions on the 
spectra which are identified as proton 1 ( ), 2 ( ) and 3 ( ) are highlighted with the respective symbols and 
corresponds to inset chemical structure. 
The three observable chemical shift regions for preliinary 1H-NMR spectrum 
of DAP are the peaks at 7.5, 6.6 and 4.8 ppm, which integrates to the 12 protons of 
DAP (Figure 6.32). The chemical shift at 7.5 ppm corresponds to the four protons on 
the benzene rings on the meta position, close to the sulfone (proton 1), while the peak 
at 6.6 ppm corresponds to the four protons on the ortho position of the benzene rings 
which are facing the amino groups (proton 2), and finally the peak at 4.8 ppm, which 
corresponds to the two NH2 on the para position on both benzene rings (proton 3). 
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6.2.3.8 1H-NMR dilution experiment of DAP 
DAP 0.02 M dilution experiment with non-deuterated acetonitrile saw all peaks 
shifted upfield, with the largest peak shift observed between 0-500 G:H ratio is 0.0015 
ppm, which is to the peak of proton 3 or the NH2 protons of DAP (Figure 6.33). Even 
though the recorded upfield peak shift is still non-significant, the obtained value and 
the direction of the shift is noted and is useful in the discussion and comparison in the 
titration experiment section for DAP. 
 
Figure 6.33. Dilution of 0.02 M DAP with non-deuterated acetonitrile. Dilution is done in a single tube, with the 
highest dilution factor used is 500:1 G:H molar ratios. 
 
6.2.3.9 1H-NMR titration experiment of DAP 
Following water titration, all protons showed downfield shifts (Figure 6.34-
35), with the largest peak shift observed in proton 3 with 0.35 ppm (Figure 6.36), 
followed by proton 2 with 0.048 ppm (Figure 6.35), while proton 1 has only shifted by 
0.016 ppm (Figure 6.34). Based on the magnitude of the peaks shift of the protons, 
proton 1 is least affected by the hydrogen bond to water, suggesting that the interaction 
point to water is furthest away from proton 1. In addition, proton 2 has shifted more 
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than proton 1, hence indicating the closer vicinity to the true site of interaction. Both 
peak shifts data complement each other, pointing towards NH2 as the DAP-water 
interaction point. 
 
Figure 6.34. A 1H-NMR peak shift for DAP proton 1, showing shift from 0-994, G:H ratio. While B shows scatter 
plot, with a linear shaped shift observed for the peak of proton 1 as more water is introduced into the system. 
 
Figure 6.35. A 1H-NMR peak shift for DAP proton 2, showing shift from 0-994, G:H ratio. While B shows scatter 
plot, with a linear shaped shift observed for the peak of proton 2 as more water is introduced into the system. 
NH2 or proton 3 peak shift shows the strongest shift, reaching significance 
early on in the titration, at 4:1 G:H ratio. This observation corroborates earlier 
assumption, confirming that proton 3 is indeed the interaction point to water. Scatter 
plot showed a non-linear shape shift (Figure 6.36B) with a plateau feature observed 
around 400:1 G:H ratio. Observation above the 400 molar ratio mark saw that the 
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magnitude of the shift is small compared to the sum of water in the system, suggesting 
that site of interaction (proton 3), is potentially saturated after the particular threshold.  
The continuous peak shift observed in proton 3 even after the plateau was 
achieved could well be due the fact that larger amount of water in this case changes 
the solvent characteristics, and with that the magnetic environment of the compound. 
Based on the direction of the peak shifts observed, the water is directly 
interacting with the DAP by accepting a hydrogen bond through proton 3,causing the 
H atom of the NH2 to lose electron density from the interaction,
18 becomes deshielded 
and resulting in the observed downfield shift (Figure 6.36 A).  
 
Figure 6.36. A shows the 1H-NMR peak shift for DAP proton 3, showing an immediate shift from 0-4, G:H ratio. 
Meanwhile B depicts the scatter plot shows a non-linear shape shift observed as more water is introduced into the 
system. 
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Figure 6.37. The Job plot of DAP revealed that the stoichiometry of interaction is favouring the 2:1 binding with 
Xmax=0.6. 
The Job plot of DAP revealed that the stoichiometry of interaction is favouring 
the 2:1 binding with Xmax=0.6 (Figure 6.37). Though peak shift from the job plot is 
small, there is a clear evidence from the Xmax value that there is a host fraction value 
which is favoured which yielded the biggest peak shift, and further accentuated upon 
factoring the host fraction value. Subsequent binding constant fitting to the 2:1 binding 
model yielded a K1 value of 0.5 M
-1 and a K21 value of 32.6 M
-1 (Table 6.7). The 
calculated G for K21 is -8.6 kJ mol-1. 
Table 6.7. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
DAP:H2O 0.2 M-1 (±1.2 %) N/A N/A 
2DAP:H2O 0.5 M-1 (±0.8%) 32.6 M-1 (±7%) N/A 
DAP:2H2O 0.2 M-1 (±5.6%) N/A 0.009 M-1 (±4.2%) 
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Based on the calculated G, DAP is placed in the grey zone, almost on the 
midpoint between the NO hydrate, and hydrate-forming zone. The relative distance to 
the neighboring compound in their respective group is +1.5 kJ mol-1 to PYZ and -1.6 
kJ mol-1 to TRN.  
 
Figure 6.38. Placement of DAP on the hydrate prediction gauge in the grey zone between the respective areas. 
Since DAP hydrate prediction is not clear-cut based on the G alone, we turn 
to the observed peak shift. We noticed that all DAP protons showed clear shifts. DAP 
showed high water affinity following water titration, showing immediate shift even at 
lower water content and achieving significance peak shift at 4:1 G:H ratio. In addition, 
the shift magnitude of NH2 (0.35 ppm) was large compared to the proton shifts that we 
have observed thus far, which showed hydrate-forming capability. Even though the 
placement on our gauge is unclear, based on overall observation of the titration 
experiment and comparison to other G values obtained thus far, we predict that DAP 
can exist as a crystalline hydrate form. 
Subsequent literature search revealed that DAP has been reported to exist as 
four polymorphic anhydrous form (Mod. I-IV)25 and a single hydrate form with 
DAP:water stoichiometry of 3:1 (0.33-hydrate),26–28 having a typical non-
stoichiometric hydration and dehydration behaviour.29 CCDC search revealed three 
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submitted single crystal structure for DAP 0.33 hydrate, with the latest submitted by 
Yathirajan et al.26–28 Based on the latest crystal structure data, the water molecules are 
not located in structural channels but in isolated-sites of the host framework, which is 
contradicting the hydration and dehydration non-stoichiometric behaviour.29 The 
submitted structure indicated that water hydrogen bonds to DAP molecule through the 
amino and sulfonyl group. Solid-state DAP-water coordination via the amino group 
revealed the role of water molecule as a proton acceptor (NH2…OH), which is similar 
and complements our earlier 1H-NMR solution observation. TGA from the Braun et 
al.29 also reveals that dehydration of the crystalline hydrate form occur between 40 to 
90 ℃ which reflects on how weakly water is bonded to DAP.29 The presence of the 
weak hydrate form does reflect our titration data. 
6.2.3.10 4,4’-Dipyridyl  
 
Figure 6.39. Chemical structure of 4,4’-Dipyridyl 
4,4’-Dipyridyl (DPY, Figure 6.39) is not a monograph drug, but it is used in 
transition-metal complex catalyst chemistry for uniform polymerisation,30 in 
luminescence chemistry,31,32 and in spectrophotometric analysis.33 DPY is made of 
two pyridine moieties which are linked by a bond between positions C-4 and C-4'. 
Similar to PYZ, the compound lacks any hydrogen bond donor, and has two acceptors 
on each side of the rings.  
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Figure 6.40. 1H-NMR spectrum of DPY in acetonitrile-d3 environment. Specific chemical shift regions on the 
spectra which are identified as proton 1 and 2 are highlighted with the respective symbols and corresponds to inset 
chemical structure. 
Preliminary 1H NMR spectrum of DPY in acetonitrile-d3 environment revealed 
two split peaks, appearing at 8.7 and 7.7 ppm. The peaks are identified as proton 1 and 
2 and integrated equally to its eight protons (Figure 6.40). 
6.2.3.11 1H-NMR dilution experiment of DPY 
DPY 0.02 M dilution experiment with protiated acetonitrile also saw the two 
split peaks shifted upfield (Figure 6.41). Since all shift occurred at fourth decimal 
place, shifting by 0.0004 and 0.0002 ppm respectively, confirms that no significant 
effect from dilution is observable for DPY dilution when diluted to up to 500:1 G:H 
ratio. Details on the peak position and as to which proton they correspond to is 
discussed in the titration section. 
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Figure 6.41. Dilution of 0.02 M DPY with non-deuterated acetonitrile. Dilution was performed in a single tube, 
with the highest dilution factor used was 500:1 G:H molar ratios. 
6.2.3.12 1H-NMR titration experiment of DPY 
Unlike the dilution experiment where both peaks have shifted (or the lack of 
it) upfield, following water titration, each peak has shifted in the opposite directions, 
upfield for the protons close to the nitrogen atom (N, proton 1, Figure 6.42), and 
downfield for the protons away from the N (proton 2, Figure 6.42). Without the 
influence of water, the N atoms would have an effect to the electron circulation of the 
ring as N is more electronegative than carbon, which is similar to the observation of 
PYZ. As water is introduced and starts to form hydrogen bond with the N atoms (O-
H…N), the N atoms gain electron density from the bridging protons of water. The 
additional electron density obtained would cause the N atoms to become less -, having 
lower affinity and influence towards the electron circulation of the benzene ring, 
observed from the shielding and deshielding effect to the monitored hydrogen atoms 
environment. The different direction in peak shift is most likely due to the nature of 
benzene ring, having ortho, para directing groups which are electron-donating groups; 
and meta directing groups which are electron-withdrawing groups. Therefore, as the 
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complexation to water affects these protons’ electronic rearrangement, the observed 
effect and shift direction difference is expected. 
 
Figure 6.42. 1H-NMR peak shift for DPY proton 1 and 2 showing peak shift in opposite direction, upfield for proton 
1 and downfield for proton 2. 
Interestingly, proton 2 experience a larger deshielding effect, hence having 
bigger shift downfield by 0.09 ppm. Compared to proton 1, which underwent a 
shielding effect, with only 0.01 ppm shift is observed. Even though the effect is small, 
it can still be clearly seen from the scatter plot curves of both peak points (Figure 6.43), 
where a steeper slope is observed for the plot of proton 1(Figure 6.43A), while a more 
gradual one for the proton 2 (Figure 6.43B).  
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Figure 6.43. Scatter plot of proton 1 and proton 2. A showed proton 1 upfield shift to lower ppm with increasing 
water:DPY ratio. B showed proton 2 downfield shift to higher ppm with increasing water:DPY ratio.  
The Job’s plot of DPY revealed that the stoichiometry of interaction favours 
the 2:1 binding with Xmax=0.6 (Figure 6.44). The K21 value of 35.3 M
-1 obtained is 
almost comparable with the value obtained for DAP, with the K21 translates into G 
of -8.8 kJ mol-1. Values for fitting to other binding model is listed Table 6.8. 
 
Figure 6.44. The Job’s plot of DPY revealed that the stoichiometry of interaction is favouring the 2:1 binding with 
Xmax=0.6. 
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Table 6.8. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
DPY:H2O 0.16 M-1 (±1.4%) N/A N/A 
2DPY:H2O 0.37 M-1 (±2.1%) 35.3 M-1 (±3 %) N/A 
DPY:2H2O 1.0 M-1 (±2.6%) N/A 0.15 M-1 (±0.9%) 
Based on the calculated G for DPY which is slightly lower than DAP, places 
DPY just inside the hydrate-forming zone on our hydrate gauge. Therefore, based on 
the placement on our gauge, and comparison to other G values obtained thus far, we 
predict that DPY can exist as a crystalline hydrate form. 
 
Figure 6.45. DPY placement on the hydrate-forming area on the gauge. 
Literature search following the end of our in-house titration experiment 
revealed that DPY exists as an anhydrous and a dihydrate form,34,35 and based on the 
submitted structure of the crystalline hydrate, the interactions between the water and 
the DPY molecule lead to the DPY…H2O…H2O…DPY motif. DPY and water are 
connected through the O-H…N, while water dimers are formed from the O-H…O 
bonding. Chains of O-H…O hydrogen-bonded water molecules are located between 
the bipyridine stacks. Altogether, four crystallographically independent water 
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molecules and two crystallographically independent bipyridine molecules are 
involved.34 Although the dihydrate is reported to be stable at ambient temperature and 
humidity, TGA curve revealed that the loss of water occur almost immediately after 
heating around 50 C, with most of the water released below 100 C.36 The reported 
hydrate form hence reflects well to our prediction. 
6.2.3.13 Flurbiprofen  
 
Figure 6.46. Chemical structure of Flurbiprofen 
Flurbiprofen (FBN, Figure 6.46) is a nonsteroidal anti-inflammatory drug 
(NSAID), used to treat mild to moderate pain, including pain and inflammation caused 
by osteoarthritis or rheumatoid arthritis.37 The structure offers interaction sites for 
hydrogen bonding through the acid group, donating proton via the OH, and accepting 
via the carbonyl. 
Similar to ACT, FBN is sparingly soluble in acetonitrile, hence DMSO-d6 is 
used. Preliminary 1H-NMR revealed that the monitored chemical shift region for FBN 
is highlighted in Figure 6.47. FBN spectra is complex to follow, especially for the 
protons of the two benzene rings. Nine peaks on the spectra can be observed, with the 
obvious peaks are the OH of the acid (proton 1) at 12.5 ppm, the CH connecting the 
acid, the methyl and the benzene ring (proton 8) appearing at 3.8 ppm, and finally the 
methyl at 1.4 ppm (proton 9). Proton 2-7 corresponds to the eight protons on the two 
benzene rings, appearing as overlapping peaks between 7.6-7.2 ppm (Figure 6.47B). 
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Careful observation on peak profile e.g. single, doublet, triplet etc. and the respective 
number of neighbouring protons was done to ascertain the peak identity. Other visible 
peaks are of the reference, TMS (0 ppm), DMSO-d6 (2.5 ppm) and water (3.3 ppm). 
 
Figure 6.47.1H-NMR spectra of FBN in acetonitrile-d3 environment. Specific chemical shift regions on the spectra 
which are identified as proton 1-9 are highlighted with the respective symbols and corresponds to inset chemical 
structure. A highlights proton 1, 8 and 9, while B highlights proton 2-7. 
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6.2.3.14 1H-NMR dilution experiment of FBN 
Dilution experiment 0.02 M FBN with non-deuterated anhydrous DMSO up to 
500:1 G:H ratio (Figure 6.48) saw no significant shift to any the protons. Similar to 
previous dilution experiments, peak shifts occurred on the fourth decimal place 
confirms the absent of influence or effect from dilution experiment towards the peak 
shift. Details on the peak position and as to which proton they correspond to is 
discussed in the titration section. 
 
Figure 6.48. Dilution of 0.02 M FBN with non-deuterated anhydrous DMSO. Dilution is done in a single tube, with 
the highest dilution factor used is 500:1 G:H molar ratios. 
6.2.3.15 1H-NMR titration experiment of FBN 
Similar to the previous observations, the (OH) proton 1 peak is broad and 
visible at zero water (Figure 6.49), however as soon as water is introduced the peak 
becomes even broader, due to fast exchanging nature of the proton on NMR timescale. 
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Figure 6.49. 1H-NMR chemical shift region for proton 1 of FBN, showing the broad nature of the peak, and its 
broadening and eventual disappearance once 20 molar ratios of water are introduced into the system 
Proton 2, 3 and 5 did not show a significant shift at lower water content, before 
shifting downfield when more water is introduced into the system (Figure 6.50). 
Dilution experiment saw these protons saw non-significant upfield shifts with 0.0003 
ppm peak shift recorded at 500:1 DMSO:H ratio. Meanwhile, following titration, the 
downfield shift recorded is between 0.004 to 0.017 ppm at 456:1 G:H ratio.  
 
Figure 6.50. A 1H-NMR peak shift for FBN proton 2-5 showing peak shift, while B shows the scatter plot of the 
peak shift for respective protons. 
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Proton 4, 6 and 7 changed profile at higher water concentration in the system 
(Figure 6.50, Figure 6.51). Proton 4 initially appeared as a broad-split peak, changed 
into a single peak with no splitting at higher water concentration in the system (Figure 
6.50). Meanwhile, proton 6 which initially appeared as double peaks ( ,  symbols 
representing the double peaks), began to change into a broad single peak, at 210:1 G:H 
molar ratios of water in the system (Figure 6.51). This change is most likely due to the 
change in solvent environment, and with that the magnetic resonance of the protons. 
The convergence of the two peaks is clearly shown in Figure 6.51B. As for proton 7 
(Figure 6.51A), the initially single peak splits into two broad peaks at 328:1 G:H ratio. 
These peak profile changes are observed to the protons of the ring attached with the 
fluorine and propanoic acid group.  
 
Figure 6.51. A 1H-NMR peak shift for FBN proton 6 ( ,  representing the slip peaks) and 7 showing peak 
shift, while B shows the scatter plot of the peak shift for respective protons. 
Dilution experiment did not show any peak profile change, even at high diluent 
concentration. This lead us to believe there is a weak interaction present, which is 
influenced by the presence of large amount of water. Overall, only small peak shifts 
are observed to all protons of FBN following the titration experiment. The peaks seem 
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to shift linearly downfield as more water is introduced, with no plateau feature 
observed even at 918:1 G:H ratios (Figure 6.50B and Figure 6.51B).  
Proton 8 and 9 did not show much shift with 0.009 and 0.013 ppm respectively 
following water titration up to 918:1 G:H molar ratio (Figure 6.52 Figure 6.53). The 
lack of peak shift to these protons are not unexpected as these protons correspond to 
the CH and CH3 respectively, hence are least likely to be affected by any electron 
rearrangement, or the effect of these rearrangements if they are indeed present, which 
are then visible on the spectra.  
 
Figure 6.52. A 1H-NMR peak shift for FBN proton 8 showing peak shift, while B shows the scatter plot of the peak 
shift for respective protons. Massive peaks at higher G:H ratios corresponds to the water peaks which is moving 
across the chemical region at its concentration increases. 
 321 
 
 
Figure 6.53. A 1H-NMR peak shift for FBN proton 9 showing peak shift, while B shows the scatter plot of the peak 
shift for respective protons. 
The Job plot of FBN revealed that the stoichiometry of interaction is favouring 
the 1:2 binding with Xmax=0.4 (Figure 6.54). The fitting to 1:2 binding model yielded 
a K12 of 25 M
-1. All K1 values from all the fitting are non-significant, while K21 suggest 
a negative cooperativity between the reactant and product, which is highly unlikely 
(Table 6.9). Hence, the K value FBN could not be directly to the other compounds, as 
all of them fits the K21 model. K12 translates into G of -8.0 kJ mol-1. 
 
Figure 6.54. The Job’s plot of FBN revealed that the stoichiometry of interaction is favouring the 1:2 binding with 
Xmax=0.4. 
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Table 6.9. K values based on the fitting to all available binding model, the 1:1, 2:1 and 1:2, H:G ratios 
H:G binding model K1 (±% error) K21 (±% error) K12 (±% error) 
FBN:H2O 0.06 M-1 (±2.7%) N/A N/A 
2FBN:H2O 0.12 M-1 (±1.7%) -21.9 M-1 (±3.1%) N/A 
FBN:2H2O 8 x10-5 M-1 (±1.8%) N/A 25 M-1 (±4.5%) 
The calculated G palaces FBN in the grey zone. The placement of FBN is 
puzzling as the peak shift magnitude were not the largest or the clearest e.g. DAP, 
however, the values from the global fitting of the protons revealed comparable value 
to that of DAP. However, it is noted that the G calculated is not based on the K21 but, 
K12 which means it is not a one-to-one comparison. We are predicting hydrate presence 
in FBN solely due its placement on our gauge favouring the hydrate-forming zone. 
 
Figure 6.55. G placement of FBN on our hydrate gauge. TRN and DPY marker on the gauge are opted out for 
clarity. 
Follow up literature search found that FBN has been reported to exists as three 
polymorphs, Form I, II, and III, as well as a 3FBN:2H2O phase (3/2 hydrate), which 
nucleates selectively from only a few polymers.38 The crystalline hydrate was grown 
from the evaporation of methanol solution in the presence of polymers such as poly 
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(n-butyl methacrylate), polycaprolactone, chlorinated polyethylene, and styrene 
butadiene ABA block copolymer. In addition, the 3/2 hydrate was also reported to 
crystallise from evaporation of ethanol solutions, mixed with sodium salt of alginic 
acid and poly (vinyl alcohol).38 Crystallisation from methanol evaporation only 
yielded the hydrate form in the presence of the mentioned polymers, and without the 
polymers, the hydrate form did not form- even in the presence of additional water in 
the methanol solution.38  
 Closer examination of the hydrate form revealed that the water molecules are 
disordered in the structure model, and is located in the channels formed by six FBN 
molecules (Figure 6.56).  
 
Figure 6.56. FBN 3/2 hydrate structure showing the channel formed by six FBN molecules, where water molecules 
are located.38 The colour code is carbon grey, oxygen red, fluorine green and hydrogen light grey 
Water is reported to hydrogen bond as a donor and acceptor following 
interaction with FBN.38 As an acceptor, water hydrogen bonds via the oxygen atom, 
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to the carboxylic acid (OH) of FBN.38 Two additional hydrogen bonds is also reported 
involving water as a donor, hydrogen bonding to the carbonyl and the oxygen of the 
acid respectively, which is indicated by the close proximity of the O… O distances.38  
Since the hydrogen bonding between FBN and water is reported to be through 
the OH group, 38 it is actually in-line with our 1H-NMR observation. Following our 
titration method, the OH was unobservable via 1H-NMR method due to the fast 
exchanging OH proton. Furthermore, the closest proton to the interaction point (OH) 
is the final two protons, proton 8 and 9 which correspond to the CH and CH3 and did 
not shift much. However, from the global fitting of all protons which have undergone 
electronic rearrangements showing peak shifts following FBN-water interaction, a 
modest was obtained, and calculated to G of -8.0 kJ mol-1. The obtained values reflect 
on the compound’s weak affinity to water. The fact that the 3/2 hydrate only form in 
the presence of a specific polymer which could influence or increase affinity towards 
water, which also points to the weak interaction observed in our titration. We suggest 
the value obtained here as the limit to our titration method, as lower value would 
obscure the distinction between weak hydrate and non-hydrate forming compound 
which is at this point G >-7 kJ mol-1. 
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6.3 Conclusion  
Titration data from the first two model compound showing no strong hydrate 
form provided initial cut-off of used to define our prediction tool. Titration of the first 
model compound NAP yielded a K21 of 9.88 M
-1 when all protons’ peak shifts were 
plotted and fitted against the respective binding model. The K was translated to G of 
-5.7 kJ mol-1. Similarly, when PCM was analysed, the resultant K and G form the 
fitting of all non-labile protons were 80 M-1 and -10.9 kJ mol-1. Based on these values 
and the previously recorded data for stable hydrate-forming compounds (DTA, CIM, 
TRN, and PXM), a hydrate prediction gauge was constructed, having hydrate and non-
hydrate-forming zone (Figure 6.9). 
A blind test on five compound were also done, and we have correctly predicted 
the hydrate-forming capabilities of the five compounds. Most of the G for the blind 
test compounds fell in the grey zone, between <-6 kJ mol-1 and >-10 kJ mol-1 of our 
initial zones limits. These limits are the adjusted based new data from our blind tests. 
We are confident that the adjusted limits based on, 1) the significant shift (>0.002 ppm) 
at low water incorporation-showing strong affinity towards water, 2) the overall shape 
of the generated curve from the chemical shifts, -reflective of a real host-guest reaction 
rather than random interactions. The energy values appeared close between the hydrate 
and non-hydrate region as they are calculated, however the actual K value obtained 
vastly differ between the zones. In principle a difference of ±1 kJ mol-1 would actually 
represent a significant difference in K and not a fixed value. For example, the K values 
of 25,.16.7 and 11.2 M-1, will correspond to the calculated G values of -8, -7 and -6 
kJ mol-1 respectively. Meaning a difference of 1 kJ mol-1 between -8 and -7 kJ mol-1 
corresponds to a difference of K by 8.3 M-1, while between -7 and -6 kJ mol-1, 5.5 M-
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1. Following the first blind test result, PYZ data provided a new cut-off for non-hydrate 
forming zone of -7.1 kJ mol-1. Initial prediction for PYZ hydrate state was done based 
on its placement on our gauge, which was in close proximity to non-hydrate zone, +1.4 
kJ mol-1, compared to -3.1 kJ mol-1 away from the hydrate zone. Subsequent literature 
search confirmed our prediction, and effectively expand our non-hydrate zone to be 
G of >-7.1 kJ mol-1. ACT hydrate state was the easiest to determine as the titration 
did not show significant shift at lower water contents, and the fitting yielded a small K 
of 0.32 M-1, which translated into positive G value. This places ACT on the non-
hydrate zone on our gauge, which subsequent literature search confirmed to be correct. 
DAP present the biggest challenge to our prediction method as the G not only 
placed the compound in the grey zone, but right in the middle of the two-defined zones 
with +1.5 kJ mol-1 to the non-hydrate zone and -1.6 kJ mol-1 to the hydrate zone. 
Observation of the peak shift behaviour helped our prediction as all of DAP’s protons 
showed clear shifts, and DAP showed high water affinity following water titration, 
with immediate shift even at lower water content. Plus, the shift magnitude of NH2 
(0.35 ppm) is very significant compared to the proton shifts that we have observed thus 
far, which showed hydrate-forming capability. 
Analysis of the final two compounds, DPY and FBN yielded comparable G 
values to that of DAP. Based on the calculated G DPY is placed on the hydrate-
forming zone of our gauge. Our prediction matches the literature search with a 
dihydrate form reported.34,35 Meanwhile FBN is place on the narrower grey zone, 
however, with the value is so close to DAP (which we now know has a hydrate form) 
with just +0.6 kJ mol-1 difference, we hence predicted that the compound to be able to 
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exist as a hydrate form. Again, our prediction was in-line with previous report of a 3/2 
hydrate.38 
By the end of the blind test, the grey zone has shrunk form the initial area 
defined at the beginning of the probe. We suggest the value obtained for FBN as the 
limit to our titration method, as lower value would obscure the distinction between 
hydrate and non-hydrate forming compound. As mentioned earlier, all of the G 
obtained from our blind tests, fell in the initial grey zone between <-6 kJ mol-1 and >-
10 kJ mol-1 of our initial zones limits. Interestingly, all of the blind test compounds 
which are now placed in the hydrate-forming zone share a common property, which is 
all of them forms weak hydrates. Whilst we cannot definitively discriminate between 
strong and weak hydrate forming compounds, we can see an emerging trend of 
comparable K and G values, with placement on the higher end on our hydrate gauge. 
The only compound which showed unusually strong affinity to water is PCM 
considering the fact that PCM hydrate forms are metastable. However, the values 
obtain for PCM still fit in hydrate forming compound zone (Figure 6.57). 
 
Figure 6.57. Overall placement of all analysed compounds which is based on the respective G, on our generated 
hydrate gauge. 
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Overall, results from chapter 5 and 6 suggest that the procedure used is able to 
show and measure the apparent binding interaction, and energies between the 
uncharged host and guest. In each of the experiments, accompanying dilution control 
experiment was done to ensure that any shift observed was based on water interaction 
rather than dilution effect. Overall, dilution experiment of all tested compounds 
yielded non-significant shifts, and bares little effect to the peak shifts of the compound. 
Dilution experiments also did not result in the change of peak profile in any of the 
spectra.  
We acknowledge that the resultant peak shifts are small, and the fitting is only 
apparent to the available model and unlike a typical host-guest titration, our binding 
curve does not reflect the true stoichiometry of the interacting components, as the 
amount of guest needed to observe the changes are massive. However, we have noticed 
an immediate shift at 1:1 G:H ratio especially for compound showing good hydrate 
forming ability, compared to the delayed shift for the poor or non-hydrate forming 
compound. Moreover, there is clear evidence that there is a degree of molecular 
recognition between the interacting components leading to the formation of pre-
nucleation aggregates. We stipulate that since the interaction is weak, the amount of 
guest added need to be overwhelmingly large, so that the chemical shift changes is 
observable on 1H-NMR.  
We have successfully showed that different compounds with different hydrate 
forming ability would show different affinity and selectivity to the tested guest (water) 
reflected by a different K values and the respective G (Figure 6.57), and listed in 
Table 6.10. Based on method and our G hydrate gauge, we are able to distinguish 
between hydrate and non-hydrate forming compound (Figure 6.57). In addition, we 
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can see an emerging trend of comparable K and G values in weak hydrates compared 
to stable hydrates, however definitive distinction between the two hydrate types 
required a larger library of compounds analysed using our method (Figure 6.57). The 
lowest K and G value was acquired from metastable hydrate forming compound, 
FBN. We propose that the value from FBN-water titration to be the minimum cut-off 
for the apparent binding which indicate hydrate formation. We also suggest that any K 
value lower than the FBN-water titration value of 25 M-1 or G bigger than -8.0 kJ 
mol-1, would indicate that hydrate formation is not possible (Figure 6.57). 
Table 6.10. All K21 and G for all the probed compounds. 
[H]:[G] binding model K21 G 
2DTA:H2O 3005 M
-1 -19.8 kJ mol-1 
2CIM:H2O 203 M
-1  -16.1 kJ mol-1 
2TRN:H2O 60.22 M
-1  -10.2 kJ mol-1 
2PXM:H2O 519.4 M
-1  -15.5 kJ mol-1 
2NAP:H2O 9.88 M
-1 -5.7 kJ mol-1 
2PYZ:H2O 18.0 M
-1 -7.1 kJ mol-1 
ACT:H2O* 0.32 M
-1 3.2 kJ mol-1 
2DAP:H2O 32.6 M
-1 -8.6 kJ mol-1 
2DPY:H2O 35.3 M
-1 -8.8 kJ mol-1 
FBN:2H2O** 25 M
-1 -8.0 kJ mol-1 
2PCM:H2O*** 157.4 M
-1 -12.5 kJ mol-1 
 330 
 
2PCMH2O****: 80.0 M
-1 -10.9 kJ mol-1 
*ACT K1, **FBN K12, ***PCM K21(NH only), ****PCM K21 (non-labile 
proton only) 
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CHAPTER 7  
 EXTENDED USE OF THE TITRATION TECHNOLOGY: PROBING 
DIMETHYLFORMAMIDE SOLVATE FORMATION AND PROSPECTIVE 
SCREENING TOOL FOR PROTEIN BINDING FRAGMENTS 
7.1 Introduction 
The titration procedure used in chapter 5 and 6 is explored further by probing 
into its potential use to measure the interactions and binding strength between other 
uncharged host-guest molecules. Throughout this chapter, dimethylformamide (DMF, 
Figure 7.1) is used as the main guest instead of water, and observation is focused on 
the binding constant determination and pre-nucleation aggregates formation between 
the model compound and DMF. DMF is a polar aprotic, clear liquid that has been 
widely used in industries as a solvent, an additive, or an intermediate because of its 
extensive miscibility with water and most common organic solvents.1 The density of 
DMF is 0.95 g cm−3 at 20 °C, which is similar to that of water.1  
 
Figure 7.1. Chemical structure of DMF 
Our initial interest in the pre-nucleation aggregates involving DMF is driven 
by the ability of our first model compound, a derivative of the tetrazole cycle, to form 
an extremely stable DMF solvate. The DMF solvate is claimed to persist even after 
passing through a silica gel column for purification after synthesis. A successful 
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connection between the extremely stable crystalline DMF solvate and 1H-NMR 
titration would allow for the expansion of the used procedure to aid in the prediction 
of a stable solvate.  
7.2 Results for the model compound: 4-(1H-Tetrazol-5-yl) phenol  
 
Figure 7.2. Chemical structure of 4-(1H-Tetrazol-5-yl) phenol  
The 4-(1H-tetrazol-5-yl) phenol (TTZ, Figure 7.2), which was used in our 
experiments was synthesised by Dr. Clinton Veale’s group at the University of 
KwaZulu Natal in South Africa. The TTZ used is a derivative of the tetrazole cycle, 
which is a promising pharmacophore fragment frequently used in the development of 
physiologically active compound as well as novel drugs.2–4  
Initial 1H-NMR in DMSO-d6 environment shows three chemical shift peaks 
corresponding to the OH of the phenol at 10.18 ppm (proton 1, ), the phenol protons 
at the ortho position, 7.85 ppm (doublet, proton 2, ), and finally the phenol protons at 
the meta position, 6.95 ppm (doublet, proton 3, ), all of which are highlighted in 
Figure 7.3. 
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Figure 7.3. 1H-NMR spectrum of TTZ in DMSO-d6 environment. Specific chemical shift regions on the spectrum 
which are identified as  proton 1 ( ), 2 ( ) and 3 ( ) are highlighted with the respective symbols and corresponding 
inset of the chemical structure. 
7.2.1 TTZ 1H-NMR dilution experiment 
Similar to the previous approach (chapter 5 and 6), TTZ-water 1H-NMR 
titration was done to investigate the binding affinity towards water as the compound 
has been reported to exist as a 1.5 hydrate.5 Before the titration was performed, a quick 
dilution experiment was done to ensure that the subsequent peak shift observed, if any 
does occur, is a result from the titration experiment, and not the effect of dilution. For 
the dilution experiment, the three mentioned protons of TTZ in DMSO-d6 are 
monitored, with only two points checked - one with no guest, and the other with 450:1, 
G:H ratio of the main solvent. Three separate tubes with the same stock were used to 
account for measurement error. Dilution with anhydrous, non-deuterated DMSO 
showed an overall upfield shift to the three observable protons, with the biggest shift 
close to -0.01 ppm observed to proton 1. The remaining protons showed a similar peak 
shift magnitude of -0.0016 ppm which is not significant based on our cut-off of ±0.002 
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ppm. The shift magnitude and direction of proton 1 in the dilution experiment is 
considered during the analysis of the subsequent titration experiment. 
Table 7.1. Dilution effect of TTZ with 450 molar equivalents of anhydrous DMSO 
Tube number (G ratio) Proton 1 Proton 2 Proton 3,  
Average  at 0:1 DMSO: TTZ ratio 10.1755 7.8747 6.9665 
Average  at 0:450 DMSO: TTZ ratio 10.1656 7.8731 6.9649 
Average shift difference -0.0099 -0.0016 -0.0016 
7.2.2 TTZ-water 1H-NMR titration in DMSO-d6  
The subsequent TTZ-water titration from 0-450:1 G:H molar ratio reveals that 
all the observed peaks underwent a downfield shift, with the biggest shift occurring to 
proton 1 ( ), which has shifted by +0.335 ppm (Figure 7.4). Compared to the dilution 
data, the peak shift recorded for the same proton was just -0.01 ppm and the shift was 
towards the opposite direction. Therefore, the large, significant peak shift observed in 
the titration experiment represent true interaction with water and suggest that OH of 
the phenol is the most likely interaction point to water in the DMSO-d6 solution. In 
addition, significant shifts are also observed to proton 2 ( ) and 3 ( ) which has shifted 
by +0.0127 and +0.0316 ppm, respectively (Figure 7.4). The larger shift to proton 3 is 
consistent with the close proximity of this proton to the mentioned interaction point, 
proton 1 as seen in our previous titration. Scatter plot of the three protons peak shifts 
revealed an almost linear curve with the increasing water molar ratios (Figure 7.5 and 
Figure 7.6). 
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Figure 7.4. 1H-NMR chemical shift region for proton 1, 2 and 3 and their respective peak shifts following water 
titration at 50 molar ratio gaps. 
 
Figure 7.5. The scatter plot corresponding to the peak shift of proton 1 following water titration up to 450 molar 
ratios. 
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Figure 7.6. The scatter plot corresponding to the peak shift of proton 2 (A) and 3 (B) following water titration up 
to 450 molar ratios. 
 
Figure 7.7. Job plot of TTZ-water interaction suggesting the stoichiometry of interaction as 1:2, with Xmax= 0.3 
Job plot for TTZ-water interaction reveals that the stoichiometry of interaction 
is 1:2, with a left-skewed plot and Xmax= 0.3. The Job plot here acts only as a guide as 
mentioned previously, the outcome is not reflective of the real interactions in our 
study. The best fit, which generates the least error between our data points and the 
modelled curve, is to the 1:1 model, with a K value of 0.06 M-1. However, this value 
is too low for a significant interaction, as we have seen from the actual chemical peak 
shift, especially of proton 1 ( ). Since we are confident that the interaction is not 
random, follow up interpretation is based on the next best fit, which is to the 2:1 
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stoichiometry model (Table 7.2), which yielded the largest K value obtained in the 
form of the K21, with 2155 M
-1 calculated from the fitted data. The K21 value translates 
into G of -19 kJ mol-1. The obtained K21 and G values are consistent with the values 
for stable hydrate obtained in chapter 5, and when placed on our hydrate gauge, it is 
indeed in the hydrate-form. Based on our predicted data, TTZ can exists as a stable 
hydrate form, which may or may not be the reported 1.5 hydrate as the stability of the 
reported hydrate remains unknown. The other K and G values from the fitting to the 
different models are listed in Table 7.2. 
Table 7.2. Calculated G of TTZ-water binding in DMSO-d6 environment based on three (3) different binding 
models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
TTZ:H2O 0.06 M
-1 
(±0.7%) 
N/A N/A +7.8 kJ mol-1 
2TTZ:H2O 3.5 x 10
-4 M-1 
(±4.5%) 
2155 M-1 
(±3.5%) 
N/A -19 kJ mol-1 
TTZ:2H2O 14 M
-1  
(±29%) 
N/A 0.05 M-1 
(±0.8%) 
-7.3 kJ mol-1 
7.2.3 TTZ-DMF 1H-NMR titration in DMSO-d6  
It has come to our knowledge that TTZ can form an extremely stable DMF 
solvate. Hence TTZ is the ideal model compound to apply our titration method and 
probe whether the same technique can be extended for stable solvate prediction. 
Similar to the TTZ-water titration (Figure 7.5 and Figure 7.6), proton 1 ( ), proton 2 
( ) and 3 ( ) all showed downfield shifts, with scatter plot showing almost linear 
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curve. However, the magnitude of the peak shifts between the two titration are 
different, showing significantly lower shift in proton 1, while higher shifts in proton 2 
and 3 (Table 7.3).  
 
Table 7.3. Comparison between the peak shift magnitude in water and DMF titration in DMSO environment 
Titration range Proton 1 (ppm) Proton 2 (ppm) Proton 3(ppm) 
0-450:1 H2O:TTZ 
titration 
+0.335 +0.0127 +0.0316 
0-450:1 DMF:TTZ 
titration 
+0.0771 +0.0743 +0.0564 
As a consequence, global fitting of the three protons’ peaks shift from the 
titration of DMF in DMSO-d6 has resulted in low K and high G. The smallest G 
obtained was from the best fitting of all monitored protons to a 1:2 model, with -8.8 
kJ mol-1. The value is considerably high compared to the -19 kJ mol-1 obtained from 
water titration. The unclear result suggests that TTZ-DMF interaction in DMSO 
environment is present, but limited. It is unclear to what could be the reason. To date 
no TTZ-DMSO solvate has been reported, and the existence of such solvate form could 
be one of the limiting factor. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
TTZ:DMF 9 x 10-3 M-1 
(±2%) 
N/A N/A +11.7 kJ mol-1 
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2TTZ:DMF -4.5 x 10-2 M-1 
(±2.3%) 
2.7 M-1 
(±1.3%) 
N/A -2.5 kJ mol-1 
TTZ:2DMF 1.8 x10-4 M-1  
(±3.2%) 
N/A 34.9 M-1 
(±21.5%) 
-8.8 kJ mol-1 
Since we observed good TTZ-water interaction before (7.2.2), a repeat in 
DMF-d7 environment will confirm the complex’s stability in solution. While 
properties of water have been discussed in detail in chapter 1, the binary solution 
mixture of DMF and water is yet to be mentioned. DMF-water mixing process is 
exothermic for all concentrations, which is a result of hydrogen bond formation 
reported to occur via the carbonilic oxygen of the amide and the molecules of water,6 
later confirmed by Raman spectroscopy.7 Hydrogen bonds between water and the 
carbonyl oxygen of DMF molecule are stronger than those between water molecules, 
and this effect is strengthened by the nitrogen atom due to the resonance structure of 
DMF.8 Water is well known to be highly structured in its pure liquid state. The 
introduction of DMF into a pure aqueous solution therefore causes disruption to the 
specific structure effects of pure water and leading to the absence of these structures.9  
7.2.4 TTZ 1H-NMR cross-titration with water and DMF: Part I 
1H-NMR TTZ-water titration has shown that TTZ has a strong affinity to water, 
which is reflective to the compound’s ability to exist as a hydrate form. Therefore, it 
is most likely that in a D2O solution environment, TTZ-water aggregates would be the 
main species present in solution. A TTZ cross-titration with water and DMF in the 
respective opposite solvent environment was done in order to compare the affinity of 
TTZ to the respective guests. TTZ-water titration in DMF-d7 environment would 
ascertain whether TTZ’s affinity towards water is preserved, while the cross-titration 
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in D2O environment would establish whether a stronger affinity towards DMF is 
present-again due to the claimed existence of the extremely stable DMF solvate. A 
greater affinity towards DMF would mean the DMF could displace TTZ-water 
aggregates in solution and form TTZ-DMF complex and vice versa. 
 
Figure 7.8. The peaks of TTZ in DMF environment for water titration (A). The peaks of TTZ in D2O environment 
for DMF titration (B). The calibration standard used in A is TMS while in B DSS, both showing peak at 0.00 ppm. 
The monitored protons of TTZ in DMF-d7 and D2O environments are 
highlighted in Figure 7.8, with two chemical shift regions representing the 4 protons 
of TTZ. The protons at the ortho position (proton 1, ) appear at 7.99 ppm while the 
protons at the meta (proton 2, ) at 7.05 ppm in DMF-d7 environment. Meanwhile, in 
D2O solution, the mentioned peaks appear at 7.74 and 6.97 ppm respectively. DMF-d7 
peaks appear at three chemical shift regions, 8.02 (singlet), 2.92 (quintet) and 2.75 
ppm (quintet), while D2O appears as a single peak at 4.8 ppm. Note that the calibration 
standard used for TTZ-DMF titration in the D2O environment is 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS), which is similar to tetramethylsilane (TMS, used in 
DMF-d7), but with much higher water solubility. The proton spectrum of DSS also 
exhibits minor peaks at 2.91 ppm (triplet), 1.75 ppm (nonet), and 0.63 ppm (triplet) at 
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an intensity of 22% of the reference peak at 0 ppm which do not shift and the peak 
does not interfere with our observation as well. 
 
Figure 7.9. 0.02 M TTZ-H2O titration in a deuterated DMF-d7 environment up to 400:1 G:H ratio. 
TTZ-water titration in DMF-d7 environment also saw two split peaks 
corresponding to the two protons on the ortho (proton 1) and meta (proton 2) position 
respectively (Figure 7.9). In addition, DMF-d7 single peak appeared in close proximity 
to proton 1, and eventually overlaps at higher DMF:H molar ratio. The OH and NH 
are not detectable due to the fast exchange nature of the proton in a water environment. 
The scatter plot following 50 molar ratio gaps of water titration from 0-400:1 G:H ratio 
shows an erratic and inconsistently peak shifts of proton 1 ( ), with an overall non-
significant change observed (0.001 ppm), while proton 2 ( ) at the meta position 
shows significantly larger change, shifting in almost a linear manner by +0.0165 ppm 
at the end of the titration (Figure 7.10). The irregular plot observed in proton 1 is due 
to the very small peak shift, which indicates that the proton’s electronic environment 
is least affected of the two by water inclusion. The different shift magnitude of proton 
1 and 2, suggest that proton 2 is at a closer proximity to the actual interaction site, 
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hence experiencing a larger electron re-arrangement and deshielding effect. TTZ-
water complexation is, therefore, most likely to take place via the OH functionality, 
which corresponds well the previous TTZ-water titration data in DMSO-d6 
environment where a larger peak shift is also observed for the meta positioned proton 
3 (+0.0316 ppm), compared to the ortho positioned proton 2 (+0.0127 ppm). The 
overall weaker peak shift magnitude correlates with a lower TTZ affinity towards the 
water in a DMF-d7 environment.  
 
Figure 7.10. A shows the scatter plot for peak shift of proton at the ortho position, while B shows the scatter plot 
for peak shift of proton at meta position on TTZ benzene ring for TTZ-water titration in DMF-d7 environment. 
As stated, the peak shift magnitude of proton 2 ( ) is just +0.0165 at 400:1 
G:H. Such shift would translate into very small peak shift in Job plot analysis, hence 
the Job plot is deemed unnecessary in this iteration of the procedure. In addition, the 
Job plot data thus far failed to reflect and represent the true interaction stoichiometry 
of our titration experiment data. The best fitting of our data to the available 
mathematical model guides the interpretation, ignoring the speciation of the host, guest 
and their complexes as again, the figures obtained are only an apparent representation 
of the true interaction. The weak peak shifts following TTZ-water titration in DMF-d7 
solvent translate into weak and non-significant K values based on the 1:1, 2:1 and 1:2 
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fitting (Table 7.4). The largest K value obtained from the fitting of all the monitored 
protons’ peaks shift of TTZ in DMF-d7 environment is the K21, with just 4.7 M-1, and 
a calculated G of -3.8 kJ mol-1. Based on the K and G values, it is safe to say that 
TTZ-water complexation is blocked, inhibited or simply does not take place in the 
presence large quantities of DMF, which also hints towards a strong TTZ-DMF 
association.  
Table 7.4. Calculated G of TTZ-water binding in the DMF-d7 environment based on three (3) different binding 
models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
TTZ:H2O 7.7 x 10
-7M-1 
(±0.02%) 
N/A N/A +39 kJ mol-1 
2TTZ:H2O 3.3 x 10
-2 M-1 
(±4.2%) 
4.7 M-1 
(±1.7%) 
N/A -3.8 kJ mol-1 
TTZ:2H2O 0.15 M
-1 
(±11.7%) 
N/A -7.6 x 10-3 M-1 
(±-6.5%) 
N/A kJ mol-1 
7.2.5 TTZ 1H-NMR cross-titration with water and DMF: Part II 
Subsequent TTZ-DMF-d7 titration in D2O environment also saw an overall 
downfield shift, but in contrast, a significant peak shifts are observed to both the ortho 
( , proton 1) and meta ( , proton 2) protons of TTZ between 0-400:1 G:H ratio (Figure 
7.11). Unlike the water titration, a larger peak shift is observed to the ortho positioned 
proton 1, with a downfield peak shift recorded of +0.215 ppm from 0-400:1 G:H ratio. 
Meanwhile, for proton 2, the peak shift recorded is +0.128 ppm, which is also 
significant and strong shift. The different peak shift magnitude between proton 1 and 
2, suggest that the interaction point between TTZ and DMF is much closer to proton 
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1, which points towards the NH on the 5-member ring of four nitrogen atoms (the 
tetrazole group). The overall larger shift observed in TTZ-DMF titration compared to 
TTZ-water titration in the respective opposite solvent environments, suggests a higher 
affinity to DMF-d7. Moreover, the overwhelmingly higher affinity to DMF is clear, 
and is able to displace TTZ-water species in water environment, considering the strong 
interaction observed earlier between TTZ and water. The scatter plot of the two 
monitored peaks reveals a curved plot and a plateau feature, with increasing G:H ratio 
(Figure 7.12). 
 
Figure 7.11. 0.02 M TTZ-DMF-d7 titration in a deuterated water environment up to 400:1 G:H ratio. Note that the 
chemical shift scale is similar to that of Figure 9. 
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Figure 7.12. A shows the scatter plot for peak shift of proton at the ortho position, while B shows the scatter plot 
for peak shift of proton at meta position on TTZ benzene ring for TTZ-DMF titration in D2O environment. 
Job’s plot for TTZ-DMF interaction in D2O solution revealed similar 
stoichiometry to the TTZ-water interaction in DMSO-d6 environment where 1:2 
interaction stoichiometry is favoured (Xmax=0.4). However, the best fitting of the three 
available binding models is the 2:1 stoichiometry, again, similar to TTZ-water titration 
earlier.  
 
Figure 7.13. Job plot of TTZ-DMF-d7 interaction suggesting the stoichiometry of interaction as 1:2, with Xmax= 
0.4 
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Table 7.5. Calculated G of TTZ-DMF-d7 binding in D2O environment based on three (3) different binding models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
TTZ:DMF 0.65 M-1 
(±3.4%) 
N/A N/A +1.2 kJ mol-1 
2TTZ:DMF 5.2 x 10-3 M-1 
(±4.2%) 
2229 M-1 
(±3.1%) 
N/A -19.1 kJ mol-
1 
TTZ:2DMF 0.84 M-1 
(±2.3%) 
N/A 4.1 x 10-2 M-1 
(±6.5%) 
+8.9 kJ mol-1 
The K21 value generated is impressive considering TTZ and water did show 
high affinity towards one another following titration in DMSO. The corresponding G 
value of -19.1 kJ mol-1 obtained for TTZ-DMF is significant and is comparable to the 
G calculated for TTZ-water titration in DMSO-d6, which is -19.0 kJ mol-1. The large 
K and G acquired in D2O environment suggests a much stronger affinity to DMF vs. 
water displacing TTZ-water aggregates and forming TTZ-DMF pre-nucleation 
complexes, which supports the existence of the reported extremely stable DMF 
solvate. In addition, the shift, or the lack of it, in TTZ-water cross-titration experiment 
in DMF-d7 environment provide further evidence which reiterate the earlier notion of 
a stronger TTZ-DMF pre-nucleation aggregates formation.  
7.2.6 1H-NMR TTZ-DMF titration in an acetone-d6 environment  
A third TTZ-DMF titration was repeated in acetone-d6 to confirm that the K 
and G values obtained from the titration in D2O environment was reproducible. In 
the acetone-d6 environment, deuterated and protiated anhydrous DMF were used as 
guests in two separate titrations. The two setup were done to compare whether the 
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deuteration status of the guests bares any impact on the peak shift and subsequent K 
and G values. In the protiated DMF setup (Figure 7.14A), a single massive DMF 
peak overlaps with the proton peak at the ortho position ( , proton 1), while the same 
peak is covered by TTZ peak due to its lower intensity in DMF-d7 setup. Therefore, 
monitoring of the peak shift of the obstructed proton 1 in protiated DMF titration 
(Figure 7.14A) was possible following titration using DMF-d7 (Figure 7.14B). Proton 
1 did not show significant peak shift following titration with just +0.0009 ppm 
recorded at 100:1 G:H ratio. Meanwhile. similar effect was observed to the proton at 
the meta position ( , proton 2)in both protiated and deuterated solvents. DMF titration 
causes proton 2 peak to shift upfield, suggesting that the proton gain electron density, 
and undergo shielding effect. 
 
Figure 7.14. 0.02 M TTZ-DMF titration (A) protiated DMF and (B) DMF-d7 in acetone-d6 environment, up to 100:1 
G:H ratio. 
In acetone environment, TTZ-DMF complexation occurs directly via the 
carbonyl of the DMF as it acts as a proton acceptor by forming a hydrogen bond with 
TTZ through the functional group (OH), as more influence from the complexation is 
observed in the peak shift of the proton at the meta position ( , proton 2) which shows 
351 
 
a significantly large upfield shift of -0.021ppm in protiated setup, and -0.022 ppm in 
deuterated setup at 100:1 G:H ratio (Figure 7.15).  
 
Figure 7.15. The scatter plot for peak shift of proton at meta position (proton 2) on TTZ benzene ring for TTZ-
DMF titration (protiated and deuterated) in the acetone-d6 environment. 
As mentioned in earlier chapters, the direction of the shift is not much of a 
concern in determining the binding association between the components, as either 
upfield or downfield peak shift would correspond to the complexation to the titrated 
guest. Following DMF titration, proton 2 peak shift reaches significance (-0.002 ppm) 
early on at 2:1 G:H ratio (Figure 7.15), signalling a strong affinity to DMF.  
Table 7.6. Calculated G of TTZ- protiated* and DMF-d7 binding in an acetone-d6 environment based on proton 2 
fitting to three (3) different binding models. 
[H]:[G] 
binding model 
K1 (±% 
error) 
K21 (±% error) K12 (±% error) Gfor K21 
TTZ:DMF* 2.2 M-1 
(±3.5%) 
N/A N/A -2.2 kJ mol-1 
2TTZ:DMF* 0.02 M-1 
(±2.2%) 
1057 M-1 
(±0.7%) 
N/A -17.25 kJ mol-
1 
352 
 
TTZ:2DMF* 1.5 M-1 
(±1.4%) 
N/A -0.36 M-1 (±-
2.0%) 
N/A kJ mol-1 
TTZ:DMF-d7 2.8 M
-1 
(±3.5%) 
N/A N/A -2.2 kJ mol-1 
2TTZ:DMF-d7 0.025 M
-1 
(±3.1%) 
1145 M-1 
(±0.99%) 
N/A -17.45 kJ mol-
1 
TTZ:2DMF-d7 2.16 M
-1 
(±2%) 
N/A -0.36 M-1 (±-
2.9%) 
N/A kJ mol-1 
The best fitting for TTZ-DMF interaction in acetone-d6 is to the 2:1 model, 
generating a significant K21 value of 1057 M
-1, which translates into -17.25 kJ mol-1 in 
G. Meanwhile, the fitting of 2 in the titration with DMF-d7, yielded a K21 value of M-
1, which translates into -17.45 kJ mol-1. Interestingly, both titration yielded comparable 
K values, and more importantly, the calculated G values, which are still significantly 
large and reflect well to the presence of the stable DMF-TTZ pre-aggregation complex 
in solution.  
7.2.7 TTZ-DMF 1H-NMR titration in water environment MD simulation 
Since Job’s plot was not able to show us the speciation of the interacting 
components for most of our titration analysis, MD simulation is done to highlight the 
interacting species in solution.  
353 
 
  
Figure 7.16. TTZ in aqueous solution TTZ in vdW representation (cyan carbon atoms). Water on the left displayed 
as a blue continuous surface. Right: detail of TTZ molecule placement in the periodic cell (water molecules are not 
displayed). 
The 5:1 DMF:TTZ molar ratio system was chosen as the starting point for 
DMF introduction in the MD simulation as we have seen significant shift of +0.016 
ppm from our NMR titration at this G:H ratio. Comparison between the first two MD 
figures (Figure 7.16 and Figure 7.17) clearly show the affinity of TTZ towards DMF, 
as from the 12 TTZ molecules in the simulated box (Figure 7.16), ½ of them have 
bonded to DMF in Figure 7.17. The observed interaction however is not limited to 1:1 
interaction as not only 1:1 (red circle, Figure 7.17) was observed, but 1:2 (light blue 
circle, Figure 7.17), 2:2 (green circle), 1:3 (yellow circle, Figure 7.17) and TTZ dimer 
(orange circle, Figure 7.17) complexations were also observed.  
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Figure 7.17. TTZ/DMF (5 eq.) system in water. TTZ (cyan carbon atoms) and DMF (all atom in orange) in vdW 
representation. Water in CPK representation (oxygen atoms only, in red). Right: TTZ/DMF molecules placement 
in the periodic cell (water molecules are not displayed). 
 
Figure 7.18. TTZ/DMF (15 eq.) system in water. TTZ (cyan carbon atoms) and DMF (all atom in orange) in vdW 
representation. Water in CPK representation (oxygen atoms only, in red). Right: TTZ/DMF molecules placement 
in the periodic cell (water molecules are not displayed). 
In the 15:1 DMF:TTZ molar ratio system (Figure 7.18), no free TTZ molecule 
was observed. This trend continues in the subsequent 25-50:1 DMF:TTZ molar ratio 
system (Figure 7.19 to Figure 7.20). 
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Figure 7.19. TTZ/DMF (25 eq.) system in water. TTZ (cyan carbon atoms) and DMF (all atom in orange) in vdW 
representation. Water in CPK representation (oxygen atoms only, in red). Right: TTZ/DMF molecules placement 
in the periodic cell (water molecules are not displayed). 
 
Figure 7.20. TTZ/DMF (50 eq.) system in water. TTZ (cyan carbon atoms) and DMF (all atom in orange) in vdW 
representation. Water in CPK representation (oxygen atoms only, in red). Right: TTZ/DMF molecules placement 
in the periodic cell (water molecules are not displayed). 
MD simulation (Figure 7.17-Figure 7.20) corresponds well to our assumption 
that in a dilute aqueous solution, there is no single species of TTZ-DMF complex 
would dominate the interaction space, but rather clusters of mixed 1:1, 1:2, 2:1 and 
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etc. are present simultaneously. The simulation also re-affirms our earlier statement 
that the binding measured thus far is an apparent value, based on the apparent 
stoichiometry. 
7.3 DMF as a prospective proteomimetic agent 
Since our method was able to measure the apparent binding for a stable DMF 
solvate, the potential to further expand the method’s usage to quantify protein-binding 
preferency through DMF titration is probed. DMF has been reported to have protein-
like property. The proteomimetic property of DMF has been first suggested by Nozaki 
and Tanford, which stated that the DMF solvent could be used as a reasonable model 
for the interior of globular proteins. They reported that the polypeptide backbone 
CONH groups and apolar hydrocarbon side-chain groups create an amide-like 
surrounding,10 which view is later supported by the statistical investigation by Roberts 
and Bohacek on side chain-side chain contacts between amino acid residues in 
proteins.11 It has been mentioned later that amides can serve as model compounds for 
the investigations of the properties of peptides in aqueous solution.12,13 Due to its 
amide-like and to an extent, proteomimetic properties, it is highly plausible to explore 
the use of DMF to predict strong protein-binding compound or fragments by using our 
titration method. Therefore, in addition to the mentioned primary aim, a follow-up 
probe is designed to assess the potential use of DMF as a proteomimetic agent though 
a series of tests with several compounds having different protein binding ability. 
Though protein binding is highly specific, our titration goal is only as a preliminary 
screen between a drug fragment to a generic protein. A successful connection will 
speed up the fragment screening and selection significantly. A series of DMF titration 
experiments, similar to that of the blind test in chapter 6 was designed to investigate 
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whether DMF titration can be used to reflect the four selected test compounds’ protein 
binding ability. Information on the respective compounds’ protein affinity is blocked 
and prediction is done based on the significant K and G values, which is set based on 
the initial TTZ-DMF titration. The significance K value is set to be in the range of 
1000- 2000 M-1 for DMF titration in D2O or acetone-d6 environment, which translate 
into a G of -17 to 19 kJ mol-1. Job’s plot is not done for any of the protein/DMF 
binding test compounds and the best fitting to the available mathematical model guides 
our data analysis and interpretation. Successful implementation of the procedure with 
DMF as the guest could potentially serve as a screening tool for promising 
pharmacophore fragments in the development of physiologically active compound and 
novel drugs. 
7.3.1 2-Chloro-4-hydroxybenzoic acid (2C4HBA) 
The first compound probed in the test series is 2-chloro-4-hydroxybenzoic acid 
or 2C4HBA in short. Observation of the structure reveals two hydrogen bond donors 
and three hydrogen bond acceptors. The compound is sparingly soluble in water and 
soluble in acetone. Therefore, 0.02 M 2C4HBA-DMF titration was done in D2O and 
acetone-d6 environment from 0-400 G:H molar ratio. Initial 2C4HBA 
1H-HNMR 
spectra in D2O and acetone-d6 reveals similar chemical shift for the three highlighted 
protons as illustrated in Figure 7.21. In addition, in acetone-d6 environment a fourth 
peak is visible, which is the broad peak at 9.8 ppm (Figure 7.21B), corresponding to a 
labile OH proton. The peak becomes too broad to be observed following the titration, 
hence focus will be on the clear peaks of the three other protons.  
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Figure 7.21. 1H-NMR spectrum of 2C4HBA in D2O (A) and acetone-d6 (B) environments. Specific chemical shift 
regions on the spectrum which are identified as proton 1 ( ), 2 ( ) and 3 ( )  are highlighted with the respective 
symbols and corresponding inset of the chemical structure. 
In D2O environment, the first monitored peak is the peak at 7.8 ppm 
corresponding to the proton ortho position on the ring (doublet, proton 1, ). Next, the 
proton on the meta position, next to the chlorine substitute, appearing as a single peak 
due to lack of other neighbouring H, at the chemical shift 7.0 ppm (proton 2, ). The 
final monitored proton is located on the meta position, next to proton 1, which appears 
on the spectrum at 6.8 ppm (doublet, proton 3, ). Following the titration from 0-150 
G:H molar ratio, all the observed peaks undergo downfield shift, with the biggest shift 
of +0.052 ppm occurring to proton 1, which is the closest proton to the acid group 
which can be monitored. Proton 2 and 3 also showed significant shift, but at a lower 
magnitude, shifting by +0.006 and +0.03 ppm respectively.   
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Figure 7.22. 0.02 M 2C4HBA-DMF titration in D2O environment, up to 150:1 G:H ratio. Note that the growing 
small peak at 7.7 ppm is one of the satellite peaks of the guest, DMF. 
Scatter plot of proton 1 ( ) reveals an almost a linear curve with increasing 
guest ratio, with a step feature observed in the generated scatter plot at 80 and 90:1 
G:H ratio (Figure 7.23). Interestingly, scatter plot of proton 2 initially showed similar 
linear trend, however at 80:1 G:H ratio a plateau feature is observed (Figure 7.24). As 
for proton 3, the scatter plot profile is very similar to that of proton 1 (Figure 7.25). 
 
Figure 7.23. The scatter plot for peak shift of proton 1 in 2C4BHA-DMF titration in D2O environment. 
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Figure 7.24. The scatter plot for peak shift of proton 2 in 2C4BHA-DMF titration in D2O environment. 
 
Figure 7.25.The scatter plot for peak shift of proton 3 in 2C4BHA-DMF titration in D2O environment. 
The fitting to the 1:1 model generated the least error following 2C4BHA-DMF 
titration in D2O environment, generating a K value of 0.27 M
-1. However, the largest 
K value obtained from the fitting to the three available models, is when the data is 
fitted to the 1:2 stoichiometry, resulting in a K12 value of 168 M
-1. Even though the K12 
obtained here shows a significant value, it is not a direct comparison to the K21 values 
obtained earlier for TTZ. In addition, 2C4HBA is commercially available as a hydrate 
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form,14 hence the complex with water in solution may hinder DMF interaction. 
Therefore, a second 2C4HBA-DMF titration in acetone-d6 environment is done as 
2C4HBA is very soluble in acetone. 
Table 7.7. Calculated G of 2C4HBA-DMF binding in D2O environment based on three (3) different binding 
models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
2C4HBA:D
MF 
0.27 M-1 
(±2.8%) 
N/A N/A +3.6 kJ mol-1 
2(2C4HBA)
:DMF 
0.84 M-1 
(±0.3%) 
-25 M-1                 
(±-5 x 10-6%) 
N/A N/A kJ mol-1 
2C4HBA:2
DMF 
8.9 x 10-4 M-1 
(±1.9%) 
N/A 168 M-1 
(±6.9%) 
-12.7 kJ mol-1 
Interestingly, an overall upfield shift is observed for three protons in 2C4HBA-
DMF titration in acetone-d6 environment, which is similar to the effects observed in 
TTZ-DMF titration in the same environment. All three plots show a linear increase 
followed by a plateau feature. Proton 1 curve reaches plateau at 150:1 G:H ratios, while 
proton 2 and 3 reach plateau at 100:1 G:H ratios. Above 110:1 G:H ratios, proton 2 
and 3 started to shift in the opposite direction, which suggest a secondary phase 
towards DMF interaction. Therefore, to probe early 2C4HBA-DMF interactions, the 
binding constant determination is calculated based on the fit of data points up to 110:1 
G:H ratio. 
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Figure 7.26. 0.02 M 2C4HBA-DMF titration in acetone-d6 environment, up to 150:1 G:H ratio 
 
Figure 7.27. The scatter plot for peak shift of proton 1 ( ) in 2C4BHA-DMF titration in acetone-d6 environment. 
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Figure 7.28. The scatter plot for peak shift of proton 2 ( ) and 3( ) in 2C4BHA-DMF titration in acetone-d6 
environment. 
Fitting to the three available models revealed that the best fitting is to the 2:1 
stoichiometry with a caculated K21 value of 1508 M
-1, and translates into G of -18.1 
kJ mol-1 which are higher than the values obtained for TTZ-DMF titration in the same 
environment, hence falls within the specified significance range. We are confident that 
2C4HBA and DMF does interact, and form pre-nucleation aggregate in solution. Note 
that TTZ-DMF in acetone fitting is only to one proton, but still give a significant K 
and G values, comparable to the values obtained here. All the data obtained here 
suggests that the compound binds well to DMF and possibly protein. 
Table 7.8. Calculated G of 2C4HBA-DMF binding in an acetone-d6 environment based on three (3) different 
binding models. 
[H]:[G] 
binding 
model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
2C4HBA:D
MF 
1.9 M-1 
(±2.1%) 
N/A N/A kJ mol-1 
2(2C4HBA)
:DMF 
0.017 M-1 
(±2.6%) 
1508 M-1 
(±1.4%) 
N/A -18.1 kJ mol-
1 
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2C4HBA:2
DMF 
1.8 M-1 
(±1.3%) 
N/A -0.16 M-1 (±-
5.6%) 
kJ mol-1 
7.3.2 4-Hydroxybenzoic acid (PHBA) 
The second compound in our test is para-hydroxybenzoic acid (PHBA). PHBA 
is very soluble in acetone, and sparingly soluble in water. However, with 0.02 M 
PHBA concentration used, no precipitation was detected during PHBA-DMF titration. 
In both deuterated solvent environment, PHBA appears as two split peaks, with proton 
close the acid (proton 1, ) appearing at 7.9 ppm and the proton close to OH (proton 
2, ) appearing at 6.9 ppm (Figure 7.30).  
 
Figure 7.29. 1H-NMR spctrum of PHBA in D2O environment. Specific chemical shift regions on the spectrum 
which are identified as  proton 1 ( ) and 2 ( ) are highlighted with the respective symbols and corresponding inset 
of the chemical structure. 
PHBA-DMF titration in D2O environment only allows for the observation of 
proton 2, as proton 1 peak overlaps with the titrated anhydrous non-deuterated DMF 
peak (Figure 7.30). Scatter plot of proton 2 reveals an upfield peak shifts from 0-50 
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G:H ratio, before reaching to a plateau between 50-70 G:H ratio and finally shifting 
downfield after the 70 molar ratio mark (Figure 7.31). Proton 2 shift reaches significant 
value (>0.002 ppm shift) at 30:1 G:H ratio. Since proton 1 is unobservable, which is 
the closer proton to the acid functional group, it is difficult to conclude the role of the 
acid and the influence on the overall binding. We speculate that early interaction to 
DMF occurs between 0-70 guest ratio, and above the mark, a secondary, forced-
interaction to DMF occurs mainly due to the large amount of DMF present. Therefore, 
to measure the early PHBA-DMF interaction and complexation, the binding constant 
determination fitting is only to the data point up to 70 molar ratios. 
 
Figure 7.30. 0.02 M PHBA-DMF titration in D2O environment, up to 400:1 G:H ratio 
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Figure 7.31. The scatter plot for peak shift of proton 2 ( ) in PBHA-DMF titration up to 100, and up to 400:1 G:H 
ratio (inset) in D2O environment. 
 
The data points for proton 2 peak shift fits poorly to all available stoichiometry 
models, resulting in K values with high errors of > 10%. The largest K calculated is 
for the 2:1 fit with 56.5 M-1, however the validity of this fitting is questionable as the 
error to the fit is >100%. The fitting error is most likely contributed to small dataset as 
only one proton is monitored, to a small number of data points between 0 and 70 G:H 
ratio, with a shift magnitude of just -0.0031 ppm, which is just above the significance 
cut-off. 
Table 7.9. Calculated G of PHBA-DMF binding in D2O environment based on three (3) different binding models. 
[H]:[G] 
binding model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
PHBA:DMF 1.7 M-1 
(±12.9%) 
N/A N/A -1.5 kJ mol-1 
2PHBA:DMF 2.1 M-1 
(±137.8%) 
56.5 M-1 
(±252.5%) 
N/A N/A kJ mol-1 
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PHBA:2DMF 0.85 M-1 
(±12.5%) 
N/A -0.95 M-1 (±-
10.7%) 
N/A kJ mol-1 
 
A follow-up PHBA-DMF titration is done in acetone-d6 environment due to its 
improved solubility in the mentioned solvent environment. Also, the acetone-d6 
environment allows for the observation of proton 1 at 7.9 ppm, as DMF peak appears 
at 7.97 ppm instead, while proton 2 appears at 6.91 ppm. Interestingly, following DMF 
titration, a downfield shift to higher ppm is observed for both protons, (Figure 7.32) 
which is similar to the two previous observations of TTZ-DMF and 2C4HBA-DMF 
titration in the same solvent. Scatter plot of both protons showed almost a linear curve 
with a plateau feature, with proton 1 achieving plateau at 200:1 G:H ratio while proton 
2 curve reaches plateau at 100:1 G:H ratio (Figure 7.33). Above 150:1 G:H ratio, 
proton 2 peak starts to shift in the opposite direction, similar to the directional change 
observed to the same peak in D2O environment at 70:1 G:H ratio, which suggest a 
second phase of the interaction involving DMF. The binding constant determination 
in acetone environment hence is fitted to data up to 150 molar ratios of both proton 
peak shifts, as the cut off would represent the initial phase of PHBA-DMF interaction. 
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Figure 7.32. 0.02 M PHBA-DMF titration in acetone-d6 environment, up to 250:1 G:H ratio 
 
Figure 7.33. The scatter plot for peak shift of proton 1 (A, ) and 2 (B, ) PBHA-DMF titration up to 250:1 G:H 
ratio in acetone-d6 environment. 
Table 7.10. Calculated G of PHBA-DMF binding in acetone-d6 environment based on three (3) different binding 
models. 
[H]:[G] 
binding model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
PHBA:DMF 1.2 M-1 
(±3.9%) 
N/A N/A -0.5 kJ mol-1 
2PHBA:DMF 0.25 M-1 
(±3.8%) 
13.5 M-1 
(±1.5%) 
N/A -6.4 kJ mol-1 
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PHBA:2DMF 0.79 M-1 
(±2.4%) 
N/A 0.11 M-1 
(±8.2%) 
+5.5 kJ mol-1 
 
The fitting to all the models from DMF titration in both water and acetone 
solvent environments generated the highest K value of just 13.5 M-1, in the form of K21 
in acetone environment, which corresponds to a G of -6.4 kJ mol-1. The values are 
not in the range of the set significance values (1000-2000 M-1 and 17-19 kJ mol-1), as 
well as the values obtained for TTZ-DMF titration in the same environments. The 
result points to the obvious fact that PHBA shows a low affinity towards DMF hence 
does not form pre-nucleation aggregate in any of the tested solution, and ultimately 
suggesting that the compound is not a good DMF or protein binder. 
7.3.3 5-Phenyl-1H-tetrazole (5PHT) 
The third compound has poor solubility in water, hence DMF titration is done 
in acetone environment. Three chemical shift regions representing the five observable 
proton is monitored. Protons on the ortho position on the phenyl appeared as split 
double peaks and identified as proton 1 ( ). Proton 2 ( ) and 3 ( ) resonance peaks 
overlaps in the acetone environment, nevertheless the peaks are still distinguishable.  
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Figure 7.34. 1H-NMR spectrum of 5PHT in acetone-d6 environment. Specific chemical shift regions on the 
spectrum which are identified as proton 1 ( ), 2 ( ) and 3 ( ) are highlighted with the respective symbols and 
corresponding inset of the chemical structure. 
 
Figure 7.35. 0.02 M 5PHT-DMF titration in acetone-d6 environment, up to 500:1 G:H ratio 
Proton 1 ( ) peak shifts downfield, with the scatter plot of the peak shift 
showing an increase in shift with the increase of molar ratio of guest added. The scatter 
plot for peak shift of proton 1 shows a steep linear curve, which come to a plateau 
above 100:1 G:H ratio (Figure 7.36). Proton 2 ( ) and 3 ( ) show similar peak shift 
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profile to one-another and different to proton 1. At lower DMF concentration, proton 
2 and 3 peaks shift upfield and level off at around 70:1 G:H ratio. Both peaks started 
to shift in the opposite direction above 70:1 G:H ratio (Figure 7.37). Proton 1 shows 
significant shift up to 100:1 G:H ratio with +0.0165 ppm downfield shift recorded, 
while proton 2 and 3 shift upfield by -0.01 and -0.009 ppm at the same range. Based 
on the shift magnitude, we suggest that DMF interact with 5PHT via the NH tetrazole 
ring, hence the effect is observed more to proton 1 ( ). The plateau curve from the 
scatter plot of proton 1 suggests that the interaction point is saturated at around 100 
molar ratio, which is then followed by a second phase of interaction to DMF above 
100. Similar change in peak shift direction was also observed during 2C4HBA and 
PHBA titration in both D2O and acetone-d6 environment at higher DMF concentration, 
The interaction at higher DMF concentration seems to influence proton 2 ( ) and 3 (
) more, ‘forcing’ interaction to DMF at higher guest ratio of >100. Therefore, to 
measure the early 5PHT-DMF interaction and complexation, the binding constant 
determination is only fitted to the three protons’ peaks shift data points up to 100 molar 
ratios.  
 
Figure 7.36. The scatter plot for peak shift of proton 1 up to 500 guest molar ratio in D2O environment. 
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Figure 7.37. The scatter plot for peak shift of proton 2 (A) and 3 (B) up to 100 guest molar ratio, and 500 (inset) 
guest molar ratio in D2O environment. 
Table 7.11. Calculated G of 5PHT-DMF binding in acetone-d6 environment based on three (3) different binding 
models. 
[H]:[G] 
binding model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
5PHT:DMF 2.9 M-1 
(±7.8%) 
N/A N/A -2.6 kJ mol-1 
2(5PHT):DMF 0.95 M-1 
(±1.8%) 
3.8 M-1 
(±1.0%) 
N/A -3.3 kJ mol-1 
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5PHT:2DMF 2.2 M-1 
(±1.8%) 
N/A 0.59 M-1 
(±3.7%) 
+1.3 kJ mol-1 
 
The best fitting for the three protons’ peaks shift is to the 2:1 model, which 
gives a K21 value of 3.8 M
-1, corresponding to G of -3.3 kJ mol-1. The low K and G 
obtained from 5PHT-TTZ titration in acetone environment are lower than the value 
obtained for PHBA-DMF titration, and even much lower than the set significance cut-
off as well as the TTZ-DMF titration values in the same environment. Therefore, we 
are confident that 5PHT have a low affinity towards DMF hence does not form pre-
nucleation aggregate in solution, ultimately suggesting that the compound is not a good 
DMF and most certainly protein binder. 
7.3.4 5-(4-Pyridyl)-1H-Tetrazole (54PYT) 
The final compound in the blind test is 5-(4-pyridyl)-1H-tetrazole (54PYT). 
Initial 1H-NMR spectrum in D2O environment shows two chemical peaks shift 
corresponding to the pyridyl proton at the meta position (doublet, proton 1,  at 8.8 
ppm), and the pyridyl protons at the ortho positions (doublet, proton 2,  at 8.4 ppm), 
all of which are highlighted in Figure 7.38.  
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Figure 7.38. 1H-NMR spectrum of 54PYT in D2O environment. Specific chemical shift regions on the spectrum 
which are identified as proton 1 ( ) and 2 ( ) are highlighted with the respective symbols and corresponding inset 
of the chemical structure. 
Following DMF titration, a clear, immediate and significant peak shift is 
observed early on, at 1:1 G:H ratio. Overall, both peaks shift downfield (Figure 7.39), 
with the scatter plot showing similar linear trend, before reaching plateau at 100:1 G:H 
ratio (Figure 7.40). Between 0-200 G:H ratio, proton 1 has shifted by 0.08 ppm while 
proton 2 by 0.094 ppm. A larger peak shift magnitude observed in proton 2 ( ), is most 
likely due to the closer proximity to the interaction point, the NH on the tetrazole ring.  
 
Figure 7.39. 0.02 M 54PYT-DMF titration in D2O environment, up to 200:1 G:H ratio 
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Figure 7.40.The scatter plot for peak shift of proton 1 (A) and 2 (B) up to 200 guest molar ratio in D2O environment. 
The best fitting for the three protons’ peaks shift is to the 2:1 model, which 
gives a K21 value of 1469 M
-1, corresponding to G of -18.1 kJ mol-1. The K and G 
value fall within the set significance cut-off and is also comparable to the values of the 
model compound, TTZ-DMF titration in D2O, which suggests significant interaction 
between 54PYT and DMF in solution, and points to a good DMF and potentially 
protein binder. 
Table 7.12. Calculated G of 54PYT-DMF binding in D2O environment based on three (3) different binding 
models. 
[H]:[G] 
binding model 
K1 (±% error) K21 (±% error) K12 (±% error) Gfor K21 
5P4YT:DMF 0.66 M-1 
(±5.9%) 
N/A N/A +1.2 kJ mol-1 
2(54PYT):DM
F 
1.0 x 10-3 M-1 
(±6.0%) 
1469 M-1 
(±0.6%) 
N/A -18.1 kJ mol-
1 
54PYT:2DMF 0.2 M-1 
(±4.3%) 
N/A -0.29 M-1 (±-
5.0%) 
N/A kJ mol-1 
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7.4 Chapter conclusion  
We have investigated TTZ-DMF titration aimed towards stable solvate 
formation by utilising our method. We have found TTZ to show a strong binding 
constant and the corresponding G, confirming the existence of TTZ respective 
crystalline hydrate and solvate forms. The K value of 2155 M-1 (calculated to G of 19 
kJ mol-1) obtained for TTZ-water titration in DMSO is comparable to the values 
obtained in chapter 5, during the probe of compounds having the ability to form stable 
hydrates. The obtained K value hence hints towards the existence of a stable TTZ 
crystalline hydrate form, which may or may not be the reported 1.5 hydrate as its 
stability is unknown. TTZ-water titration reiterates our method’s ability to screen 
hydrate and the data obtained is added to our hydrate-gauge library (Figure 7.41). 
 
Figure 7.41. G of TTZ and its placement on our hydrate gauge with respect to previously analysed compound 
using our titration method 
The TTZ-DMF titration also revealed that the procedure used is flexible and 
can be applied to guests other than water. The high K value obtained in TTZ-DMF-d7 
titration of 2229 M-1 (calculated to G of 19.1 kJ mol-1) in water environment and 1057 
(protiated) and 1145 M-1 (deuterated, calculated to G of 17.25 and 17.45 kJ mol-1 
respectively) in acetone environments reflects well the claimed existence of an 
extremely stable DMF solvate. What is more impressive, the K value from DMF 
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titration in D2O is even larger than the K value for TTZ-water titration in DMSO-d6, 
which is already quite significant.  
Further use of our procedure is probed, as strong and weak interaction between 
the amide solvent (DMF), and four different compounds with different protein binding 
ability was successfully distinguished, in aqueous and acetone solution. The 
consistently high values obtained for DMF titration of > 1000 M-1 which corresponds 
to G of <-17 kJ mol-1 for compound showing good protein binding ability (TTZ, 
2C4HBA and 54PYT), sets the lower limit for significance of DMF binding, regardless 
of the used solvent, D2O or acetone-d6. We also consistently saw higher peak shift 
magnitude to proton which is closer to the interaction point vs proton further away, 
which helps in identifying the functional group at play with the respective guest. In the 
TTZ-water titrations regardless of the environment, DMSO or DMF, the protons on 
the ring which is closer to the OH consistently have higher peak shift magnitude. While 
for compound having the NH 5-membered ring, in DMF titration, protons which are 
at closer proximity to this ring would experience bigger peak shift magnitude.  
Overall, the method used is able to reflect on the existence of the stable TTZ-
DMF solvate formation. Though we have shown positive correlation between the 
solution and the solid state with respect to solvate prediction, a larger scope and variety 
of solvate-forming compound analysed by our method would confirm, and expand the 
use of our method predict solvate formation. Using DMF as the guest, we were able to 
probe the binding of four compounds to DMF, and the result obtained thus far reflect 
on the protein-binding ability of those compound. This means that DMF can be used 
as a proteomimetic agent and be used an early screening tool for other relevant 
compounds or pharmacophore fragments. On the grand scheme of things, the result 
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opens up door for other uncharged guest to be used, allowing probe into pre-nucleation 
aggregates and subsequent prediction of the solid phase. For hydrate prediction, the 
grey area between hydrate-forming and non-hydrate forming is becoming clearer with 
every compound analysed using our method and updated into our library. With enough 
database, distinction between weak and strong hydrate can also be made.  
Table 7.13. All K21 or K12 and G for all the probed compounds. 
[H]:[G] binding model K, K21 or 
K12
G Our prediction 
and 
conclusion 
Hydrate/Actual 
protein binding 
ability 
2TTZ:H2O in DMSO-d6 2155 M-1 -19 kJ mol-1 YES for 
hydrate 
1.5 hydrate 
2TTZ:H2O in DMF-d7 4.7 M-1 -3.8 kJ mol-1 N/A N/A 
TTZ:2DMF-d7 in DMSO 34.9 M-1 -8.8 kJ mol-1 Unclear DMF solvate 
2TTZ:DMF-d7 in D2O 2229 M-1 -19.1 kJ mol-1 Stable solvate 
Good DMF 
binder 
DMF solvate 
Good protein 
binder 
2TTZ:DMF in ACO-d6 1057 M-1 -17.25 kJ mol-1 Good DMF 
binder 
Good protein 
binder 
2TTZ:DMF-d7 in ACO-
d6 
1145 M-1 -17.45 kJ mol-1 Good DMF 
binder 
Good protein 
binder 
2C4HBA:2DMF in D2O* 168 M-1 -12.7 kJ mol-1 Unclear Hydrate 
present Good 
protein binder 
2(2C4HBA):DMF in 
ACO-d6 
1508 M-1 -18.1 kJ mol-1 Good DMF 
binder 
Good protein 
binder 
PHBA: DMF in D2O 1.7 M-1 -1.3 kJ mol-1 High error fit Unclear 
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2PHBA:DMF in ACO-d6 13.5 M-1 -6.4 kJ mol-1 Not a good 
DMF binder 
Unclear 
2(5PHT):DMF in ACO-
d6 
3.8 M-1 -3.3 kJ mol-1 Not a good 
DMF binder 
Not a good 
protein binder 
2(54PYT):DMF in D2O 1469 M-1 -18 kJ mol-1 Good DMF 
binder 
Good protein 
binder 
*2C4HBA K12, ** PHBA K11  
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